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ABSTRACT 
 
Normal mechanical loading potently induces bone formation mediated by 
osteocyte effects on osteoblasts. Current in vitro bone models do not reflect these 
cellular interactions, either focusing on mechanical loading of osteoblasts in 
monolayers or in 3D and therefore not elucidating the osteocyte-osteoblast 
interactions that regulate mechanically-induced bone formation. Adenosine, calcium-
sensing and glutamate signalling have been shown to influence bone biology, with 
both adenosine precursors and glutamate having been implicated in 
mechanotransduction. The aims were to develop a novel in vitro 3D co-culture model 
of bone to investigate mechanically-induced signalling, and to determine the 
expression of adenosine, calcium-sensing and glutamate signalling components 
within the 3D model and their contribution to the regulation of mechanically-induced 
bone formation markers. 
A 3D model was developed as a two-phase culture system where MLO-Y4 
osteocytes were embedded within type I collagen gels and MC3T3-E1osteoblasts 
were layered on top.  In this model, cells were viable over 7 days (100 % osteoblasts, 
87 % osteocytes), maintained appropriate morphology and contacted neighbouring 
cells through CX43 labelled projections. RT-qPCR revealed Runx2, OCN and E11 
mRNA expression in both osteoblasts and osteocytes. COL1A1 mRNA expression 
was significantly higher in the osteoblasts (P=0.0001), whereas ALP mRNA was 
higher in the osteocytes (P=0.001). RT-PCR revealed expression of adenosine 
receptors A2A and A2B and glutamate transporter GLAST1 in osteoblasts and 
osteocytes, as well as glutamate receptors AMPAR2 and KA1 in osteocytes. 
Immunostaining confirmed expression of A2A, GLAST1 and KA1, and revealed 
expression of CaSR, in both osteoblasts and osteocytes.  
A novel mechanical loading device was developed which was used to apply 
osteogenic loads (5 min, 10 Hz, 2.5 N) to 3D osteocyte mono-cultures and 3D 
osteocyte-osteoblast co-cultures. A minimum of 48 hr pre-load time was required for 
a reliable load response. 3D osteocyte mono-cultures cultured for 48-72 hr or 7 days 
pre-load, remained viable, significantly increased PGE2 0.5 hr after load (48-72 hr: 
P=0.0249, 7 days: P=0.041) and decreased their IL-6 synthesis. RT-qPCR revealed 
a load-induced decrease in E11 (P=0.018) and RANKL (P=0.0486) mRNA, in 48-
72 hr cultures. In 7 day cultures, E11 mRNA (P=0.041) increased as a result of 
loading. Preliminary data showed that the same loading conditions increased PINP 
synthesis, a bone formation marker, in 3D co-cultures (P=0.022). The AMPA/KA 
receptors antagonist NBQX increased PINP synthesis by 2-fold over 5 days, similar 
levels induced by loading in untreated cultures, suggesting that NBQX has similar 
anabolic effects as mechanical stimuli. Similarly, the A2A receptor antagonist SCH 
442416 increased osteoblast ALP mRNA expression by 3.5-fold at day 1 post-load 
and increased PINP synthesis by 1.9-fold, in co-cultures after 5 days. 
This 3D osteocyte-osteoblast co-culture model represents a useful in vitro 
model for the investigation of the osteocyte-osteoblast interactions that lead to 
mechanically-induced signalling and regulation of bone formation markers. 
Adenosine, calcium-sensing and glutamate signalling components are expressed 
within the model, facilitating future investigations of their roles in mechanically-
induced signalling. Preliminary experiments indicated that adenosine and glutamate 
signalling may each contribute individually to the regulation of mechanically-
induced bone formation markers.  
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CHAPTER 1 
 
INTRODUCTION 
                  Chapter 1 
1. Introduction 
 
1.1 Bone structure  
 
The mature human skeleton has 213 bones, excluding sesamoid bones (bones 
within a tendon, e.g. patella). Bones are composed of a hard outer-layer of cortical 
bone (80%) and a spongy inner layer of trabecular bone (20%) (Standring, 2004). 
Cortical bone is found in external bone surfaces and in the diaphysis (Figure 1.1A), 
whereas trabecular bone is found in the marrow space and in the epiphysis (Figure 
1.1A). However, the molecular and cellular composition of cortical and trabecular 
bone are the same (White and Folkens, 1999, Clarke, 2008). 
 
Cortical bone contains osteons (Figure 1.1B) (Bourne, 1972), each composed 
of concentric circles or lamellae of bone matrix (Figure 1.1B). Between lamellae, 
small cavities called lacunae (Figure 1.1B) contain osteocytes, and minute fluid-
filled passageways known as canaliculi (Figure 1.1B), extend from one lacuna to 
another and from the Harvesian canal to each lacuna. This allows cells in the 
mineralised matrix to communicate and undergo nutrient/waste exchange (Bourne, 
1972, White and Folkens, 1999). Harvesian canals are hollow channels within 
osteons through which blood and lymph vessels, together with nerve fibres, pass. 
Smaller Volkmann canals link osteons and supply nutrients to all cells (White and 
Folkens, 1999), running perpendicular to the sheath of connective tissue covering the 
outer bone surface (periosteum) (Figure 1.1A and B),  and the cellular membrane 
covering the inner bone surface (endosteum) (Figure 1.1A) (White and Folkens, 
1999, Standring, 2004, Clarke, 2008).  
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Figure 1.1 Bone structure. A) Diagram of a partially sectioned humerus. B) Diagram representing the structure of compact bone 
(Tortora and Derrickson, 2006).  This material is reproduced with permission of John Wiley & Sons, Inc. 
2 
Chapter 1 
1.2 Bone constituents 
 
1.2.1 Bone matrix 
 
  The mechanical properties of bone result from the composition of its matrix 
which has an organic and a mineral component (Currey, 1984, Weiner, 1986, Weiner 
and Traub, 1986). The mineral component of mature bone consists of inorganic 
mineral salts (Doty et al., 1976, Glimcher, 1981), with the major component being an 
analogue of hydroxyapatite: Ca10(PO4)6(OH)2, but it also contains calcium 
carbonate, calcium fluoride and magnesium phosphate (Posner, 1987, Glimcher, 
1992, Standring, 2004). It is the mineral phase that gives bone its rigidity and load-
bearing strength, making it able to withstand compression but not twisting or bending 
(Currey, 1984, Landis, 1995). The organic phase of mature bone consists mainly of 
proteins with type I collagen (ColI) being the major component. However, it also 
includes lipids, glycoproteins and proteoglycans (Tracy et al., 1987, Robey et al., 
1988). Traces of other collagen types such as II, V and XI are also present which 
may derive from vascular tissues (Leushner, 1983, Robey et al., 1992). Non-
collagenous proteins present in bone matrix include osteocalcin (OCN), osteopontin 
(OPN) and fibronectin (Stevenson and Lindsay, 1998). It is the organic phase that 
gives bone its elasticity, making it able to withstand twisting and bending, but not 
compression (Currey, 1984). Mineral and organic phases interact so that collagen 
fibres provide a scaffold in which mineral crystals can form in between the fibres 
(Martini et al., 2011).  
 
1.2.2 Bone cells 
 
1.2.2.1 Osteoblasts 
 
Osteoblasts were first identified as large, mononucleated cells situated on the 
bone surface by Gegenbaur in 1864, who suggested that these cells were responsible 
for the manufacture of bone matrix (Bourne, 1972) (Figure 1.2). 
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1.2.2.1.1 Morphology 
 
Osteoblasts  range in shape from ovoid to cuboidal (Figure 1.2), being more 
compact than, for example, connective tissue fibroblasts which are more elongated 
(Bourne, 1972). Cytoplasmic processes extend out of osteoblast cell bodies 
connecting them to  nearby cells such as other osteoblasts, pre-osteoblasts and 
osteocytes (Bourne, 1972). Active osteoblasts usually form a single cell layer, laying 
perpendicular to the bone surface (Bourne, 1972) (Figure 1.2), with their nuclei 
uppermost and away from the bone surface (Bourne, 1972). However, osteoblasts 
may also lie with their long axis parallel to the bone surface, diagonally overlapping 
like roof tiles (Bourne, 1972), or be organised into a rosette fashion, as seen at 
growing points of trabeculae. Osteoblasts have a large Golgi apparatus and rough 
endoplasmic reticulum, and numerous mitochondria, typical of high metabolic 
activity and secretion (Bourne, 1972).  
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BONE MARROW 
Figure 1.2 Osteoblasts. Cuboidal bone forming osteoblasts (arrows) can be seen 
aligned perpendicular to the bone surface, with a thick layer of newly formed 
osteoid underneath. *Osteocytes within mineralised bone matrix. Figure adapted 
from Russ Turner, the American Society for Bone and Mineral Research 
(ASBMR).  
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1.2.2.1.2 Function  
 
Osteoblasts are actively involved in bone formation through the synthesis of 
bone matrix by generating osteoid (unmineralised bone matrix) (Bourne, 1972, 
Parfitt, 1977). They produce ColI and non-collagenous proteins such as OCN, bone 
sialoprotein (BSP), OPN and osteonectin (ON) (Lian et al., 1999, Aubin et al., 2006). 
Osteoblasts also show high alkaline phosphatase (ALP) activity, an enzyme involved 
in mineralisation, on their plasma membrane suggesting that they not only produce 
osteoid, but they also mineralise it (Whyte, 1994, Mornet et al., 2001, Nakamura, 
2007). These proteins are all highly expressed by osteoblasts compared to other bone 
cells and are therefore considered osteoblast phenotypic markers (Aubin et al., 2006). 
Other markers include runt-related transcription factor 2 (Runx2) and osterix, which 
are essential for osteoblast differentiation (Nakashima et al., 2002, Komori, 2010). 
Osteoblasts synthesise and secrete proteoglycans and glycoproteins which can bind 
calcium ions for calcification, and control the growth of hydroxyapatite avoiding 
excess calcification (Lian et al., 1999). Osteoblasts also regulate the activity of 
osteoclasts and bone growth through the secretion of various hormones, such as 
prostaglandins and cytokines. Mature osteoblasts may die, become embedded in the 
bone matrix and differentiate into osteocytes, or become quiescent bone lining cells 
(Parfitt, 1987, Miller et al., 1989). 
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1.2.2.2 Osteoclasts 
 
 Osteoclasts were first described by Robin in 1849, who distinguished them 
from megakaryocytes (Bourne, 1972). However, it was Kölliker in 1873 who 
suggested that osteoclasts are the main agents in bone resorption (Bourne, 1972) 
(Figure 1.3).  
 
1.2.2.2.1 Morphology 
 
 Osteoclasts are large multinucleated cells (Figure 1.3) which result from the 
fusion of monocyte macrophage lineage cells (Cormack and Ham, 1987) in the 
presence of macrophage colony stimulating factor (M-CSF) and receptor activator of 
nuclear factor κB ligand (RANKL), a member of the tumour necrosis factor (TNF) 
family (Felix et al., 1990, Kodama et al., 1991, Suda et al., 1992, Nakagawa et al., 
1998). Osteoclasts attach to bone to commence resorption. They are motile cells and 
so their shape varies. They can appear as flattened cells against bone or as a roughly 
spherical mass (Figure 1.3). Their many nuclei are usually found close together and 
their cell body may contain processes or be separated into lobes (Bourne, 1972). 
Active osteoclasts are polarised with an apical plasma membrane in contact with 
bone and a basolateral membrane opposite to it (Mulari et al., 2003). The apical 
membrane contains a ruffled or brush border, which increases surface area for 
resorption (Bourne, 1972); and a sealing zone which anchors the osteoclast to the 
bone restricting protons and enzymes to the resorption compartment (Vaananen et 
al., 2000, Nakamura, 2007). The basolateral membrane is involved in cell-cell 
communication with neighbouring cells through RANKL and osteoprotegerin (OPG) 
(Bourne, 1972, Vaananen et al., 2000). Osteoclasts contain many mitochondria, 
indicative of active bone resorption (Bourne, 1972). 
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Figure 1.3 Osteoclasts. Multinucleated, roughly spherical, bone resorbing osteoclasts 
(*) can be seen within the erosion cavity (dotted line) on the bone surface. 
Osteoblasts (arrows) can be seen perpendicular to the bone surface. Figure adapted 
from Russ Turner, ASBMR.  
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1.2.2.2.2 Function 
 
Osteoclasts resorb bone (Bourne, 1972) by attaching to the bone matrix and 
forming a closed compartment. This is where they pump out hydrogen ions, lowering 
the pH leading to the mobilisation of the mineral component of the bone matrix 
(Silver et al., 1988, Delaisse et al., 1991, Blair et al., 1993, Delaisse et al., 1993, 
Goto et al., 1993, Wucherpfennig et al., 1994, Holliday et al., 1997). Osteoclasts then 
secrete enzymes including tartrate-resistant acid phosphatase (TRAP), cathepsin K 
and gelatinase, which digest the organic component of the bone matrix forming an 
erosion cavity (Delaisse et al., 2003). This process of resorption, together with 
formation and activation of osteoclasts, is induced by RANKL (Boyle et al., 2003, 
Blair and Athanasou, 2004), a membrane bound protein expressed by osteoblasts 
(Atkins et al., 2003, Singh et al., 2012) and osteocytes (Zhao et al., 2002, Nakashima 
et al., 2011). RANKL binds to RANK, a surface membrane receptor present in pre-
osteoclasts and osteoclasts (Lacey et al., 1998, Yasuda et al., 1998b). OPG, a soluble 
decoy receptor for RANKL secreted by osteoblasts and osteocytes, competes with 
RANK for RANKL binding (Yasuda et al., 1998a, Yasuda et al., 1998b) and 
therefore inhibits bone resorption and osteoclastogenesis (Mizuno et al., 1998). 
TRAP, RANK and cathepsin K are osteoclast phenotypic markers; whereas the 
RANKL/OPG ratio is an indicator of activation of bone resorption (Grimaud et al., 
2003). 
 
1.2.2.3 Osteocytes 
 
 Osteocytes are the most abundant cell type in mature bone where there are ten 
times more osteocytes than those of osteoblasts (Parfitt, 1977). They are terminally 
differentiated, non-proliferative cells derived from mature osteoblasts that are 
synthesising osteoid (Dudley and Spiro, 1961, Baud, 1968, Palumbo, 1986). 
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1.2.2.3.1 Morphology 
 
 Osteocytes are dendritic cells encased within lacunae in the bone matrix 
(Figure 1.4). In the adult human, osteocyte cell bodies are smaller than osteoblasts; 
they have lost many of their organelles (Jande and Belanger, 1973, Irie et al., 2008) 
and contain a sparse endoplasmic reticulum and an underdeveloped Golgi apparatus, 
typical of low amounts of synthesis and secretion (Bourne, 1972, Mullender et al., 
1996). Osteocytes produce E11, a glycoprotein involved in the formation and 
maintenance of dendritic processes (Wetterwald et al., 1996, Hadjiargyrou et al., 
2001), which extend and retract through canaliculi allowing communication between 
adjacent osteocytes, bone marrow and surface bone cells (Doty, 1981, Menton et al., 
1984, Palumbo et al., 1990) (Figure 1.4). The dendritic processes are able to connect, 
disconnect and re-connect with neighbouring cells (Zhang et al., 2006). Osteocytes 
interconnect through gap junctions, for example connexin 43 (CX43), at the ends of 
their processes which are essential for osteocyte activity, maturation and survival 
(Baud, 1968, Doty, 1981, Knothe Tate et al., 2004). Osteocytes reside within the 
lacunocanalicular system (LCS) (Plotkin et al., 2002) which permits metabolic traffic 
and exchange.  
 
1.2.2.3.2 Function 
 
Osteocytes have many functions in bone, which depend on the maturation 
state of the cell. Genes that distinguish osteocytes from osteoblasts are those 
expressed by mature osteocytes, such as fibroblast growth factor 23 (FGF23) and 
sclerostin (SOST) (Bonewald, 2011) (Figure 1.5). 
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Figure 1.4 Osteocytes. Dendritic osteocytes can be seen extending their long 
processes within the bone matrix forming an osteon. Figure by Tim Arnett, from the 
Bone Research Society. 
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Figure 1.5 Expression of markers during osteoblast-to-osteocyte differentiation. 
Osteoblasts express Runx2 for differentiation, and ColI and ALP for matrix synthesis. 
OCN is expressed by late osteoblasts and continued to be expressed by osteocytes. 
Some osteoblasts are then embedded within the osteoid and become osteoid 
osteocytes where they develop dendritic processes through the expression of E11. At 
this stage, mineralisation markers phosphate-regulating gene with homologies to 
endopeptidases on the X chromosome (PHEX) and matrix extracellular 
phosphoglycoprotein (MEPE) begin to be expressed followed by dentin matrix 
protein 1 (DMP1). Finally mature osteocytes express FGF23 and SOST. Figure 
adapted from (Bonewald, 2011).  
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1.2.2.3.3 Mechanotransduction 
 
Osteocytes are ideal candidate cells within bone to detect and respond to the 
physical stimuli from forces exerted on bones, because of their abundance, 
morphology, position within bone and ability to form an extensive network 
(Mullender and Huiskes, 1997, Nomura and Takano-Yamamoto, 2000, Plotkin et al., 
2002, Turner et al., 2002, Klein-Nulend et al., 2013). Furthermore, osteocytic 
processes are considered the principal structure involved in sensing mechanical 
stimuli and they are mainly composed of actin filaments which may have an 
important role in mechanosensing (You et al., 2001, McGarry et al., 2005). 
Osteocytes also have primary cilia (Xiao et al., 2006, Malone et al., 2007) which, as 
in other cell types, have been shown to be involved in mechanosensing (Hoey et al., 
2011, Xiao et al., 2011, Nguyen and Jacobs, 2013). In addition, proteins involved in 
the connection of osteocytes to surrounding cells and/or the extracellular matrix 
(ECM), like focal adhesions, CX43 and integrins, have been found to be involved in 
osteocyte response to mechanical stimuli (Litzenberger et al., 2010, Zhang et al., 
2011). Consequently, osteocytes have been shown to respond to loading in vivo and 
in vitro and details of these studies can be found in page 34. 
 
1.2.2.3.4 Regulation of bone remodelling 
 
There are many factors that regulate bone remodelling, including systemic 
factors such as calcitonin, which inhibits osteoclast resorption (Zaidi et al., 2002); 
parathyroid hormone (PTH), which not only induces osteoclastic bone resorption and 
stimulates renal calcium reabsorption to balance serum calcium levels (Talmage and 
Elliot, 1958), but also induces bone formation (Selye, 1932, Dempster et al., 1993) 
(page 18), vitamin D3  which indirectly regulates bone resorption through osteoblasts 
(Baldock et al., 2006, Crockett et al., 2011) and oestrogen, which regulates osteoclast 
(Nakamura et al., 2007, Krum et al., 2008) and osteocyte (Tomkinson et al., 1997, 
Tomkinson et al., 1998, Mann et al., 2007) survival .  
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Osteocytes are thought to regulate bone formation by orchestrating the 
formation and activity of osteoblasts and osteoclasts (Klein-Nulend et al., 2013) 
(page 34). Osteocytes release prostaglandins and bone morphogenetic protein 2 
(BMP2), which stimulate osteoblast recruitment and activity (Li et al., 2002, Rawadi 
et al., 2003). Osteocytes also regulate bone formation through components of the 
wingless related integration site (Wnt) signalling pathway. SOST is an osteocyte 
specific protein (Poole et al., 2005) and a Wnt signalling pathway antagonist, which 
inhibits bone formation by preventing osteoblast differentiation (Winkler et al., 2003, 
van Bezooijen et al., 2004, Poole et al., 2005, van Bezooijen et al., 2005, Lowik and 
van Bezooijen, 2006, van Bezooijen et al., 2007). The Wnt signalling pathway 
stimulates osteoblast differentiation and SOST inhibits this pathway by binding to 
low density lipoprotein receptor-related protein 5/6 (LRP5/6) (Li et al., 2005c, 
Semenov et al., 2005, Semenov and He, 2006). SOST expression is responsive to 
mechanical stimulation (Robling et al., 2008). Inactivating mutations in the SOST 
gene lead to a high bone mass phenotype in mice (Li et al., 2008) and humans 
(Balemans et al., 2002) (page 18). 
 
Osteocytes have also been shown to support osteoclast formation and 
activation as they express large amounts of RANKL, OPG and M-CSF along their 
processes which come into contact with marrow cells (Kamioka et al., 2001, Zhao et 
al., 2002, You et al., 2008, Nakashima et al., 2011, Xiong et al., 2011). Furthermore, 
osteocyte apoptosis is thought to trigger bone resorption signals in defined areas of 
microdamage (Noble, 2003). Osteocytes undergo apoptosis before osteoclasts start 
the bone resorption process, suggesting that a signal is generated from dying 
osteocytes to trigger osteoclastic resorption (Noble et al., 1997, Verborgt et al., 2002, 
Noble, 2003). It is important to note that osteocyte apoptosis is a common event in 
both healthy and unhealthy bone (Noble et al., 1997), is age related (Frost, 1960, 
Dunstan et al., 1990), but it can also be triggered by disruption of cell-cell and cell-
matrix interactions (Xing and Boyce, 2005). However, it is reduced by mechanical 
stimulation (Plotkin et al., 2005).  
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1.2.2.3.5 Mineralisation 
 
Osteocytes express low levels of ALP. However, they can regulate 
mineralisation and phosphate metabolism through the expression of phosphate-
regulating gene with homologies to endopeptidases on the X chromosome (PHEX), 
found in osteoid osteocytes (Bonewald, 2011); matrix extracellular 
phosphoglycoprotein (MEPE), which influences mineralisation through activation of 
BMP2 (Rowe et al., 2004), also found in osteoid osteocytes (Petersen et al., 2000); 
dentin matrix protein 1 (DMP1), involved in hydroxyapatite formation  and found in 
mineralising osteocytes (Feng et al., 2003, Feng et al., 2006); and FGF23, a 
phosphaturic hormone  expressed by mature osteocytes (Feng et al., 2006) (Figure 
1.5).  
 
1.2.2.4 Bone-lining cells 
 
 Bone-lining cells are flattened in shape and cover most of the bone surfaces 
that are not undergoing remodelling. They have cytoplasmic processes that pass 
through the osteoid connecting them to mature osteoblasts and early osteocytes 
(Miller et al., 1989). Bone-lining cells have low amounts of cytoplasm, rough 
endoplasmic reticulum and free ribosomes, suggesting low metabolic activity. These 
cells form the endosteum on trabecular surfaces and are present below the 
periosteum on the cortical bone surface (Parfitt, 1994, Clarke, 2008). Elimination of 
bone lining cells, leading to exposure of bone matrix, is essential for bone 
remodelling to occur (Jones and Boyde, 1976, Zambonin Zallone et al., 1984). Bone-
lining cells are thought to be quiescent osteoblasts (Nakamura, 2007), but retain the 
ability to re-differentiate into osteoblasts (Dobnig and Turner, 1995, Leaffer et al., 
1995). These cells are joined to mature osteoblasts by adherens junctions (Shin et al., 
2000, Shin et al., 2004) and may be involved in regulation of calcium and phosphate 
movement in bone tissue, thereby acting as a bone-blood barrier (Miller et al., 1989, 
Dobnig and Turner, 1995). Bone-lining cells also aid resorption by secreting 
collagenase which removes bone matrix so osteoclasts can attach to bone (Parfitt et 
al., 1996) 
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1.2.3 Bone marrow 
 
 Bone marrow is present in the cavities of long bones and in the pores of 
trabecular bone, extending to the blood vessel canals where the blood supply of both 
bone and bone marrow are directly connected (Brookes, 1961, Standring, 2004). In 
long bones, marrow is yellow and mainly composed of fat cells, whereas in flat and 
short bones, marrow is red and is mainly composed of haematopoietic cells, 
including osteoclasts (Standring, 2004). Red marrow can also be found in the 
epiphyses of long bones (Figure 1.1A). Bone turnover and marrow composition are 
directly linked, with a higher turnover rate found in trabecular bone associated with 
haematopoietic marrow (Krempien et al., 1978, Eventov et al., 1991). Osteoclasts 
and osteoblasts differentiate from haematopoietic and non-haematopoietic stem cells 
respectively which are also present in the bone marrow (Compston, 2002). Non-
osteogenic marrow cells, such as mononuclear cells of monocyte or macrophage 
linage, regulate osteoclastogenesis and osteoclast activity through the production of 
interleukin 1 (IL-1) and TNF-α (Jilka, 1998, Pacifici, 1999, Compston, 2001). 
Megakaryocytes have also been found to be involved in bone remodelling as they 
express RANKL (Kartsogiannis et al., 1999), transforming growth factor beta (TGF-
β) and its receptors (Bord et al., 2001), as well as glutamate receptors (Genever et al., 
1999) and calcium-sensing receptors (House et al., 1997).  
 
1.3 Modelling and remodelling 
 
Bone is a dynamic tissue that undergoes modelling and remodelling.  
 
1.3.1 Bone modelling 
 
 The process of modelling, defined by Frost (1990), involves bones altering 
their overall shape as a result of growth, mechanical loading or physiological effects, 
adjusting the skeleton to its environment. Modelling may lead to the addition or 
removal of bone and/or to bones changing their axis. However, bone growth is the 
major type of modelling (Frost, 1990b, Clarke, 2008).  
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In 1892, Wolff observed that trabeculae are orientated according to the paths 
of the mechanical stresses applied to the bone. Therefore, he proposed that long 
bones adapt their shape to accommodate stresses experienced by them (Wolff, 1986).  
During modelling, bone formation and resorption are not strongly linked and occur 
continuously but at different locations in bone (Frost, 1990b, Kobayashi et al., 2003). 
Modelling is less common than remodelling in the adult human (Kobayashi et al., 
2003) but may be enhanced in several pathologies such as hypoparathyroidism 
(Ubara et al., 2005) and renal osteodystrophy (Ubara et al., 2003). Treatment with 
anabolic therapies can also increase bone modelling (Lindsay et al., 2006). 
 
1.3.2 Bone remodelling 
 
 Bone remodelling is the process by which old bone is replaced with new bone 
in order to maintain strength and mineral homeostasis. There are no changes in the 
morphology of the bone, and resorption and formation are balanced and occur in the 
same site (Frost, 1990a). Bone remodelling takes place in small groups of cells called 
‘Basic Multicellular Units’ (BMUs) (Frost, 1990b). Bone remodelling is initiated by 
the recruitment of pre-osteoclasts from the circulation (Roodman, 1999). The 
endosteum and bone lining cells are lifted to reveal the bone surface allowing pre-
osteoclasts to fuse and form large multinucleated cells which attach to the bone 
matrix. Pre-osteoclasts form a resorbing compartment and differentiate into mature 
osteoclasts (Clarke, 2008) that resorb bone matrix by releasing hydrogen ions and 
enzymes forming an erosion cavity. Osteoclasts then die and mononuclear cells 
prepare the bone surface for bone formation (Eriksen, 1986, Reddy, 2004). Bone 
formation occurs when osteoblasts begin to synthesise new organic matrix and 
regulate its mineralisation (Anderson, 2003). The new matrix (osteoid) fills in the 
erosion cavity, 70% of osteoblasts die and the rest are buried within it to differentiate 
into osteocytes, or convert into bone lining cells, and finally the osteoid is 
mineralised (Burger et al., 2003). Resorption and formation processes are thought to 
be coupled, ensuring old bone is removed and restored with new bone, therefore 
maintaining bone mass (Parfitt, 2000). 
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1.3.3 Bone diseases 
 
Common diseases occur as a consequence of abnormal bone remodelling. 
These result from an imbalance between the activities of osteoblasts and osteoclasts 
and speed of remodelling, leading to disproportionate bone formation and resorption. 
Many of these pathologies have no or limited treatments and therefore would benefit 
from alternative therapies.  
 
1.3.3.1 Osteoporosis 
 
 Osteoporosis is the most common bone disease (Raisz, 1997) and is 
characterised by decreased bone mass and weakening of the bone resulting in 
increased risk of fractures. Osteoporosis leads to accelerated bone remodelling, with 
increased rates of bone formation which are not sufficient to replace the bone lost by 
resorption (Raisz, 2005) suggesting a decrease in osteoblast activity which could be 
due to senescence or the lack of systemic and global growth factors (Raisz, 2005). 
Osteoporosis can be classified into primary type 1, primary type 2 or secondary 
osteoporosis (Rosen et al., 2008). Females are more affected than men as bone mass 
in women is lower and reduced oestrogen production causes female bone mass to 
abruptly decrease during the menopause (Riggs et al., 1986, Wark, 1993). 
Menopause-induced osteoporosis is primary type 1 osteoporosis. Primary type 2 
osteoporosis is age-related and affects 1 in 2 women and 1 in 5 men over 50 in the 
United Kingdom (UK) (van Staa et al., 2001). Secondary osteoporosis occurs as a 
result of other medical conditions, such as hyperparathyroidism, vitamin D 
deficiency, anorexia and renal disease; or prolonged use of certain medications such 
as glucocorticoids, immunosuppressants and chemotherapy (Rosen et al., 2008). 
 
Osteoporosis can also be caused by reduced mechanical loading of the 
skeleton, in which case it is known as disuse osteoporosis and is characterised by 
increased bone resorption (Weinreb et al., 1989, Bain and Rubin, 1990, Zerwekh et 
al., 1998, Rantakokko et al., 1999, Li et al., 2005a). It affects bed ridden patients and 
astronauts, who undergo reduced loading or weightlessness respectively, for long 
periods of time (Szollar et al., 1998, Kanis et al., 2001, Wang et al., 2001). 
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Most of the available osteoporosis treatments involve anti-resorptive agents 
such as oestrogen, selective oestrogen-receptor modulators (SERMs), calcitonin and 
bisphosphonates. However, none of these cause a great increase in bone mass. 
Strontium ranelate (PROTELOS®) and PTH (Teriparatide) are the only two available 
therapies that induce bone formation. Teriparatide is the only food and drug 
administration (FDA) approved drug, however it was only approved for use of up to 
2 years due to safety issues (Dempster et al., 2001, Neer et al., 2001, Rubin and 
Bilezikian, 2003, Sato et al., 2004). 
 
Oestrogen and SERMs are considered hormone replacement therapy. 
Oestrogen used to be the only pharmacological approach to osteoporosis, however 
since other therapies have been approved, it has been proposed that hormones should 
only be used for treatment of post-menopausal osteoporosis and only after all other 
treatments have been considered, due to its increased cancer risk (Rosen et al., 2008). 
SERMs were developed as an alternative to oestrogen. They are molecules that 
interact with oestrogen receptors producing similar effects to oestrogen itself, 
however, they have been linked to an increased risk of thrombo-embolic disease 
(Rosen et al., 2008). 
 
Calcitonin is a peptide secreted by thyroid gland cells which inhibits bone 
resorption as a result of increased serum calcium levels. It was first used as a 
treatment for Paget’s disease of bone (page 21), but since then it has been used for 
less severe osteoporosis and in patients who cannot tolerate newer drugs (Rosen et 
al., 2008).  
 
Bisphosphonates are internalised by osteoclasts and inhibit bone resorption 
(Russell, 2007), but their retention in bone (Lin, 1996, Khan et al., 1997, Rodan, 
1997, Papapoulos and Cremers, 2007) and association with osteonecrosis in the jaw 
(Marx, 2003, Ruggiero et al., 2004, Marx et al., 2005) have led to concerns about 
their long term use.  
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Strontium ranelate (PROTELOS®) is a drug composed of two atoms of 
strontium (Sr2+) used for post-menopausal osteoporosis. It has been suggested that 
strontium ranelate triggers bone formation by activating the calcium-sensing receptor 
(CaSR) to induce osteoblast proliferation (Brown, 2003, Coulombe et al., 2004); and 
it decreases bone resorption by downregulating RANKL and upregulating OPG 
(Marie, 2007, Brennan et al., 2009).  
 
Denosumab (Prolia®) is a monoclonal antibody against RANKL, which 
prevents osteoclast activation and inhibits bone resorption (McClung et al., 2006). It 
has no major adverse effects (Cummings et al., 2009) and is FDA approved for the 
treatment of osteoporosis in post-menopausal women (McClung et al., 2006, 
Cummings et al., 2009) and osteoporotic men.  
 
Teriparatide is a recombinant fragment of human parathyroid hormone 
(rhPTH1-34), the main regulator of bone and kidney calcium and phosphate 
metabolism, and is used for the treatment of advanced osteoporosis for a maximum 
of 18 months. However, its association with increased osteosarcoma risk in animals 
(Vahle et al., 2004, Schneider et al., 2005, Tashjian and Gagel, 2006) has limited its 
use.  
 
Rare autosomal recessive inherited bone disorders, such as sclerosteosis and 
Van Buchem disease, which are caused by loss of function mutations in the SOST 
gene (Balemans et al., 1999, Balemans et al., 2001, Brunkow et al., 2001, Winkler et 
al., 2003, van Bezooijen et al., 2004)  or SOST enhancer (Balemans et al., 2002, 
Staehling-Hampton et al., 2002, Loots et al., 2005) respectively, result in increased 
bone formation without affecting bone resorption. The study of these diseases has led 
to the development of monoclonal antibodies against sclerostin which mimic its 
downregulation (Li et al., 2009, Papapoulos, 2011). 
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1.3.3.2 Paget’s disease of bone 
 
 Paget’s disease of bone is characterised by accelerated and disorganised bone 
remodelling in localised areas of  bone, as a result of highly increased bone 
resorption and formation (Kanis, 1998, Cundy and Reid, 2012, Ralston and Layfield, 
2012). This rapid bone remodelling leads to woven bone formation, which has 
reduced mechanical strength than normal bone (Ralston and Layfield, 2012). Paget’s 
disease affects one or more bones such as the femur, lumbar spine, skull and tibia, 
with the pelvis being the most common (Kanis, 1998). It is prevalent in middle-aged 
and older people with up to 8 % of men and 5 % of women by the age of 80 being 
affected in the UK (van Staa et al., 2002, Haddaway et al., 2007). Paget’s disease can 
be asymptomatic, or present with bone pain, secondary arthritis, pathological 
fractures and larger distorted bones. If the skull is affected, it can also cause deafness 
and increasing hat size (Cundy and Reid, 2012). It is also associated with increased 
risk of osteoarthritis, back pain and reduced quality of life (Langston et al., 2007). 
Paget’s disease is usually treated with potent bisphosphonates which lead to long-
term suppression of the disease (Reid et al., 2005). 
 
It has been suggested that Paget’s disease is triggered by environmental 
factors including vitamin D deficiency (Barker and Gardner, 1974),  low calcium 
intake (Siris, 1994), rural lifestyle (Merlotti et al., 2005) and, more controversially, 
viral infections such as measles, respiratory syncytial virus (Mills et al., 1984, 
Friedrichs et al., 2002, Rima et al., 2002), and paramyxovirus (Ralston et al., 2007, 
Ralston and Layfield, 2012). As reviewed in (Cundy and Reid, 2012), Paget’s 
disease of bone is also inherited as an autosomal dominant trait caused by mutations 
in the SQSTM1 gene (Morales-Piga et al., 1995, Hocking et al., 2002, Laurin et al., 
2002), which encodes a protein involved in the control of NFκB, extracellular signal 
regulated kinases (ERK), and mitogen activated protein kinase (MAPK) signalling, 
as well as transcriptional activation. In addition, common variants of other genes, 
such as CSF1, TNFRSF11A and TM7SF4, have been linked to increased risk of 
developing Paget’s disease of bone.  
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1.3.3.3 Osteoarthritis 
 
 Osteoarthritis (OA) is the most common degenerative joint disease in the UK, 
affecting 1 million people per year. OA usually develops in people over the age of 50 
and is more common in women than men, however younger people can also be 
affected. OA is characterised by joint pain and stiffness associated with loss of 
articular cartilage, the formation of osteophytes (bony outgrowths) and subchondral 
bone sclerosis (Castaneda et al., 2012). Subchondral bone, underlying the articular 
cartilage, acts as a shock absorber, provides support (Imhof et al., 2000) and is 
subject to increased remodelling, microfractures, sclerosis and increased 
vascularisation in OA (Castaneda et al., 2012). The increased stiffness and 
thickening of the subchondral bone decreases its shock absorbing capacity, leading to 
increased mechanical load and breakdown of the articular cartilage (Radin and Rose, 
1986, Burr and Radin, 2003).   
 
Current OA treatments, such as painkillers, steroid injections, physiotherapy 
and joint replacement surgery do not stop the progression of the disease but instead 
alleviate symptoms such as joint pain, inflammation and stiffness; and so there is a 
need for disease-halting drugs. Thus, it is unsurprising that anti-osteoporotic drugs 
have been tested as possible novel OA therapies. From the previously mentioned 
osteoporosis therapies (page 18), it was found that oestrogens (Turner et al., 1997, 
Ham et al., 2002, Ho et al., 2011), bisphosphonates (Doschak et al., 2004, Hayami et 
al., 2004, Karsdal et al., 2008, Kadri et al., 2010, Moreau et al., 2011), anti-RANKL 
antibodies (Castaneda et al., 2012), Teriparatide (Chang et al., 2009) and strontium 
ranelate (Tat et al., 2011, Cooper et al., 2012, Reginster et al., 2013) improve the 
biomechanical properties of subchondral bone. 
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1.3.3.4 Rheumatoid arthritis 
 
 Rheumatoid arthritis (RA) is the second most common degenerative joint 
disease in the UK, with 580,000 people affected in England and Wales. RA usually 
develops between 40 and 70 years of age and is more common in women than men, 
however RA can affect people of any age. RA is an autoimmune disorder 
characterised by chronic systemic inflammation of various tissues and organs, but 
mainly of the synovial joints. It is also associated with cardiovascular, pulmonary 
and psychological disorders. Joint pathology includes destruction of cartilage and 
subchondral and periarticular bone (Goldring, 2003, McInnes and Schett, 2011). 
Focal erosions in RA bone are associated with osteoclasts (Bromley and Woolley, 
1984, Gravallese et al., 1998) and do not form in RA animal models unable to 
produce mature osteoclasts (Pettit et al., 2001, Redlich et al., 2002, Li et al., 2004a).  
 
There is no cure for RA but it is managed with a combination of surgery, 
physiotherapy, painkillers, and drugs such as non-steroidal anti-inflammatory drugs 
(NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), biological response 
modifiers (BRMs), anti-cytokines, such as TNF inhibitors, and steroids, depending 
on the severity of RA and patient responses (Goldring, 2003, Geiler et al., 2011, 
McInnes and Schett, 2011). Denosumab (Prolia®) (page 18) has been in clinical trials 
for the treatment of RA, where it has been shown that it attenuates the development 
and progression of bone erosions in RA patients (Cohen et al., 2008, Deodhar et al., 
2010). 
 
1.4 Mechanical loading in bone 
 
1.4.1 The mechanostat theory 
 
 Bones must tolerate voluntary physical activities without breaking. There are 
physical and biological factors which act together to strengthen bones enough to 
sustain load-bearing (Frost, 1987b, Frost, 1998). Physical factors include the cross-
sectional area, bone size and shape; tissue distribution and presence of microdamage 
(Martin and Burr, 1989, Martin, 1991). Bone modelling and remodelling, and 
microfracture repair are the biological determinants (Parfitt, 1983). 
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The mechanostat theory originates with Frost’s proposal (1964) of a 
minimum effective strain (MES), strain being a measure of how much bone deforms 
in response to force application (Skerry, 2008a). There are a range of strain values 
that will not induce an adaptive response to mechanical load (Figure 1.6A). A single 
strain above this range (MES) leads to an increase in bone mass (Figure 1.6B), 
whereas, a strain below this range leads to loss of bone mass (Figure 1.6C). The 
mechanostat theory also states that strains above 1500 microstrain (µε) stimulate 
modelling-induced bone formation (Figure 1.6D); and remodelling-induced bone loss 
occurs at strains below 100 µε (Figure 1.6E). It is because of the difference in strain 
values that modelling and remodelling are not stimulated at the same time on the 
same bone surface (Frost, 1987a, Ferretti et al., 1995, Frost, 1996, Frost, 1998). Even 
though the forces suffered in limb bones of animals decrease as a function of body 
size, for example 6.9 G in a 7 kg turkey and 0.8 G in a 2500 kg elephant; the peak 
strains in vertebrates ranging from horses and humans to turkeys and dogs, are very 
similar ranging from 2000-3500 µε (Rubin and Lanyon, 1984a, Rubin and Lanyon, 
1984b, Rubin et al., 1990).  
 
The mechanostat theory inspired Frost to generate the ‘Utah paradigm of 
skeletal physiology’ which proposed the following (Frost, 1996):  
1) Skeletal health and disease is determined by biological mechanisms requiring 
effector cells and non-mechanical stimuli. 
2) Biological mechanisms are guided by biomechanics. 
3) Biological mechanisms are dominated by neuromotor anatomy and 
physiology after birth. 
4) Non-mechanical factors can facilitate or hinder mechanical control but cannot 
replace or duplicate it. 
This paradigm was the first to account for the significant effects of mechanical 
loading on bone structure, changing the dogma in bone physiology. 
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Figure 1.6 The effect of mechanical strain on bone mass. The graph shows bone 
mass is maintained with moderate strain (A), increased with strains higher than 
2000-3000 µε (B), and lost with trivial strains (C).  The graph also shows mechanical 
strains at which modelling (D) and remodelling (E) occur. MES: minimum effective 
strain. Figure adapted from (Bailey et al., 1996). 
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Bone adapts to its environment by regulating its own mass (Lanyon and 
Smith, 1970, Lanyon, 1973, Lanyon et al., 1975, Jones et al., 1977, Goodship et al., 
1979, Woo et al., 1981, Rubin and Lanyon, 1984b). This dynamic link between bone 
structure and its mechanical environment (Lanyon and Smith, 1970, Lanyon, 1973, 
Lanyon et al., 1975) is seen in tennis players whose humeri in their ‘racquet arm’ 
tends to have 35 % higher bone mass than in their other arm (Lanyon et al., 1975, 
Jones et al., 1977, Haapasalo et al., 2000, Kontulainen et al., 2003), and in astronauts 
who experience long periods of weightlessness (Baldwin et al., 1996, Goodship et 
al., 1998, Carmeliet et al., 2001), or patients subject to paralysis or prolonged bed 
rest (Gross and Rubin, 1995) resulting in reduced bone mass. 
 
Early bone loading experiments in avian ulnae (Rubin and Lanyon, 1984b) 
showed that adaptive (re)modelling is largely responsive to short periods of high 
strain suggesting that it is a process controlled by signals to which bone is not 
accustomed (Skerry, 2008a). Short periods of high strain (Rubin and Lanyon, 
1984b), high strain rates (Mosley and Lanyon, 1998) and periods of rest interrupting 
strain cycles (Robling et al., 2000) all increase osteogenic potential (Skerry, 2008a). 
 
1.4.2 Mechanical loading models  
 
1.4.2.1 In vivo models 
 
The starting point for developing mechanical loading models requires 
assessment of strains experienced in vivo. This has been done by attaching strain 
gauges directly onto the bone surfaces of sheep (Lanyon, 1973), horses (Rubin and 
Lanyon, 1982, Gross et al., 1992), turkeys (Rubin and Lanyon, 1985, Adams et al., 
1997), goats (Roszek et al., 1993), dogs (Rubin and Lanyon, 1982) and even humans 
(Lanyon et al., 1975, Hillam et al., 1996), in order to measure the strains engendered 
during daily activities. Although the attachment of strain gauges to bone in vivo has 
proven to be very useful for the study of load, bone growth and adaptation, this 
method is invasive and only measures strains. Non-invasive loading models, such as 
the rat ulna, mouse tibia, rodent vertebrae and tail suspension models, have been 
developed to study bone mechanotransduction and are briefly described below. 
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1.4.2.1.1 Ulna loading 
 
 The loading of a rodent ulna was first described by Torrance et al. in 1994. 
They developed a cyclic, axial loading model where the rat forearm is placed 
between two cups, holding the wrist and the elbow, and compressed in a cyclic 
manner, which elicits osteogenesis when peak physiological strains are exceeded 
(Torrance et al., 1994) (Figure 1.7A). Since then, this model has been used in many 
mechanotransduction studies. For example, it was used to show that bone resorption 
is inhibited whilst formation is stimulated by loading (Hillam and Skerry, 1995), that 
oestrogen and loading produce a greater osteogenic response together than separately 
(Cheng et al., 1994) and that the glutamate signalling pathway may be involved in 
mechanotransduction, as glutamate/aspartate transporter 1 (GLAST1) is 
mechanically regulated (Mason et al., 1997). The use of the ulna as a loading model 
has also been applied to birds (Lanyon and Rubin, 1984, Rubin and Lanyon, 1984b, 
Lanyon et al., 1986, Pead et al., 1988, Rubin et al., 1996), mice (Hsieh et al., 2001, 
Robling et al., 2008) and sheep (O'Connor et al., 1982). 
 
1.4.2.1.2 Tibial loading 
 
 The loading of a rodent tibia was first described by Seireg and Kempke in 
1969 as a technique for the investigation of degenerative and regenerative influence 
of cyclic loads on living bone (Seireg and Kempke, 1969). Rats were exposed to long 
periods of low and short periods of high cyclic loading. This model was then updated 
to the four point bending of the rat tibia, causing compression and tension on 
different areas of the bone by applying large rods directly on the skin and the 
underlying periosteum (Figure 1.7B). This method causes dense bone to form in low 
strain regions, and woven bone to form in high strain regions (Turner et al., 1991). 
Other interesting results have been found using the four point bending rat tibia 
model, such as the increase in osteocyte insulin growth factor 1 (IGF-1) mRNA 
expression (Reijnders et al., 2007b) and OPN expression (Miles et al., 1998) after 
load; and load induced cyclooxygenase 2 (COX-2) expression mediation of bone 
formation induction (Forwood, 1996).  
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1.4.2.1.3 Vertebrae loading 
 
 The loading of rodent vertebrae was first described by Chambers et al. in 
1993. In this loading model pins are inserted into the seventh and ninth caudal 
vertebrae of rats which are used to load the eighth caudal vertebra through cyclic 
compression (Chambers et al., 1993, Chow et al., 1993) (Figure 1.7C). Woven and 
lamellar bone formation could be induced with short loading regimes (Chambers et 
al., 1993), with a single 10 minute loading episode inducing 24-fold increases in 
bone formation (Chow et al., 1993). Although the vertebrae loading model is more 
invasive than ulna or tibial loading models, interesting results have been obtained 
including that oestrogen enhances osteogenic responses after load (Jagger et al., 
1996); that nitric oxide (NO) is necessary but not sufficient to induce bone formation 
(Chow et al., 1998a), and that mechanical loading induces bone formation by 
reactivating bone lining cells (Chow et al., 1998b). Mice vertebrae have also been 
used as loading models (Webster et al., 2008, Webster et al., Lambers et al., 
Wasserman et al.). 
 
1.4.2.1.4 Tail suspension 
 
 The tail suspension model was first developed in the 1970s with the aim to 
provide a gravity-based model that could mimic the effects of weightlessness 
(Morey-Holton and Globus, 1998). In this model rodents are held by a harness in a 
head-down position, so that they have the use of the front limbs for movement, 
eating, and grooming, with the hind limbs being unloaded (Morey-Holton and 
Globus, 1998) (Figure 1.7D). Studies using this model have shown that after a short 
period of unloading, there was a higher incidence of osteocyte apoptosis which 
correlated with sites of resorption suggesting that osteocyte death precedes bone loss 
(Aguirre et al., 2006), that OPN is required for bone resorption as a result of 
unloading (Ishijima et al., 2001) and that OPN is associated with NFκB during this 
process (Ishijima et al., 2006). This model was also used to show the effects of 
bisphosphonates on bone changes (Apseloff et al., 1993) (page 18).  
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Figure 1.7 In vivo bone loading models. Diagrams of the ulna (A), tibia (B), vertebrae 
(C) and tail (D) loading models, adapted from (Turner et al., 1991, Robling et al., 2001, 
Barbosa et al., 2011, Lambers et al., 2011). CV: caudal vertebra. 
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1.4.2.2 In vitro models 
 
Although cell specific knockout (KO) animal models are a powerful tool in 
unravelling specific cellular responses to mechanical loading, the in vivo bone 
environment is highly complex. Bone organ cultures, involving bone explants, have 
also been used to investigate mechanical loading responses (Davies et al., 2006, 
Rawlinson et al., 1995, Chan et al., 2009). Although organ cultures have the 
advantage of simplifying the complexity of the in vivo environment whilst 
maintaining bone cells within their native ECM, they contain a heterogeneous cell 
population, are awkward to maintain and have a limited life-span (Arnett et al., 1998, 
Pitsillides and Rawlinson, 2012). Therefore the investigation of direct cell-cell 
interactions has depended on in vitro loading models. The loading method used, the 
cell type and the cell environment all need to be considered when designing an in 
vitro bone loading model. It is the combination of these factors that will lead to a 
model which resembles a physiological situation and can therefore be used to answer 
a range of scientific questions.   
 
1.4.2.2.1 Loading methods  
 
In vitro loading models generally involve cell culture systems, which are 
subjected to mechanical stimuli such as hydrostatic pressure, fluid shear stress, or 
substrate strain in a precise manner. For this reason, many mechanical loading 
devices have been designed which range in complexity, accuracy and consistency of 
loading (Brown, 2000). Pioneering work on in vitro mechanical loading devices 
started in 1939 (Glücksmann, 1939) and quantitative devices started to be used in the 
mid-1970s. Since then a range of compression, stretch, substrate bending, distension 
and fluid shear devices, involving either contact or contactless-loading, have been 
developed (Brown, 2000). Early devices limited to low loading frequencies have 
been superseded by those that can mimic osteogenic in vivo frequencies of 10-100 
Hz (Brown, 2000, Rubin et al., 2001a). Commercially available bone loading 
systems include BOSE, FlexCell® and ZETOS. For instance, BOSE ElectroForce® 
devices allow the application of tension, compression, bending, stress, torsion or 
fluid shear to in vivo (Macione et al., 2011), ex vivo (Price et al., 2011, Xiao et al., 
2011) and three-dimensional (3D) in vitro cultures (Sittichockechaiwut et al., 2009), 
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but not to two-dimensional (2D) cell cultures. FlexCell® has a smaller range of 
devices which are only applicable to ex vivo and 2D or 3D in vitro cultures, and has 
been previously used to load 2D osteocyte cultures in vitro (Plotkin et al., 2005, 
Zhang et al., 2006). Finally, ZETOS systems have been mainly used for long term ex 
vivo loading (Davies et al., 2006, Endres et al., 2009, Aw et al., 2012). The main 
disadvantage of these industrial designs is the number of specimens or cultures that 
can be loaded at the same time. The majority of BOSE® systems can only load one 
sample at a time, with a maximum of 6 for FlexCell®.  
 
1.4.2.2.2 Cell type 
 
The majority of in vitro bone loading investigations focus on osteoblasts 
(page 32). Although osteocytes are the principal load sensors in vivo, much less 
loading research has been done on these cells (pages 9 and 34). This is possibly due 
to the limited availability of osteocytes. Primary osteocytes are difficult to isolate and 
culture due to their position within bone. To date, only chick (Nijweide et al., 2003, 
van der Plas and Nijweide, 2005), mouse (Nakashima et al., 2011, Halleux et al., 
2012, Stern et al., 2012) and rat (Gu et al., 2006) primary osteocytes have 
successfully been isolated using sequential bone digestion. Nevertheless, the yield of 
live osteocytes after digestion is low and they do not proliferate in culture, limiting 
their use for experimental procedures. Two mouse osteocyte cell lines, MLO-A5 
(osteoid pre-osteocyte) (Kato et al., 2001) and MLO-Y4 (osteocyte-like) (Kato et al., 
1997) have been developed to facilitate the study of these cells. Although MLO-Y4 
cells are ‘osteocyte-like’ (Kato et al., 1997), they do not express late-osteocyte 
markers and therefore are not a true representation of mature osteocytes. A recently 
developed osteoblast-to-late-osteocyte cell line (IDG-SW3) that expresses all mature 
osteocyte genes when differentiated, provides new potential for investigating 
osteocyte biology (Woo et al., 2011). 
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1.4.2.2.3 Cell environment 
 
Over the last three decades, the mechanisms involved in mechanically-
induced bone formation have been largely revealed by applying forces to primary 
osteoblasts or osteoblast-like cell-lines cultured in 2D monolayers. These showed 
that loading regulates osteoblast survival (Carvalho et al., 1995, Cillo et al., 2000, 
Cheng et al., 2002, Ogata, 2003, Bucaro et al., 2004), differentiation (Chen et al., 
2003, Jagodzinski et al., 2004, Li et al., 2004b, Henriksen et al., 2006) and function 
(You et al., 2000, Di Palma et al., 2003, Kapur et al., 2003, Li et al., 2004b, Liegibel 
et al., 2004, Mullender et al., 2004).  
 
The few studies investigating loading of osteocytes in 2D have revealed some 
of the mechanisms involved in mechanotransduction. For example, the secretion of 
prostaglandins and NO, mediators of adaptive bone formation, in response to fluid 
shear (Klein-Nulend et al., 1995a, Klein-Nulend et al., 1995b, Ajubi et al., 1999, 
Burger and Klein-Nulen, 1999); and also the involvement of the cytoskeleton in 
mechanotransduction (Ajubi et al., 1996). These investigations supported the idea of 
osteocytes being the most mechanosensitive cells in bone, as when exposed to fluid 
shear, osteocytes were more responsive than osteoblasts (Klein-Nulend et al., 1995a). 
 
Studying either osteoblasts or osteocytes in 2D loading models has 
undoubtedly shed light into the signalling underlying mechanotransduction. 
However, the more physiological model of 2D co-culture started to reveal how 
loaded osteocytes control the activities of other bone cells. For example, loaded 
MLO-Y4 cells regulate osteoclasts by inhibiting osteoclastogenesis of pre-osteoclasts 
and bone marrow stromal cells (BMSCs) through direct cell-cell contact (You et al., 
2008) and by expressing RANKL and OPG, and releasing M-CSF (Zhao et al., 
2002). Furthermore, loaded osteocytes rapidly increase ALP activity of osteoblasts 
through direct communication via gap junctions (Taylor et al., 2007). In addition, 
osteoblasts also regulate osteoclasts when in 2D co-cultures by reducing 
osteoclastogenesis when mineralising (Deyama et al., 2000) by increasing secretion 
of OPG (Schroder et al., 2012) in the absence of load. However, these in vitro 
investigations do not reflect the complex 3D dynamics that control the structure and 
function of the living bone organ and the interactions of the cells within it (Parfitt, 
32 
 
Chapter 1 
1994, Collin-Osdoby, 1994, Parfitt, 2000, Pogoda et al., 2005, Matsuo and Irie, 2008, 
Tortelli and Cancedda, 2009). 
 
In recent years, 3D in vitro bone models have become increasingly popular. 
Some of these models use type I collagen gels as the matrix within which bone cells 
are embedded (Kurata et al., 2006, Murshid et al., 2007, Qi et al., 2007, Atkins et al., 
2009), in an attempt to mimic the bone matrix, however, most of these (Murshid et 
al., 2007, Qi et al., 2007, Atkins et al., 2009) have not been exposed to loading. 
Instead these 3D bone models revealed differences in cytoskeleton composition 
between osteoblast-like cells and primary osteocytes when in 3D collagen gels 
(Murshid et al., 2007); that adenosine tri-phosphate (ATP) decreases osteoblast-like 
cells integrins expression (Qi et al., 2007); and that MLO-Y4s increase expression of 
RANKL and M-CSF but decrease OPG expression when in 3D collagen gels with 
polyethylene particles, involved in orthopaedic implant bone destruction (Atkins et 
al., 2009). Interestingly, Kurata et al. applied an undefined load to mimic 
microdamage by scratching embedded MLO-Y4 cells co-cultured with BMSCs, and 
as a result MLO-Y4 cells secreted M-CSF and RANKL and induced TRAP positive 
cells (Kurata et al., 2006).  
 
3D cultures made out of other materials such as other hydrogels (Chatterjee et 
al., 2010), polybicarbonate membranes (Boukhechba et al., 2009), and scaffolds 
(Santos et al., 2009, Tortelli et al., 2009, Barron et al., 2010), have also been used. 
Here cells are not embedded within a matrix, but instead are attached to the scaffold 
surface and therefore do not accurately capture the environment of an osteocyte 
within bone. Nevertheless, these systems have proven the feasibility of reproducing 
the synthesis of an organised matrix (Tortelli et al., 2009) and cell-mediated matrix 
degradation (Nakagawa et al., 2004, Domaschke et al., 2006, Tortelli and Cancedda, 
2009). Still, there are no models that co-culture osteoblasts and osteocytes in 3D and 
at the same time are mechanically stimulated. This highlights a major gap in the 
understanding of the interactions that lead to mechanically-induced bone formation. 
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1.5 Mechanical signalling in bone 
 
Mechanotransduction has been suggested to use similar intracellular 
signalling cascades to those generated by ligand-receptor binding, resulting in 
changes in gene expression (Rubin et al., 2006). This has been well demonstrated in 
endothelial cell responses to shear stress where mechanical stimuli activates signal 
transduction cascades, including increases in intracellular cyclic adenosine 
monophosphate (cAMP) (Lavandero et al., 1993), inositol triphosphate (IP3) and 
intracellular calcium (Dassouli et al., 1993, Li et al., 2004b), guanine regulatory 
proteins (Gudi et al., 2003) and MAPK (Rubin et al., 2002). 
 
Application of mechanical load to bone cells such as osteoblasts, marrow 
stromal cells, periosteal fibroblasts and osteocytes, leads to modulation of cell 
proliferation (Kaspar et al., 2002, Boutahar et al., 2004, Li et al., 2004b), 
differentiation (Li et al., 2004b), secretion of inflammatory modulators (Klein-
Nulend et al., 1995a, Smalt et al., 1997, Klein-Nulend et al., 1998, McAllister and 
Frangos, 1999, Zaman et al., 1999, Sanchez et al., 2009) and extracellular matrix 
protein synthesis (Dumas et al., 2009, Sittichokechaiwut et al., 2010). Therefore, 
there has been a lot of speculation around the identification of the mechanosensor in 
bone tissue. Osteoblasts and osteoclasts respond to strain signals (Rubin et al., 2006). 
Endothelial and smooth muscle cells of the bone blood vessels (Davis et al., 2001, 
Boo and Jo, 2003), together with stromal cells  in the bone marrow (Li et al., 2004b),  
may also contribute to mechanoresponses (Skerry et al., 1989). However, the 
osteocyte intercommunicating network within bone, which is connected to bone 
surface cells, that integrates hormonal, growth factor and prostaglandin signals, is 
thought to be the main regulator of bone remodelling (Skerry et al., 1989, Lanyon, 
1993, Duncan and Turner, 1995, Klein-Nulend et al., 1995a, Klein-Nulend et al., 
1995b, Mullender and Huiskes, 1997, Burger and Klein-Nulen, 1999, Han et al., 
2004).  
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Osteocytes contain the necessary cellular machinery to sense mechanical 
loading (page 13) and they have been shown to respond to loading in vivo and in 
vitro. In vivo, osteocytes increase transcriptional and metabolic activities in response 
to short loading periods (Pead et al., 1988, Skerry et al., 1989); increase their DMP1 
and MEPE expression, controlling bone matrix mineral quality (Gluhak-Heinrich et 
al., 2003, Harris et al., 2007); increase IGF-1 and related proteins involved in 
mechanically-induced bone formation (Reijnders et al., 2007a, Reijnders et al., 
2007b), and stimulate NO production (Zaman et al., 1999), an early mediator of 
mechanically-induced bone formation (Fox et al., 1996). Furthermore, recent in vivo 
studies have shown that load-regulated gene expression in trabecular osteocytes is 
different to that of compact osteocytes and the genes involved are related to 
osteoblast and osteoclast life cycles (Zaman et al., 2010, Wasserman et al., 2013). In 
vitro, ultrasound loaded MLO-Y4 cells in 2D increase COX-2 expression, necessary 
for  prostaglandin E2 (PGE2) synthesis, and decrease RANKL:OPG ratios (Li et al., 
2012a). Primary osteocytes under fluid flow secrete prostaglandins (Klein-Nulend et 
al., 1995b, Ajubi et al., 1996, Ajubi et al., 1999) and produce NO (Klein-Nulend et 
al., 1995b). MLO-Y4 cells under cyclic hydraulic pressure decrease apoptosis (Liu et 
al., 2010); and under fluid flow activate CX43 (Cheng et al., 2001b) resulting in 
adenosine tri-phosphate (ATP) release (Genetos et al., 2007). 
 
Interestingly, mechanically loaded osteocytes have been shown to directly 
regulate osteoblast activity through various mechanisms including the 
downregulation of SOST expression (Robling et al., 2008, Tu et al., 2012) and 
release of NO, which has an anabolic effect on osteoblast activity (Fox et al., 1996) 
in vivo, and the communication with neighbouring osteoblasts through gap junctions 
(Taylor et al., 2007), and release of PGE2, which regulates osteoblast proliferation 
and differentiation (Li et al., 2012b) in vitro. Furthermore, loaded osteocytes also 
regulate osteoclast activity by regulating RANKL expression (Nakashima et al., 
2011), inducing in vivo bone resorption in unloading situations (Xiong et al., 2011) 
increasing SOST expression promoting osteoclast formation (Wijenayaka et al., 
2011) and releasing NO after loading inhibiting osteoclast bone resorption (Tan et 
al., 2007) in vitro. 
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1.5.1 Adenosine, CaSR and glutamate signalling in bone 
 
 The adenosine, calcium-sensing and glutamate signalling pathways have been 
implicated in bone biology, with several in vivo studies showing that KO animals of 
some of these receptors display a bone phenotype (Morimoto et al., 2006, Chang et 
al., 2008a, Skerry, 2008b, Kara et al., 2010b, Carroll et al., 2012, Mediero et al., 
2012). In vitro studies have also associated these pathways to bone cell biology, with 
glutamate (Mason et al., 1997, Spencer and Genever, 2003, Mason, 2004) and ATP 
(Genetos et al., 2005, Li et al., 2005b, Genetos et al., 2007, Riddle et al., 2007, Liu et 
al., 2008) being implicated in mechanotransduction. GLAST1, a glutamate 
transporter, has been shown to be mechanically-regulated in osteocytes (Mason et al., 
1997),  as well as N-methyl-D-aspartate (NMDA), 2-amino-3-(3-hydroxy-5-methyl-
isoxazol-4-yl) propanoic acid (AMPA) and kainate (KA) glutamate receptors in 
osteoclasts and bone lining cells (Szczesniak et al., 2005). These findings are highly 
indicative of a role for glutamate in mechanotransduction.  Furthermore, a 
hypothetical model on mechanically-induced glutamate signalling in  bone has been 
proposed (Mason, 2004). On the other hand, ATP has been shown to be released as a 
result of mechanical stimuli in osteoblasts (Pavlin et al., 2000, Romanello et al., 
2001, Genetos et al., 2005, Li et al., 2005b) and osteocytes (Genetos et al., 2007); 
and consequently, to mediate prostaglandin release (Genetos et al., 2005) and 
activate ERK 1/2 intracellular signalling (Liu et al., 2008), indicative of a role in 
mechanotransduction. 
 
1.5.1.1 Adenosine signalling 
 
Adenosine is an endogenous, ubiquitous nucleoside and a metabolite of ATP 
that acts as an extracellular signalling molecule (Drury and Szent-Gyögyi, 1929). It 
is usually present at low concentrations (less than 1 µM) in the extracellular space 
and accumulates in response to metabolic stress and cell damage eliciting 
physiological responses by binding to and activating one or more of the four G-
protein coupled adenosine receptors (A1, A2A, A2B and A3)  (Jacobson and Gao, 
2006, Evans and Ham, 2012). Adenosine receptor signalling occurs through the 
inhibition or stimulation of adenylyl cyclase, leading to a decrease or an increase in 
intracellular cAMP concentration ([cAMP]i) respectively. Therefore, adenosine 
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receptors are classified according to the effect they have on cAMP concentration: A1 
and A3 decrease [cAMP]i  (Jin et al., 1997), whereas A2A and A2B increase [cAMP]i 
(Bruns et al., 1986).  
 
Adenosine research in bone has been recently reviewed (Evans and Ham, 
2012). All adenosine receptor messenger ribonucleic acids (mRNAs) are expressed 
in MG63 osteoblasts (Russell et al., 2007), and all adenosine receptor proteins are 
expressed in human primary osteoblasts (Costa et al., 2011). A2A and A2B receptors 
are expressed in human osteoclasts (Pellegatti et al., 2011, Mediero et al., 2012). No 
data have yet been published on the expression or functionality of adenosine 
receptors in osteocytes, or as a result of mechanical stimuli in vivo or in vitro (Evans 
and Ham, 2012). Although there is a lack of publications on the expression of these 
receptors in bone, they have an effect on bone biology as a result of activation or 
inhibition in osteoblasts and osteoclasts (Evans and Ham, 2012). 
 
1.5.1.1.1 Adenosine receptor A1 in bone 
 
The role of A1 receptors in osteoblasts is unclear, with some studies not 
detecting expression in osteoblast-like cells (Lerner et al., 1987). No effects on 
osteoblast morphology or function were observed in A1 KO mice (Kara et al., 
2010b), although the higher bone volume, smaller osteoclasts with no ruffled border 
and an absence of osteoclast bone resorption (Kara et al., 2010b) revealed A1 to be 
essential for osteoclast differentiation and function (Kara et al., 2010a). A1 receptors 
play a role in adipocyte differentiation (Gharibi et al., 2011, Gharibi et al., 2012). 
 
1.5.1.1.2 Adenosine receptor A2A in bone 
 
In osteoblasts, A2A is upregulated during final stages of osteoblast 
differentiation, during which activation of the receptor stimulates ALP activity 
(Gharibi et al., 2011). In osteoclasts, deletion of A2A increased bone resorption and 
osteoclast activity as seen in A2A KO mice (Mediero et al., 2012). In a mouse model 
of RA, adenosine was shown to decrease bone resorption through the A2A receptor 
(Mazzon et al., 2011) (page 23). 
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1.5.1.1.3 Adenosine receptor A2B in bone 
 
In osteoblasts, deletion of A2B decreases osteoblast differentiation and 
expression of osteoblast-related transcription factors by mesenchymal stem cells 
(MSCs) (Evans and Ham, 2012, Mediero and Cronstein, 2013). The A2B KO mouse 
showed a lower bone density, delayed fracture physiology and lower expression of 
osteoblast differentiation related genes (Carroll et al., 2012). Consistent with this, 
when overexpressed or activated, A2B stimulates mineralisation, ALP activity and 
ALP and Runx2 gene expression (Gharibi et al., 2012). In osteoclasts, very little is 
known about the expression and function of A2B. Although adenosine produced 
during inflammation inhibits differentiation of mouse bone marrow macrophages 
through A2B receptor (Xaus et al., 1999), and A2B is expressed in human osteoclast 
precursors, inhibition of A2B does not affect osteoclast formation (Pellegatti et al., 
2011). 
 
1.5.1.1.4 Adenosine receptor A3 in bone 
 
A3 is expressed in osteoblasts (Russell et al., 2007, Costa et al., 2011), but 
there are no published studies on its expression in osteoclasts. Activation of A3 
receptors increases human primary osteoblast proliferation (Costa et al., 2011) and 
decreases osteoclast number and expression of RANKL in a RA mouse model (Rath-
Wolfson et al., 2006).  
 
1.5.1.2 Calcium-sensing signalling 
 
Bone is a calcium (Ca2+) reservoir. Hormonal systems are coupled to bone 
tissue in order to transport Ca2+ in and out of bone according to the body’s needs.  
Parathyroid gland cells ensure extracellular Ca2+ homeostasis, secreting PTH when 
extracellular free ionised calcium concentration ([Ca2+]o) decreases below a 
threshold. This increases bone resorption, as well as acting on the kidney, to increase 
[Ca2+]o into the circulation. Ca2+ is sensed by cells through the CaSR, a G-protein 
coupled receptor (Brown et al., 1993). CaSR can be activated not only by 
extracellular calcium, but by other compounds including polyamines, Mg2+ and L-
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amino acids (Riccardi and Brown, 2010) such as glutamate, which acts as a positive 
allosteric modulator of the CaSR (Conigrave et al., 2000). 
 
In bone, CaSR is expressed in rat and bovine osteoblasts, osteocytes and bone 
marrow cells in vivo, but not in mature osteoclasts (Chang et al., 1999), as well as in 
osteoblasts, osteocytes and osteoclasts in rat femur and human undecalcified bone 
(Dvorak et al., 2004). In vitro, CaSR is present in rat calvarial osteoblasts 
(Chattopadhyay et al., 2004) and in several osteoblast-like cell lines (Yamaguchi et 
al., 1998b, Yamaguchi et al., 2001) including MC3T3-E1 cells (Yamaguchi et al., 
1998a, Ye et al., 2000), in addition to pre- and mature osteoclasts (Kameda et al., 
1998, Mentaverri et al., 2006). However, no studies have been published yet on the 
expression of CaSR mRNA in osteocytes in vitro.  
 
1.5.1.2.1 CaSR in bone 
 
CaSR tissue-specific KOs in parathyroid gland cells and osteoblasts both 
display severe growth retardation, small undermineralised skeletons and reduced 
body weights (Chang et al., 2008a, Dvorak-Ewell et al.). In addition, the parathyroid 
specific KO also suffers fractures in the ribs and tibiae (Chang et al., 2008a) whereas 
the osteoblast specific KO has impaired osteoblast bone forming activity (Dvorak-
Ewell et al., 2011). 
 
Cultured osteoblasts lacking the CaSR showed decreased type I collagen 
(COL1A1), OCN, ALP and DMP1 gene expression and reduced mineralisation 
(Yamauchi et al., 2005, Dvorak-Ewell et al., 2011), suggesting a role of CaSR in 
osteoblast differentiation. The CaSR is also involved in the proliferation and 
chemotaxis of osteoblasts (Yamaguchi et al., 1998a, Chattopadhyay et al., 2004, 
Dvorak et al., 2004). In cultured osteoclast precursors, high [Ca2+]o activates the 
CaSR and reduces osteoclast formation (Kanatani et al., 1999), and deletion of CaSR 
in these cells leads to a decrease in differentiation to mature osteoclasts (Mentaverri 
et al., 2006). In mature osteoclasts, high [Ca2+]o induces apoptosis (Mentaverri et al., 
2006) and inhibits resorptive activity (Zaidi et al., 1991, Kameda et al., 1998).  
Deletion of CaSR in osteoblasts increased expression of RANKL and induced 
osteoclastogenesis in co-cultured pre-osteoclasts (Dvorak-Ewell et al., 2011). 
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1.5.1.3 Glutamate signalling 
 
Glutamate is a ubiquitous amino acid and the main excitatory 
neurotransmitter in the vertebrate central nervous system (CNS), where it is involved 
in cognitive functions, e.g. memory and learning (McEntee and Crook, 1993). 
Glutamate signals through receptors which are classified into two groups according 
to signalling mechanism; ionotropic receptors (iGluRs) which act as glutamate gated 
ion channels, and metabotropic receptors (mGluRs) which are G-protein coupled 
receptors (Reynolds and Miller, 1988, Hollmann et al., 1989, Nakanishi, 1998, 
Mason, 2004). iGluRs are categorised into three groups according to homology and 
selective agonists; NMDA, AMPA and KA (Wisden and Seeburg, 1993, Hollmann 
and Heinemann, 1994). mGluRs are categorised in to three groups (I, II and III) 
according to functional groups, agonist sensitivity and signalling (Masu et al., 1991, 
Tanabe et al., 1992, Wisden and Seeburg, 1993). Glutamate concentrations across 
cell membranes are maintained by transporters driven by ion-exchange pumps 
(Schousboe and Divac, 1979, Danbolt, 2001). There are three types of glutamate 
transporters; excitatory amino acid transporters (EAATs), vesicular glutamate 
transporters (VGLUTs) and the cysteine/glutamate antiporters. EAATs (5 members), 
are high-affinity, sodium-dependent glutamate transporters that transport 
extracellular glutamate into the cell (Kanai and Hediger, 1992, Pines et al., 1992, 
Storck et al., 1992, Arriza et al., 1994, Fairman et al., 1995, Arriza et al., 1997). 
VGLUTs have lower affinity to glutamate than EAATs, comprise three transporters 
and release glutamate from vesicles (Shigeri et al., 2004). Finally, the 
cysteine/glutamate antiporters are sodium and chloride-dependent, high-affinity 
transporters which pack glutamate into vesicles ready for release (Bannai and 
Kitamura, 1980, Bannai and Kitamura, 1981, Waniewski and Martin, 1984, Cho and 
Bannai, 1990). 
 
Glutamate signalling was first associated with bone when GLAST1, also 
known as EAAT1 in humans, was identified in a gene screening investigation to 
reveal mechanically regulated genes in  rodent osteocytes (Mason et al., 1997). Since 
then, other studies reported the expression of glutamate signalling components in 
bone cells. NMDA and AMPA receptors, together with EAATs are expressed by 
osteoblasts, osteoclasts and osteocytes, whereas mGluR and KA receptors have only 
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been detected in osteoblasts and osteoclasts (Brakspear and Mason, 2012). Although 
receptor function has been reported in both osteoblasts and osteoclasts, no studies to 
date have been performed in osteocytes. Furthermore, NMDA, AMPA and KA 
receptors were also shown to be mechanically-regulated in osteoclasts and bone 
lining cells (Szczesniak et al., 2005). Glutamate concentrations were also found to 
vary  in arthritic joints increasing from 6 µM in healthy joints (Plaitakis et al., 1982, 
McNearney et al., 2000) to 332.3 ±29.3 and 240 ±38 µM in RA and OA joints 
respectively (McNearney et al., 2004) (pages 22-23). 
 
1.5.1.3.1 NMDA receptors in bone 
 
In vivo, NMDAR2A and NMDAR2B expression has been reported to be 
mechanically-regulated in osteoclasts and bone lining cells (Szczesniak et al., 2005). 
Furthermore, the development of an osteoblast/osteocyte specific NMDAR1 KO 
mouse, which displayed delayed development, thin bone structure and poor 
mineralisation of the axial and appendicular bones (Skerry, 2008b), indicates NMDA 
receptors  play a role in bone biology.  Inhibition of NMDA receptors delayed onset 
of RA and reduced bone resorption, swelling and pain symptoms in animal models of 
RA (Sluka et al., 1994, Lam and Ng, 2010) (page 23). 
 
In osteoblasts in vivo, NMDA receptor expression decreased in rats with 
disuse-induced bone loss (Ho et al., 2005) and mice treated with an NMDA 
antagonist display reduced cortical thickness (Burford et al., 2004). In rat primary 
osteoblasts, NMDA receptor antagonists downregulate Runx2 expression, reduce 
mineralisation, and inhibit ALP activity and OCN expression (Hinoi et al., 2003, Ho 
et al., 2005, Lin et al., 2008). Consistent with this, NMDA receptor agonists increase 
OCN expression and mineralisation in osteoblasts (Lin et al., 2008). In osteoclasts in 
vitro, NMDA receptor activation reduces osteoclast differentiation and activity, and 
promotes apoptosis through a decrease in NO production (Chenu et al., 1998, Peet et 
al., 1999, Itzstein et al., 2000, Mentaverri et al., 2003). 
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1.5.1.3.2 AMPA/KA receptors in bone 
 
In vivo, AMPA and KA receptors were shown to be mechanically-regulated 
(Szczesniak et al., 2005). Rats injected with AMPA showed increased bone volume 
in their tibia (Lin et al., 2008), whereas mice treated with AMPA/KA receptor 
antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione 
(NBQX), displayed decreased trabecular thickness (Burford et al., 2004). 
Furthermore, NBQX also reduces bone remodelling in rat antigen-induced arthritis 
(Bonnet, Williams and Mason unpublished data). Consistent with this, in cultured 
osteoblasts, AMPA receptor agonists increased OCN expression and mineralisation 
(Lin et al., 2008), whereas the AMPA/KA receptor antagonist NBQX inhibits 
mineralisation and reduces cell number (Bonnet, Williams and Mason unpublished 
data). Interestingly, in vitro, AMPA  treatment of osteoclasts had no effect on 
osteoclastogenesis (Lin et al., 2008), however, NBQX treatment inhibited osteoclast 
resorptive activity (Szczesniak et al., 2005). 
 
1.5.1.3.3 mGluRs in bone 
 
To date, there are no studies on the function of mGluRs in osteoblasts. 
However, agonists for mGluR8 inhibit glutamate release and bone resorption, whilst 
antagonists activate bone resorption (Morimoto et al., 2006). 
 
1.5.1.3.4 Glutamate transporters in bone 
 
In vivo, GLAST1 expression has been reported to be mechanically regulated, 
and therefore is a candidate in bone biology (Mason et al., 1997). However, a 
GLAST1 KO did not affect bone length (Gray et al., 2001). In contrast, a VGLUT1 
KO mouse showed low bone mass and large reductions of trabecular bone as a result 
of an increase in osteoclastic resorption (Morimoto et al., 2006). 
 
In vitro, inhibition of EAATs has been shown to prevent bone formation by 
calvarial osteoblasts and change their osteoblastic phenotype to a more adipogenic 
one (Taylor, 2002) and to affect the bone forming phenotype and cell number of 
osteoblast cell lines by influencing OCN, ALP and OPG mRNA expression, ALP 
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activity and mineralisation (Brakspear, 2010). On the other hand, there are currently 
no studies on the direct role of VGLUTs in osteoblasts. Nevertheless, the 
cysteine/glutamate antiporter has been shown to be functionally required for pre-
osteoblast differentiation. The antiporter was also shown to suppress pre-osteoblast 
proliferation (Uno et al., 2007, Takarada-Iemata et al., 2011) and downregulate 
Runx2 expression and ALP activity in differentiating osteoblasts (Uno et al., 2011). 
Osteoclast differentiation requires activation of the cysteine/glutamate antiporter 
(Hinoi et al., 2007) and VLGUT1 accumulates glutamate with bone degradation 
products in vesicles for release (Morimoto et al., 2006). There are no studies to date 
on the role of EAATs in osteoclast biology. 
 
1.5.1.4 Heterodimerisation of receptors in the CNS 
 
In the CNS, glutamate receptors can be controlled by other neuromodulators 
(Conn and Pin, 1997). Adenosine is a key neuromodulator in the CNS (Phillis and 
Wu, 1981) and inhibits glutamate signalling in various regions of the brain (Peris and 
Dunwiddie, 1985). Group I mGluR responses are enhanced by the action of A1 
adenosine receptors (Ogata et al., 1994, Toms and Roberts, 1999). In the CNS, in 
vivo and in vitro, mGluR1α and A1 receptors co-localise and have direct molecular 
interactions, specific to the mGluR1α splice variant (Ciruela et al., 2001). The CaSR 
heterodimerises with mGluR1α in vivo and in vitro (Gama et al., 2001) after CaSR 
and mGluR1α expression patterns were shown to overlap in the brain (Testa et al., 
1995, Chattopadhyay et al., 1997, Rogers et al., 1997, Ferraguti et al., 1998, 
Tallaksen-Greene et al., 1998, Ferry et al., 2000, Stinehelfer et al., 2000, Tanaka et 
al., 2000). mGluR5 also co-localises, heterodimerises and has synergistic interactions 
with both CaSR and adenosine receptor A2A (Pintor et al., 2000, Gama et al., 2001, 
Popoli et al., 2001, Diaz-Cabiale et al., 2002). Interestingly, A2A/mGluR5 
heterodimerisation regulates c-fos expression in the brain (Ferre et al., 2002), a 
proto-oncogene found to be key in osteoclast formation and bone remodelling 
(Grigoriadis et al., 1994) and in osteoblast differentiation (Hipskind and Bilbe, 
1998). The fact that these G-protein coupled receptors, which have been found to 
have a role in bone remodelling, heterodimerise to enhance their activity in the CNS, 
suggests similar events may also take place in bone (Mason et al., 2006, Mattinzoli et 
al., 2009). 
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1.6 Hypothesis and aims  
 
Currently, in vitro mechanical loading models do not reflect the interactions 
of the cells within bone. The majority focus on mechanical loading of osteoblasts in 
monolayers (Wang et al., 2011, Xiao et al., 2011, Li et al., 2012c) (page 30) and the 
available 3D in vitro bone models (page 32), do not elucidate the osteocyte-
osteoblast interactions (page 13) that regulate mechanically-induced bone formation 
(Kurata et al., 2006, Tortelli and Cancedda, 2009, Tortelli et al., 2009, 
Papadimitropoulos et al., 2011a, Papadimitropoulos et al., 2011b, Barthelemi et al., 
2012). Therefore the following hypothesis was generated: 
 
“A 3D osteocyte-osteoblast co-culture model, where osteocytes embedded 
within type I collagen gels are overlaid with osteoblasts, represents a useful in vitro 
model for the investigation of the regulation of mechanically-induced bone formation 
markers.” 
 
Furthermore, the adenosine, calcium-sensing, and glutamate signalling 
pathways have been shown to be involved in bone biology (page 36), as seen in KO 
animals involving signalling components of these pathways. Additionally, all 
adenosine receptors have been found to be expressed in osteoblasts (Evans and Ham, 
2012) (page 37), and CaSR (page 38) and a variety of glutamate receptors and 
transporters (Brakspear and Mason, 2012) (page 40) have been found to be expressed 
in both osteoblasts and osteocytes. Interestingly, two adenosine receptors (A1, A2A) 
and CaSR have been shown to heterodimerise with glutamate receptors mGluR1 
and/or 5 in the CNS (page 43), and both glutamate and the adenosine precursor ATP 
have been implicated in mechanotransduction (page 36). However the role of the 
adenosine, CaSR and glutamate signalling pathways in mechanically-induced bone 
formation is not fully understood. Therefore the following hypothesis was 
formulated: 
 
“Adenosine, calcium-sensing and glutamate signalling components are expressed in 
the 3D osteocyte-osteoblast co-culture model and contribute, individually or in 
combination, to the regulation of mechanically-induced bone formation markers.” 
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To investigate these hypotheses, the aims of the project were: 
1. To establish and characterise a novel in vitro mouse 3D osteocyte-osteoblast 
co-culture model. 
2. To determine the expression of osteocyte and osteoblast phenotypic markers. 
3. To determine the expression of adenosine receptors, CaSR and glutamate 
receptors and transporters within the 3D co-culture model. 
4. To determine whether embedded osteocytes respond to mechanical load in 
the 3D model by assessing PGE2 and IL-6 release, and expression of 
signalling and phenotypic markers. 
5. To determine the responses of 3D co-cultures to mechanical load by assessing 
PGE2 release, pro-collagen type I (PINP) synthesis and expression of bone 
formation markers. 
6. To determine the effects of receptor antagonists on the response of 3D co-
cultures to mechanical stimuli (as in aim 5). 
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2. Materials and Methods 
 
2.1 Materials 
 
All reagents were purchased from Sigma-Aldrich® (Poole, UK) unless 
otherwise stated below. 
 
2.1.1 Tissue culture 
 
Alpha Minimum Essential Medium with L-glutamine and without ribo- and 
deoxynucleosides (αMEM), Dulbecco’s Modified Eagle’s Medium with high 
glucose, GlutaMAX™ and pyruvate (DMEM), 10X Minimum Essential Medium 
(MEM); foetal bovine serum (FBS), newborn calf serum (NCS), penicillin-
streptomycin (PenStrep), and trypsin-EDTA with phenol red were purchased from 
GIBCO (Life Technologies™, Paisley, UK). Dialysed FBS (DFBS), dialysed by 
ultra-filtration with a 10,000 molecular weight cut-off membrane was obtained from 
Sera Laboratories International Ltd. (Bolney, UK). Rat tail tendon type I collagen for 
coating flasks was from Becton Dickinson Bioscience (BD) (VWR®, Leicestershire, 
UK). Tissue culture treated plasticware was from BD Falcon (VWR®). CellTiter 96® 
AQueous One Solution Cell Proliferation Assay (MTS) was from Promega 
(Southampton, UK).  NBQX and 2-(2-Furanyl)-7-[3-(4-methoxyphenyl)propyl]-7H-
pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine (SCH 442416) were from 
Tocris Bioscience (Bristol, UK). 
 
2.1.2 Molecular biology 
 
TRIzol® reagent, Quant-iT™ dsDNA High-Sensitivity Assay Kit and 
SuperScript® III Reverse Transcriptase were purchased from Life Technologies™. 
DNA-free™ and sodium acetate were obtained from Ambion® (Huntington, UK). All 
primers were synthesised and purified by MWG (Milton Keynes, UK). QIAquick 
Gel Extraction Kit was obtained from Qiagen (Crawley, UK). Ampicillin was 
purchased from Bioline (London, UK). Random primers, deoxynucleotide 
triphosphates (dNTPs), Recombinant RNasin® Ribonuclease Inhibitor, agarose, tris-
borate-EDTA (TBE), pGEM®-T plasmid vector, Escherichia coli (E. coli) JM109 
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competent cells, isopropyl β-D-1-thiogalactopyranoside (IPTG), X-Galactosidase (X-
Gal) and Wizard® Plus SV Miniprep  deoxyribonucleic acid (DNA) Purification kit 
were purchased from Promega. Safeview was obtained from NBS Biologicals 
(Huntingdon, UK) and low molecular weight DNA ladder from New England 
Biolabs Inc.® (Herts, UK). Polypropylene Reverse Transcriptase-quantitative 
Polymerase Chain Reaction (RT-qPCR) plates and optical strip caps were purchased 
from Agilent Technologies (Berkshire, UK). All plasticware and consumables were 
certified ribonuclease (RNase)/deoxyribonuclease (DNase) free.  
 
2.1.3 Immunolocalisation and histochemistry 
 
Ethidium homodimer, anti-CX43 mouse monoclonal antibody (clone: CX-
1B1), and goat anti-rabbit secondary antibody conjugated with Alexa 594 were from 
Life Technologies™. Anti-ColI mouse monoclonal antibody was obtained from 
Developmental Studies Hybridoma Bank (Iowa, USA). Anti-E11 (podoplanin) goat 
polyclonal antibody was obtained from R&D Systems® (Abingdon, UK). Anti-A1, 
anti-A2A, anti-AMPAR2, anti-mGluR1 and anti-KA1 rabbit polyclonal antibodies 
were obtained from Abcam® (Cambridge, UK). Anti-A2B, anti-A3, anti-GLAST1, 
and anti-excitatory amino acid carrier 1 (EAAC1) rabbit polyclonal antibodies were 
purchased from Alpha Diagnostics Int. (San Antonio, USA). Anti-CaSR rabbit 
polyclonal antibody was purchased from AnaSpec (Fremont, USA). Rabbit anti-goat 
peroxidase conjugated secondary antibody, goat anti-rabbit peroxidase conjugated 
secondary antibody. Dylight594 streptavidin; Vectamount Universal Elite ABC 
rabbit kit; rabbit immunoglobulins control (IgG), goat IgG, normal rabbit serum; 
normal horse serum, mouse IgG, and 3,3'-diaminobenzidine (DAB) were obtained 
from Vector Laboratories (Peterborough, UK). Optimal cutting temperature (OCT) 
compound mounting medium for cryotomy, coverslips, and poly-lysine coated slides 
were purchased from VWR®. Dibutyl phthalate xylene (DPX) was from Raymond A. 
Lamb Laboratory Supplies (VWR®).  
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2.1.4 Protein assays 
 
CytoTox 96® Non-Radioactive Cytotoxicity Assay was from Promega. PGE2 
Enzyme-linked Immunosorbent Assay (ELISA) kit was purchased from Enzo Life 
Sciences® (Exeter, UK). DuoSet mouse Interleukin-6 (IL-6) ELISA Development kit 
was obtained from R&D Systems®. Rat/Mouse N-terminal pro-peptide of type I pro-
collagen (PINP) Enzymeimmuno assay (EIA) was from Immunodiagnostic systems 
(Tyne & Wear, UK). 
 
2.1.5 Loading device 
 
TECH-SIL 25 Silicone Elastomer for the loading device was purchased from 
Technovent Ltd. (Newport, South Wales, UK). Face paint for strain measurements 
was from Snazaroo™ (Minehead, UK). 
 
2.2 Equipment and software 
 
2.2.1 Molecular biology 
 
RNA quantitation was carried out using a Thermo Scientific NanoDrop 2000 
with Thermo Scientific NanoDrop 2000/2000c Software. Thermocycling was carried 
out on a Techne TC-312 Thermal Cycler (Cambridge, UK), or using a Stratagene 
Mx3000P cycler for quantitative reactions. Quantitative amplifications were 
monitored using MxPro RT-qPCR software (Agilent Technologies). Agarose DNA 
gels were viewed using a GelDoc system from BioRad (Hempstead, UK) and 
photographed using BioRad GelDoc Software. 
 
2.2.2 Microscopy 
 
Light microscope images of live cultures were obtained with a Nikon Coolpix 
4500 camera attached to a Nikon eclipse TS100 inverse-light microscope (Surrey, 
UK). Cryosectioning was carried out using a Bright OTF 5000 cryostat (Huntingdon, 
UK). Light-microscope images of stained cryosections were obtained with a Motic 
Moticam 2000 digital camera (Barcelona, Spain) attached to a Leica DMRB light 
48 
 
Chapter 2 
microscope (Milton Keynes, UK) and using the Motic Images Plus 2.0ML basic 
image acquisition software. Fluorescence microscope images were obtained with an 
Olympus Soft Imaging Systems F-view black and white digital camera (Tokyo, 
Japan) attached to an Olympus BX61 epi-fluorescence microscope and using the 
Olympus AnalySIS software. Confocal images were obtained with a Leica TCS SP2 
AOBS confocal scanning laser microscope and using the Leica Confocal Software. 
 
2.2.3 Microplate assays 
 
All assays requiring a microplate reader were performed using a BMG 
Labtech FLUOstar Optima plate reader (Bucks, UK) and readings were recorded 
with the Optima Software for FLUOstar V2.00 R3 (BMG Labtech). 
 
2.2.4 Mechanical loading 
 
A Richmond aerovac vacuum chamber (Fareham, UK) attached to a DVP 
vacuum pump (San Pietro in Casale, Italy) was used for the manufacturing of the 
silicone loading plate. Strain measurements of the loading device were performed 
using a Losenhausen Servo Hydraulic Testing Machine (Delhi, India) with MTS 
FlexTest® Controller Software and using DANTEC Correlated Solutions cameras 
with DANTEC Dynamics Q-400 System Software (Columbia, USA). Mechanical 
loading of cultures in the silicone plate was performed using a BOSE ElectroForce® 
3200 instrument (Kent, UK) and controlled with WinTest® Software 4.1 with 
TuneIQ control optimisation (BOSE). 
 
2.2.5 Statistics 
 
Statistical analysis was performed using Minitab 16 statistical software 
(Coventry, UK). 
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2.3 Methods 
  
2.3.1 Cell lines and cell culture 
 
2.3.1.1 MC3T3-E1(14) 
 
MC3T3-E1 is an osteoblast-like cell line initially derived from newborn 
mouse calvaria by in vitro differentiation. This is a spontaneously immortalised cell 
line (Sudo et al., 1983) which has been characterised into pre-osteoblast subclones 
(Wang et al., 1999). MC3T3-E1 subclones were defined by their ability to mineralise 
extracellular matrix and expression of osteoblast-related genes. MC3T3-E1 subclone 
14 (MC3T3-E1(14)), a kind gift of Dr Bronwen Evans (School of Medicine, Cardiff 
University, UK), is a mineralising subclone which expresses high levels of BSP, ColI 
and OCN mRNA (Wang et al., 1999). 
 
MC3T3-E1(14) cells were cultured in 75 cm2 flasks with αMEM 
supplemented with 100 U/ml penicillin, 100 µg/ml streptomycin, 10 % FBS at 37°C 
in 5 % carbon dioxide (CO2) /95 % air atmosphere (Wang et al., 1999). Medium was 
replaced every 2-3 days. After reaching 80 % confluency, cells were treated with 
0.25 % (w/v) trypsin-EDTA and re-seeded into new flasks. Passages 15-30 were 
used for experiments. 
 
2.3.1.2 MLO-Y4 
 
 MLO-Y4 osteocyte-like cells were kindly donated by Prof Lynda Bonewald 
(University of Missouri, USA). The cells were isolated by sequential collagenase 
digestion from the long bones of transgenic mice expressing the simian virus 40 
(SV40) large T-antigen oncogene under the control of the OCN promoter. These 
cells have been shown to behave like primary osteocytes as they express high 
amounts of OCN, low amounts of ALP and ColI, and they have complex cytoplasmic 
processes expressing CD44, CX43 and OPN (Kato et al., 1997). 
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MLO-Y4 osteocyte-like cells (Kato et al., 1997) were cultured on collagen 
coated 75 cm2 or 225 cm2  flasks (0.15 mg/ml rat tail tendon type I collagen in 0.02 N 
glacial acetic acid) (Kato et al., 1997) in αMEM supplemented with 100 U/ml 
penicillin, 100 µg/ml streptomycin, 2.5 % heat-inactivated FBS (HIFBS) and 2.5 % 
heat-inactivated NCS (HINCS) at 37°C in 5 % CO2/95 % air atmosphere ((Kitase et 
al., 2010), personal communication with Prof Lynda Bonewald). Media was replaced 
every 2-3 days. At 70-80 % confluency, cells were treated with 0.25 % (w/v) trypsin-
EDTA and re-seeded into new flasks. Passages 29-50 were used for experiments. 
 
2.3.2 Serum heat inactivation 
Both FBS and NCS were heat-inactivated following the instructions provided 
by Cambrex (Wiesbaden, Germany). The frozen sera bottles were placed at room 
temperature (rt) for 3-4 hr before thawing completely in a 37ºC water bath. The 
bottles were then agitated to mix the contents and placed for 30 min in a 56ºC water 
bath where the water level is above the serum level, and mixed occasionally. 
Temperature was controlled by placing a thermometer in a bottle with water of equal 
volume to the sera.  
 
2.3.3 Sera batch test 
 
To maintain optimum culture conditions for MC3T3-E1(14) and MLO-Y4 
cells in monolayer, new batches of FBS and NCS were tested using CellTiter 96® 
AQueous One Solution Cell Proliferation Assay (MTS). In a 96-well plate, 1,500 
cells/well were seeded and incubated overnight (o/n) at 37°C in 5 % CO2/95 % air 
atmosphere in 100 µl of their corresponding culture medium (page 50). Medium was 
removed and replaced with medium containing either old (control) or new (test) FBS 
and/or NCS and cells were incubated o/n at 37°C in 5 % CO2/95 % air atmosphere. 
The CellTiter 96® AQueous One Solution Cell Proliferation Assay (MTS) was 
performed at day 2 and 3 following manufacturer’s instructions. Briefly, 20 µl of 
CellTiter 96® AQueous One Solution reagent was added to each well. The plate was 
then incubated for 2 hr at 37°C in 5 % CO2/95 % air atmosphere wrapped in foil to 
avoid exposure to light. Finally the plate was read at 490 nm using a BMG Labtech 
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FLUOstar Optima plate reader and absorbance was recorded using Optima Software 
for FLUOstar V2.00 R3. For results see page 266. 
 
2.3.4 3D collagen co-cultures 
 
Rat tail tendon type I collagen (2.5 mg/ml in 7 mM glacial acetic acid) was 
mixed on ice in a 4:1 ratio with 5X MEM containing 11 g/L sodium bicarbonate 
(NaHCO3), and neutralised to pH 7.4 with 1 M tris (hydroxymethyl)aminomethane 
(Tris) base (pH 11.5) to give a 2 mg/ml collagen solution. MLO-Y4 (1.5x106 cells/ml 
gel, page 50) cells were diluted in their corresponding medium (less than 10 % of 
total gel volume) and then mixed thoroughly into the collagen solution on ice. The 
collagen-cell mix was dispensed into 48-well plates (250 µl/well) and incubated at 
37°C in 5 % CO2/95 % air atmosphere for 1 hr for polymerisation. 1 ml of MLO-Y4 
medium was added on top before gels were incubated o/n at 37°C in 5 % CO2/95 % 
air atmosphere. MLO-Y4 medium was then removed and MC3T3-E1(14) cells 
(1.5x105 cells/well, page 50) were then layered on top of the collagen gels in DMEM 
GlutaMAX™ supplemented with 100 U/ml penicillin, 100 µg/ml streptomycin and 5 
% DFBS. Co-cultures were kept for up to 7 days and medium was changed every 2-3 
days. 
 
2.3.5 Molecular biology 
 
2.3.5.1 RNA extraction from 3D co-cultures 
 
Total RNA was extracted from 3D co-cultures using TRIzol® reagent 
according to the manufacturer’s protocol except with a 2-propanol incubation of 1 hr 
at -80 ºC. Surface zone cells were treated with 0.5 ml TRIzol® for exactly 10 sec, and 
deep zone cells with 1 ml TRIzol®, until the collagen gel was completely dissolved, 
by re-suspending with a pipette. Briefly, 0.2 ml of chlorophorm was added per 1 ml 
of TRIzol®, samples shaken, centrifuged (12,000 rpm, 15 min, 4ºC), and aqueous 
phase precipitated with 0.5 ml 2-propanol per 1 ml of TRIzol® (1 hr, -80 ºC) before 
centrifugation (12,000 rpm, 10 min, 4ºC). RNA pellets were washed with 1 ml 75 % 
ethanol, centrifuged (7,500 rpm, 5 min, 4ºC), and pellets dried and redissolved in 50 
µl DEPC-treated water. Isolated total RNA was DNase-treated using DNA-free™ 
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according to the manufacturer’s instructions to remove DNA contamination. Total 
RNA was then re-precipitated to ensure the removal of all organic contaminants. 
Briefly, 0.1 volume of 3M sodium acetate (CH3COONa, pH 5.5) and 3 volumes of 
ice-cold 100 % ethanol were added to each sample and incubated for 1 hr at -80ºC  or 
o/n at -20ºC. Samples were resuspended by vortexing and centrifuged (7,500 rpm, 
4ºC, 5 min). Supernatant was decanted and pellets dried at rt. Finally, pellets were 
dissolved in DEPC-treated water (25 µl for surface zone; 50 µl for deep zone) and 
incubated for 10 min at 55ºC. All RNA samples were then used immediately or 
stored at -80ºC until needed. 
 
2.3.5.1.1 Estimation of RNA concentration and purity 
 
 Total RNA was quantified after precipitation using a NanoDrop (page 48). 
All measurements were done against a blank of DEPC-treated water. RNA purity 
was indicated by the 260 nm/280 nm (A260/A280) absorbance ratio for the presence of 
protein contaminants; and the 260 nm/230 nm (A260/A230) absorbance ratio for the 
presence of carbohydrates, salts and phenol. Pure RNA has an A260/A280 ratio of 2.0 
and an A260/A230 ratio of 1.8-2.2. Samples with A260/A280 and A260/A230 ratios of 
≥1.8 were deemed of good quality.  
 
2.3.5.2 DNA extraction from 3D co-cultures  
 
 Total DNA was extracted from 3D co-cultures using TRIzol® reagent 
according to the manufacturer’s protocol. Surface and deep zone cells were treated 
with TRIzol® as described in page 52. Briefly, 0.2 ml of chlorophorm was added per 
1 ml of TRIzol®, samples shaken and centrifuged (12,000 rpm, 15 min, 4ºC).  The 
aqueous phase was removed for RNA extraction (page 52) and the DNA in the 
interphase and organic phase precipitated with 0.3 ml 100 % ethanol (4°C) per 1 ml 
TRIzol® (2-3 min, rt) before centrifugation (2,000 rpm, 5 min, 4ºC). DNA pellets 
were washed with 1 ml  0.1 M sodium citrate in 10 % ethanol per 1 ml TRIzol® (30 
min, rt, with periodic mixing) and centrifuged (2,000 rpm, 5 min, 4ºC). The DNA 
pellets were washed twice and then resuspended with 1.5 ml 75 % ethanol per 1 ml 
TRIzol® (20 min, rt, with periodic mixing) before centrifugation (2,000 rpm, 5 min, 
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4ºC). DNA pellets were dried and redissolved in 50 µl diethylpyrocarbonate (DEPC) 
treated water by incubating at 37°C o/n. 
 
2.3.5.2.1 Estimation of DNA concentration 
 
 Total DNA was quantified after precipitation using a Quant-iT™ dsDNA 
High-Sensitivity Assay Kit following the manufacturer’s instructions.  Briefly 
Quant-iT™ dsDNA HS reagent (contents are trade secret, CTS) was diluted (1:200) 
in Quant-iT™ dsDNA HS buffer (CTS) in a plastic container, and 200 µl of the 
working solution added to the appropriate wells of a microplate. 10 µl of λ DNA 
standards (0-100 ng/µl) (CTS) and experimental samples were added to the 
corresponding wells and mixed well. The plate was read immediately using a plate 
reader (page 49) at 510/527 nm fluorescein wavelength. Fluorescence was recorded 
using the provided software (page 49). The standard curve was used to determine 
DNA concentration of the experimental samples. An example of a DNA standard 
curve can be found in page 270. The sensitivity of the assay was 0.5 ng/µl and was 
calculated by adding two standard deviations to the mean absorbance value of 0 
ng/µl standard replicates and then determining the concentration from the standard 
curve. 
 
2.3.5.3 Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) 
 
2.3.5.3.1 Reverse transcription 
 
Total RNA was reverse transcribed to make complementary DNA (cDNA) 
using SuperScript® III Reverse Transcriptase according to manufacturer’s protocol. 
Quantities of RNA reverse transcribed varied between 0.2-29.8 ng/µl for the surface 
zone of the model and 12.8-219.4 ng/µl for the deep zone of the model. Briefly, total 
RNA (8.5 µl) was mixed with 2.5 mM dNTPs and 250 ng of random primers and 
incubated for 5 min at 65°C and then placed on ice for 2 min. 5X first strand 
synthesis buffer, 0.1M dithiothreitol (DTT), 40 units Recombinant RNasin® 
Ribonuclease Inhibitor and 200 units SuperScript® III Reverse Transcriptase were 
added in a total reaction volume of 20 µl. The reverse transcription reaction was 
carried out (25°C for 5 min, 50°C for 50 min and 70°C for 15 min), and held at 4ºC 
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on a thermal cycler (page 48). Samples were used immediately or stored at -20ºC 
until needed. 
 
2.3.5.3.2 Standard PCR 
 
After reverse transcription, PCR was carried out for non-quantitative 
amplifications in 25 µl reactions containing 1.5-3.5 mM magnesium chloride 
(MgCl2), 0.2 µM of each forward and reverse primer, GoTaq® Flexi buffer (pH 8.5), 
200 nM dNTPs and 1 unit GoTaq® Flexi DNA polymerase. Using a thermal cycler 
(page 48), after an initial denaturation step of 3 min at 95°C, samples were amplified 
for 30-40 cycles at 95°C for 30 sec, 55-66°C for 30 sec (annealing) and 72°C for 30 
sec (extension) followed by a final extension step for 10 min at 72°C. Samples were 
held at 4ºC before the products were separated by agarose gel electrophoresis. Each 
gene assay was optimised by varying cycle number (30-40), MgCl2 concentration 
(1.5-3.5 mM), primer concentration (0.02 µM, 0.1 µM and 0.2 µM), and annealing 
temperature (55-66°C). No template (water blank) and positive controls were 
included in all reactions.  
As a result, these conditions varied between optimised primer pairs (Tables 2.1 and 
2.2). PCR was also carried out for 18S ribosomal RNA (18S rRNA) to check the 
integrity of cDNA. 
 
2.3.5.3.3 Agarose gel electrophoresis 
 
PCR products were separated in 2 % agarose gels containing SafeView 
nucleic acid stain at 10 µl/100 ml. Gel electrophoresis was carried out in 1X TBE 
(appendix 9.2) buffer together with a low molecular weight DNA ladder spanning 
25-766 base pairs (bp) (page 268). Gels were visualised and photographed under 
ultraviolet (UV) light (page 48). 
 
2.3.5.3.4 Quantitative PCR (qPCR) 
 
qPCR reactions were carried out using SYBR® Green I fluorescent dye which 
binds to all double stranded DNA. The fluorescence signal of the dye increases 
proportionally as more double stranded DNA accumulates during amplification. The 
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threshold of this increase was automatically set to the centre of the logarithmic phase 
of the amplification curve for each gene (qPCR software, page 48). As a result, a 
cycle threshold value (Ct), i.e. the cycle number at which the fluorescence crosses 
the threshold, was generated. Following amplification, the PCR products are melted 
during a dissociation cycle. The decrease in fluorescence with increasing temperature 
gives a dissociation curve of the specificity of the reaction, as the dissociation 
temperature depends on the length and sequence of the product. 
 
Using a Real-Time PCR System (page 48), polypropylene RT-qPCR plates 
and optical strip caps, amplifications were carried out for each cDNA sample in 25 
µl reactions. Each reaction contained 0.1 or 0.2 µM forward and reverse primers 
(Tables 2.1 and 2.2), 12.5µl of 2X JumpStart™ Taq ReadyMix™ with SYBR® Green I 
dye, 2.5 or 3.5 mM MgCl2  (Tables 2.1 and 2.2), 1 µl of cDNA and DEPC-treated 
water to make up the reaction volume to 25 µl. Thermocycling consisted of 10 min 
denaturation cycle at 95°C, followed by 40 cycles of 95°C for 30 sec, 60°C for 30 
sec (annealing), 72°C for 30 sec (extension) and one dissociation cycle at 95°C for 1 
min, 55°C for 1 min and 95°C for 30 sec. Results were analysed using the qPCR 
Software (page 48). 
 
2.3.5.3.4.1 cDNA standard curves 
  
 Standard curves were performed to assess the efficiency and linear range of 
detection for all primers and optimise their reaction conditions. Stock MLO-Y4 or 
MC3T3-E1(14) cDNA (1-5 µg RNA reverse transcribed) was serially diluted 1:10 in 
DEPC-treated water giving a range of cDNA concentrations from 101 (stock) to 10-
6  or 1:5 to give a range of cDNA concentrations from 101 (stock) to 6.4x10-5. Each 
gene assay was optimised by varying MgCl2 concentrations (2.5 and 3.5 mM) and 
primer concentrations (0.1 and 0.2 µM). Standard curves of 90-110 % efficiency and 
with an R2 value of ≥0.99 were accepted as valid. An example of a standard curve 
can be found in page 268. 
 
 
 
56 
 
Chapter 2 
2.3.5.3.4.2 Reference genes (RG) 
 
 RGs act as internal controls when performing RT-qPCR. Ideally, a RG would 
be universally recognised and should have constant expression levels regardless of 
sample, treatment and experimental design. However, several studies have shown 
that no such gene has been found (Thellin et al., 1999, Bustin, 2000, Schmittgen and 
Zakrajsek, 2000, Suzuki et al., 2000, Warrington et al., 2000, Bustin, 2002, Tricarico 
et al., 2002) and reported expression variation of RGs (Thellin et al., 1999, Bustin, 
2000, Suzuki et al., 2000, Tricarico et al., 2002, Bemeur et al., 2004, Sugden et al., 
2010). Therefore, identification and validation of a stable RG for each experimental 
design is important. 
 
 In all cases, RT-qPCR was carried out using three RGs, 18S rRNA, 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and hypoxanthine-guanine 
phosphoribosyltransferase (HPRT1). The most stable RG was determined via 
NormFinder. Expression data for each gene in an experiment were transformed from 
log10 to linear scale using a standard curve and then loaded into the NormFinder 
Microsoft Excel Add-In (http://www.mdl.dk/publicationsnormfinder.htm) (Andersen 
et al., 2004). NormFinder, is a mathematical algorithm which finds the best RG or 
combination of two genes from a set of candidates by ranking them according to 
expression stability in a given sample set and experimental design (Andersen et al., 
2004). This algorithm works by calculating the intragroup variation, e.g. differences 
in expression within all surface zone and all deep zone samples, and the intergroup 
variation, e.g. differences in expression between surface zone and deep zone samples 
(Andersen et al., 2004). The intra- and intergroup variation values are then combined 
to give a stability value which represents the systematic error that will occur when 
using a particular RG. This approach then ranks the top three genes  and combination 
of two genes with minimum intra- and intergroup variation and provides a stability 
value for the best gene (Andersen et al., 2004).  The top ranked gene or combination 
of two genes, combined by calculating the geometric mean, was used for 
normalisation and is clearly stated in the methods section of the appropriate 
experimental chapter and relevant figure legends of this thesis.  
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2.3.5.3.4.3 Relative RT-qPCR 
  
 Relative quantification involves normalising the expression of the gene of 
interest to that of a stable RG in a particular sample, e.g. treated sample, and then 
calibrating this expression to a reference sample, e.g. an untreated control. The 
experimental sample group used as calibrators is clearly stated in the methods section 
of the corresponding chapters. This method requires that both primer sets for the RG 
and the gene of interest have similar efficiencies (90-110 %) for all samples. Relative 
quantitation of RT-qPCR products was calculated using the 2(-∆∆Ct) method as 
described by (Livak and Schmittgen, 2001). Briefly, the appropriate RG was 
determined as in page 57, then for each experimental sample the Ct value of the RG 
was subtracted from the Ct value of the gene of interest (GOI) (CtGOI – CtRG). This 
gives normalised values called delta Ct (∆Ct). Then, the ∆Ct for each experimental 
sample was subtracted from the ∆Ct of the chosen calibrator, giving a delta-delta Ct 
value (∆∆Ct) resulting in values expressed relative to the calibrator. Finally, all ∆∆Ct 
values were converted to Relative Expression Units (REU) by 2(-∆∆Ct). Means, 
Standard Deviation (STDEV) and Standard Error of the Mean (SEM) were obtained 
from the REU values. 
 
2.3.5.4 Primer design 
 
Primers were designed for known gene sequences 
(http://www.ncbi.nlm.nih.gov/gene) using the Primer-BLAST option from the 
National Center for Biotechnology Information (NCBI) website 
(http://www.ncbi.nlm.nih.gov), unless otherwise stated. Primer-BLAST uses the 
Primer 3 web-based program (http://primer3.sourceforge.net/) to design PCR primers 
and then uses BLAST (Basic Alignment Search Tool) and a global alignment 
algorithm to avoid primer pairs that may cause non-specific amplifications. Primer-
BLAST also ensures similar melting temperatures and GC % content, minimum 
primer-dimer formation and excludes 3’ end complementation. For each gene, except 
OCN, primers spanned an intron in order to discriminate genomic DNA products and 
amplicon sizes were between 100-150 bp. Accession number, nucleotide sequences, 
amplicon size and source for each primer used can be found in Tables 2.1 and 2.2. 
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Table 2.1 Primer details for RGs and bone markers with their optimum conditions for RT-PCR and RT-qPCR 
Gene Primers (5'-3') 
Amplicon 
size (bp) 
PCR conditions qPCR conditions Source 
   
[Primers] &  
[MgCl2] 
Cycle 
Nº 
Tm 
(ºC) 
[Primers] &  
[MgCl2] 
Tm 
(ºC) 
 
GAPDH Fwd - GACGGCCGCATCTTCTTGTGCA 
114 
0.2 µM Primers 
2.5 mM MgCl2 
 
32 60 
0.1 µM Primers 
60 Primer-BLAST 
NM_008084.2 Rev - TGCAAATGGCAGCCCTGGTGAC 3.5 mM MgCl2 
18S rRNA Fwd - GCAATTATTCCCCATGAACG 
125 
0.2 µM Primers 
2.5 mM MgCl2 
 
30 60 
0.2 µM Primers 
60 Dr Sophie Gilbert 
NR_003278.3 Rev - GGCCTCACTAAACCATCCAA 3.5 mM MgCl2 
HPRT1 Fwd - CGTGATTAGCGATGATGAACCAGGT 
149 
0.2 µM Primers 
2.5 mM MgCl2 
 
35 55 
0.1 µM Primers 
60 Primer-BLAST 
NM_013556.2 Rev - CCATCTCCTTCATGACATCTCGAGC 2.5 mM MgCl2 
COL1A1 Fwd - ACTGCCCTCCTGACGCATGG 
140 
0.2 µM Primers 
2.5 mM MgCl2 
 
35 60 
0.1 µM Primers 
60 Primer-BLAST 
NM_007742.3 Rev - TCGCACACAGCCGTGCCATT 3.5 mM MgCl2 
ALP Fwd - GCTGGCCCTTGACCCCTCCA 
132 
0.2 µM Primers 
2.5 mM MgCl2 
 
35 64 
0.1 µM Primers 
60 Primer-BLAST 
NM_007431.2 Rev - ATCCGGAGGGCCACCTCCAC 2.5 mM MgCl2 
SOST* 
NM_024449.5 
Fwd - CCAAAGACGTGTCCGAGTACAG 
112 
0.2 µM Primers 
2.5 mM MgCl2 
 
40 66 NI NI Dr Karen Brakspear 
Rev - CACTGGCCGGAGCACAC 
E11  Fwd - AAGATGGCTTGCCAGTAGTCA 
118 
0.2 µM Primers 
2.5 mM MgCl2 
 
35 60 
0.2 µM Primers 
60 Dr Deborah Mason 
NM_010329.2 Rev - GGCGAGAACCTTCCAGAAAT 3.5 mM MgCl2 
OCN Fwd - CCGCCTACAAACGCATCTAT 
153 
0.2 µM Primers 
2.5 mM MgCl2 
 
35 60 
0.1 µM Primers 
60 Primer-BLAST 
NM_007541.2 Rev - TTTTGGAGCTGCTGTGACAT 3.5 mM MgCl2 
Runx2 Fwd - GACGAGGCAAGAGTTTCACC 
120 
0.2 µM Primers 
2.5 mM MgCl2 
 
35 58 
0.1 µM Primers 
60 Dr Deborah Mason 
NM_001145920.2 Rev - GTCTGTGCCTTCTTGGTTCC 2.5 mM MgCl2 
RANKL Fwd - CGCTCTGTTCCTGTACTTTCGAGC 
116 
0.2 µM Primers 
2.5 mM MgCl2 
 
35 55 
0.2 µM Primers 
60 Primer-BLAST 
NM_011613.3 Rev - TCGAGTCCTGCAAATCTGCGTTTT 2.5 mM MgCl2 
OPG Fwd - GAGTGTGAGGAAGGGCGTTAC 
111 
0.2 µM Primers 
2.5 mM MgCl2 
 
40 55 
0.2 µM Primers 
60 Dr Deborah  Mason 
NM_008764.3 Rev - GCAAACTGTGTTTCGCTCTG 2.5 mM MgCl2 
SV40 large T-antigen Fwd - AGGGGGAGGTGTGGGAGGTTTT 
100 
0.2 µM Primers 
2.5 mM MgCl2 
 
35 64 
0.1 µM Primers 
60 Primer-BLAST 
 YP_003708382.1 Rev - TCAGGCCCCTCAGTCCTCAC 2.5 mM MgCl2 
*Optimised conditions for femur cDNA (positive control) only; NI: not investigated. 
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Table 2.2 Primer details for adenosine, calcium-sensing and glutamate receptors and transporters with their optimum conditions for 
RT-PCR and RT-qPCR 
 
Gene Primers (5'-3') 
Amplicon 
size (bp) 
PCR conditions qPCR conditions Source 
   
[Primers] &  
[MgCl2] 
Cycle 
Nº 
Tm 
(ºC) 
[Primers] &  
[MgCl2] 
Tm 
(ºC) 
 
A1* Fwd - GATCGGTACCTCCGAGTCAA 160 0.2 µM Primers 35 60 NI NI Dr Bronwen Evans 
NM_001008533.2 Rev - TTGGCTATCCAGGCTTGTTC 2.5 mM MgCl2 
A2A Fwd - GGCTATTGCCATCGACAGAT 
228 
0.2 µM Primers 
35 62 
0.2 µM Primers 
60 Dr Bronwen Evans 
NM_009630.2 Rev - ATGGGTACCACGTCCTCAAA 2.5 mM MgCl2 2.5 mM MgCl2 
A2B Fwd - TGCTCACACAGAGCTCCATC 
158 
0.2 µM Primers 
35 60 
0.1 µM Primers 
60 Dr Bronwen Evans 
NM_007413.4 Rev - AGTCAATCCAATGCCAAAGG 2.5 mM MgCl2 3.5 mM MgCl2 
A3* Fwd - TCCCTGATTACCACGGACTC 151 0.2 µM Primers 40 60 NI NI Dr Bronwen Evans 
NM_001174169.1 Rev - TCCTTCTGTTCCCCACATTC 2.5 mM MgCl2 
CaSR (exons 6-7)* Fwd - GTGGTGAGACAGATGCGAGT 100 0.2 µM Primers 35 55 NI NI (Chang et al., 2008a) 
NM_013803.2 Rev - GCCAGGAACTCAATCTCCTT 2.5 mM MgCl2 
AMPAR2 Fwd - GGAAGTAAGGAAAAGACCAGTGCCCTC 
85 
0.2 µM Primers 
40 60 
0.2 µM Primers 
2.5 mM MgCl2 
NI Dr Cleo Bonnet 
NM_001083806.1 Rev - TTGCCAAACCAAGGCCCCCG 2.5 mM MgCl2 
KA1 Fwd - GAACTTGGGATGGTGTCAGC 
135 
0.2 µM Primers 
40 60 
0.1 µM Primers 
3.5 mM MgCl2 
NI Dr Cleo Bonnet 
NM_146072.4 Rev - AGAAAGCATGGGATTGGTTG 2.5 mM MgCl2 
mGluR1* Fwd - TGGGCGAGTTCTCACTCATT 169 0.2 µM Primers 40 60 NI NI Dr Cleo Bonnet 
NM_016976.3 Rev - TTCCTTGTGTTGGTGTCCAG 2.5 mM MgCl2 
GLAST1 Fwd - GGTCACTGCTGTCATTGTGG 
123 
0.2 µM Primers 
40 60 
0.1 µM Primers 
60 Dr Karen Brakspear 
NM_148938.3 Rev - AGCATCTGCAGCATCCTCAT 2.5 mM MgCl2 2.5 mM MgCl2 
EAAC1 Fwd - ATCCAGCATGATCACAGGTG 
104 
0.2 µM Primers 
2.5 mM MgCl2 
40 60 NI NI Dr Karen Brakspear 
NM_009199.2 Rev - TTACAGCAATGACGGTGGTG 
*Optimised conditions for femur cDNA (positive control) only; NI: not investigated. 
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2.3.5.5 Plasmid preparations for cloning 
 
RT-PCR products from each of the primer pairs used (Tables 2.1 and 2.2) 
were cloned and sequenced to confirm primer and target specificity. 
 
2.3.5.5.1 Purification of DNA from gel 
 
PCR products from each gene amplification reaction were excised from an 
agarose gel using sterile scalpels under UV light and weighed in 1.5 ml 
microcentrifuge tubes. DNA was extracted and purified using a QIAquick Gel 
Extraction Kit according to manufacturer’s instructions. Briefly, PCR products were 
incubated at 50ºC for 10 min in Buffer QG (CTS) to dissolve the gel. DNA was 
mixed with 2-propanol (1 volume) and bound using QIAquick columns with 
collection tubes by centrifugation (1 min). 0.5 ml of Buffer QG was added and 
columns centrifuged (1 min). DNA was washed with Buffer PE (0.75 ml, CTS), 
centrifuged (1 min) and any remaining Buffer PE was removed by a further 
centrifugation step (1 min). Finally, DNA was eluted into 1.5 ml microcentrifuge 
tubes with 30 µl DEPC-treated water by centrifugation (1 min). All centrifugation 
steps were carried out at 13,000 rpm and rt. 
 
2.3.5.5.2 Cloning into pGEM ®-T vector 
 
DNA (5-11.4 ng, according to primer pair amplicon size) was ligated into 50 
ng pGEM®-T plasmid vector (page 269), o/n at 4ºC, in the presence of 3 units of T4 
DNA ligase and Rapid Ligation Buffer (containing 30 mM Tris-HCl pH 7.8, 10 mM 
MgCl2, 10 mM DTT, 1 mM ATP, 5 % polyethylene glycol) in a 10 µl reaction 
volume. 
 
2.3.5.5.3 Transformation into E. coli competent cells 
 
Ligation reactions were transformed into 25 µl E. coli JM109 competent cells 
according to manufacturer’s protocol by incubating on ice for 20 min and then heat-
shocking for 50 sec at 42ºC. Reactions were then incubated on ice (2 min) before 
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adding super optimal broth with catabolite repression (SOC) medium (475 µl) and 
incubating for 1.5 hr at 37°C with shaking (150 rpm). 100 µl of each transformation 
was then plated onto lysogeny broth (LB) agar plates (containing 100 µg/ml 
ampicillin, 500 µg/ml IPTG and 100 µg/ml X-gal) (page 267) and incubated o/n at 
37°C. Recombinant (white) colonies were picked at random and directly screened for 
inserts by PCR (page 55, primers as in Table 2.1 and 2.2) using a 10 min 95°C 
denaturation step to lyse all cells. Positive colonies were grown in LB broth 
(containing 100 µg/ml ampicillin) (page 267) o/n at 37°C with shaking (150 rpm). 
 
2.3.5.5.4 Plasmid DNA purification 
 
Plasmid DNA was purified from recombinant colony broth cultures using a 
Wizard® Plus SV Miniprep Kit following the manufacturer’s instructions. Briefly, 5 
ml broth cultures were pelleted by centrifugation (5 min), supernatant discarded and 
pellets thoroughly resuspended with Cell Resuspension Solution (250 µl, CTS). Cell 
Lysis Solution (250 µl, CTS) was then added and mixed. Alkaline Protease Solution 
(10 µl, CTS) was mixed and samples were then incubated (5 min). Neutralisation 
Solution (350 µl, CTS) was mixed with samples before centrifugation (10 min). 
Plasmid DNA was bound by using Spin Columns with collection tubes and by 
centrifugation (1 min). Samples were washed with Wash Solution (750 µl, CTS) and 
centrifuged (1 min). Samples were washed for a second time with Wash Solution 
(250 µl, CTS) and centrifuged (2 min). DNA was eluted into a clean 1.5 ml 
microcentrifuge tube with 100 µl DEPC-treated water by centrifugation (1 min). All 
mixing steps were done by inverting 4 times. All centrifugation steps were done at 
13,000 rpm and at rt. 
 
2.3.5.5.5 DNA sequencing 
 
 pGEM®-T cloned inserts were sequenced by the Cardiff University Molecular 
Biology Unit DNA sequencing core facility using T7 forward and SP6 reverse 
primers. nBLAST (nucleotide collection BLAST) was then used to check the identity 
of the insert sequence with the target sequence. 
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2.3.6 Microscopy 
 
2.3.6.1 Light microscopy 
 
Monolayer cultures were observed using an inverse-light microscope and 
images taken with a Coolpix 4500 camera prior to incorporation into gels (page 48). 
For the duration of each experiment, 3D collagen co-cultures were observed every 
day, as above, at random fields of view across gel depth and imaged as above at 
various time points. 
 
2.3.6.2 Specimen preparation for cryosection imaging  
 
3D collagen co-cultures were washed with phosphate buffered saline (PBS) 
(page 267), fixed with 1 % paraformaldehyde (PFA) (page 267) for 30 min at 4°C 
and then washed 3-4 times with PBS over 2 days at 4°C. They were then infiltrated 
with a 1:1 dilution of OCT mounting media compound for cryotomy in PBS o/n at 
4°C in order to reduce ice crystal formation. Specimens were removed from wells 
and cut into quarters (Figure 2.1A) which were then orientated into square plastic 
moulds; embedded in OCT compound and frozen in 2-methyl butane, previously 
cooled in dry ice. Specimens were then transferred to a cryostat, removed from the 
mould and mounted on a cryostat chuck by freezing with OCT compound. 20 µm 
transverse sections (Figure 2.1B), showing the surface zone down to the bottom of 
the collagen gel (Figure 2.1C), were cut using a cryostat (page 48) and placed on 
poly-lysine coated slides (Figure 2.1D). Sections were stored at -20°C until needed. 
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B A 
D C 
Figure 2.1 Processing of 3D co-cultures for cryosectioning. A) Diagram showing a 3D 
co-culture cut into quarters looking down on the surface zone (osteoblasts). B) Position 
of a 3D co-culture quarter indicating the direction of cryosectioning to give transverse 
sections which also show cells from the outside into the middle of the 3D co-culture. C) 
Transverse section of a 3D co-culture showing the full depth of the gel. D) Position of 
cryosections in a poly-lysine coated slide.  
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2.3.6.3 Immunolocalisation and histochemistry 
 
Details on blocking sera, primary and secondary antibodies and nonimmune 
immunoglobulins used, including concentrations and incubation times, can be found 
in Tables 2.3 and 2.4. For all immunolocalisation 4-6 sections of each replicate co-
culture were observed. 
 
2.3.6.3.1 Immunocytochemistry 
 
2.3.6.3.1.1 Quenching of endogenous peroxidases  
 
Hydrophobic rings were drawn around each cryosection on poly-lysine 
coated slides using an ImmEdge pen. Cryosections were then rehydrated in PBS 0.1 
% TWEEN® 20 (PBST), incubated in 0.3 % hydrogen peroxide (H2O2)  in PBST for 
30 min to block endogenous peroxidase activity and washed in PBST (3 times in 5 
min). 
 
2.3.6.3.1.2 Primary and secondary antibody application 
 
For immunostaining with a secondary antibody conjugated to horseradish 
peroxidase (HRP), sections were blocked for non-specific binding with serum and 
incubated with primary antibody (Table 2.3). The primary antibody was replaced in 
control sections with PBST alone as a control for general non-specific binding of the 
procedure, or with nonimmune immunoglobulins (Table 2.3), to show non-specific 
binding that may result from the primary antibody. All sections were then washed 
(page 65) and incubated with the corresponding secondary antibody. Washing in 
PBST was then repeated (page 65).  
 
For immunostaining using a Vectamount Universal Elite ABC kit, sections 
were treated with primary antibody or controls as above. After washing in PBST (3 
times in 5 min), following manufacturer’s instructions, sections were incubated with 
biotinylated secondary antibody (CTS) for 30 min (Table 2.3), washed (PBST, 3 
times in 5 min), and incubated with ABC reagent (100 µl Reagent A, avidin DH 
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solution) and 100 µl Reagent B (biotinylated enzyme, usually HRP or alkaline 
phosphatase) mixed together in 5 ml PBST) for 30 min. Washing was repeated as 
previously described. 
 
2.3.6.3.1.3 Disclosure 
 
All immunostaining was detected by incubating 2-5 min at rt with nickel-
enhanced DAB, which acts as a substrate to the HRP or biotinylated enzyme by 
binding to the secondary antibody. DAB is then oxidised giving a visible brown 
colour or a grey-black colour if the reaction is nickel-enhanced. Briefly, 2 drops of 
Buffer Stock Solution (CTS), 4 drops of DAB Stock Solution (CTS), 2 drops of 
Hydrogen Peroxide Solution (CTS) and 2 drops of Nickel Solution were added to 5 
ml of distilled water and mixed well. The reaction was stopped by washing the slides 
in tap water (3 times in 5 min). All slides were dehydrated in alcohols and cleared in 
xylene before mounting with DPX. Slides were left to dry o/n before imaging with a 
digital camera attached to a light microscope, and analysed with the software 
provided (page 49). All controls, where primary antibodies were omitted or 
substituted with nonimmune immunoglobulins, showed no labelling.  
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2.3.6.3.2 Immunofluorescence 
 
For immunostaining with a secondary antibody conjugated to a fluorescent 
dye, hydrophobic rings were drawn around cryosections (page 65), rehydrated (page 
65) and blocked (page 65). Cryosections were either incubated with primary 
antibody or with PBST or non-immune immunoglobulins as negative controls (Table 
2.4), washed (PBST, 3 times in 5 min) and incubated with a secondary antibody 
conjugated to a fluorescent dye (Table 2.4). Cryosections were washed (PBST, 3 
times in 5 min), and mounted with Fluoroshield™ with DAPI as a nuclear 
counterstain. For immunofluorescence of CaSR, cryosections were incubated with 50 
mM ammonium chloride (NH4Cl) in PBS for 10 min prior to blocking and all 
washing steps consisted of 4 washes in PBS for 5 min each (personal communication 
with Mr Martin Schepelmann). Results were analysed with an epi-fluorescence 
microscope with the provided software (page 48), except for CX43 results which 
were analysed by confocal microscopy (page 72). 
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Table 2.3 Immunocytochemistry conditions.  
Protein Primary antibody Secondary antibody 
Immunoglobulins 
control 
Block 
E11 
(#) 
2.5 µg/ml anti-mouse E11 
(podoplanin) antibody                                       
(goat polyclonal) 
1:800 rabbit anti-goat  
(HRP conjugated) 
2.5 µg/ml goat IgG 
5 % normal 
rabbit serum 
o/n at 4°C 30 min at rt o/n at 4°C 20 min 
EAAC1 
(^) 
5 µg/ml anti-rat EAAC1 IgG       
(rabbit polyclonal) 
1:100 goat anti-rabbit 
(HRP conjugated) 
5 µg/ml rabbit IgG 
5 % normal 
goat serum 
o/n at 4°C 30 min at rt o/n at 4°C 20 min 
GLAST1  
(^) 
5 µg/ml anti-rat glutamate 
transporter (GLAST1) antiserum 1 
(rabbit polyclonal) 
1:100 goat anti-rabbit 
(HRP conjugated) 
5 µg/ml rabbit IgG 
5 % normal 
goat serum 
o/n at 4°C 30 min at rt o/n at 4°C 20 min 
KA1* 
(^) 
0.156 µg/ml anti-KA1 antibody  
(rabbit polyclonal) 
7.5 µg/ml  anti-rabbit 
biotinylated antibody 
in PBST with 1.5 % 
serum 
0.156 µg/ml rabbit 
IgG 
1.5 % normal 
goat serum 
o/n at 4°C 30 min at rt o/n at 4°C 20 min 
mGluR1 
(~) 
5 µg/ml anti-mGluR1 antibody 
(rabbit polyclonal) 
o/n at 4°C 
1:100 goat anti-rabbit 
(HRP conjugated) 
5 µg/ml rabbit IgG 
5 % normal 
goat serum 
30 min at rt o/n at 4°C 20 min 
Adenosine 
receptor A1 
(+) 
2.5 µg/ml anti-adenosine A1 
receptor antibody                                     
(rabbit polyclonal) in 5 % mouse 
serum 
1:100 goat anti-rabbit 
(HRP conjugated) 
2.5 µg/ml rabbit 
IgG in 5 % mouse 
serum 
5 % normal 
goat serum 
o/n at 4°C 30 min at rt o/n at 4°C 20 min 
Adenosine 
receptor A2A 
(+) 
2.5 µg/ml anti-adenosine receptor 
A2A antibody                             
(rabbit polyclonal) in 5 % mouse 
serum 
1:100 goat anti-rabbit 
(HRP conjugated) 
2.5 µg/ml rabbit 
IgG in 5 % mouse 
serum 
5 % normal 
goat serum 
o/n at 4°C 30 min at rt o/n at 4°C 20 min 
Adenosine 
receptor A2B 
(+) 
5 µg/ml anti-human A2BR IgG 
(rabbit polyclonal) in 5 % mouse 
serum 
1:100 goat anti-rabbit 
(HRP conjugated) 
5 µg/ml rabbit IgG  
in 5 % mouse 
serum 
5 % normal 
goat serum 
o/n at 4°C 30 min at rt o/n at 4°C 20 min 
Adenosine 
receptor A3 
(+) 
5 µg/ml anti-rat A3R IgG         
(rabbit polyclonal) in 5 % mouse 
serum 
1:100 goat anti-rabbit 
(HRP conjugated) 
5 µg/ml rabbit IgG  
in 5 % mouse 
serum 
5 % normal 
goat serum 
o/n at 4°C 30 min at rt o/n at 4°C 20 min 
*Avidin-biotin complex was added after secondary antibody (30 min at rt). Primary antibodies were kind 
gifts from (#) Dr Bronwen Evans, (^) Dr Cleo Bonnet (School of Bioscience, Cardiff University, UK), (~) 
Prof Daniela Riccardi (School of Bioscience, Cardiff University, UK) and (+) Dr Jack Ham (School of 
Medicine, Cardiff University, UK). All dilutions were in PBST unless otherwise stated. 
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Table 2.4 Immunofluorescence conditions. 
Protein Primary antibody Secondary antibody 
Immunoglobulins 
control 
Block 
Type I 
collagen 
(-) 
5 µg/ml anti-type I collagen                   
(mouse monoclonal) 
5 µg/ml goat anti-mouse                  
(Alexa Fluor 594) 
5 µg/ml mouse IgG 
5 % normal goat 
serum 
1 hr at rt 1 hr at rt 1 hr at rt 20 min 
CX43 
(-) 
5 µg/ml anti-connexin 43     
(mouse monoclonal) 
2.5 µg/ml horse anti-
mouse (Dylight 594) 
0.25 µg/ml mouse 
IgG 
5 % normal 
horse serum 
o/n at 4°C 1 hr at rt o/n at 4°C 20 min 
SV40 
large T-
antigen 
 
5 µg/ml anti-SV40 T-antigen 
antibody                             
(mouse monoclonal) 
5 µg/ml horse anti-mouse 
(Dylight 594) 
5 µg/ml mouse IgG 
5 % normal 
horse serum 
1 hr at rt 1 hr at rt 1 hr at rt 20 min 
CaSR 
(~) 
2 µg/ml anti-CaSR                 
(rabbit polyclonal) diluted in 
0.1 % (v/v) Triton X100 with 1 
% (w/v) BSA in PBS 
4 µg/ml goat anti-rabbit                 
(Alexa Fluor 594) diluted 
in 0.1 % (v/v) Triton X100 
with 1 % (w/v) BSA in PBS 
2 µg/ml rabbit IgG 
diluted in 0.1 % (v/v) 
Triton X100 with 1 % 
(w/v) BSA in PBS 
0.1 % (v/v) 
Triton X100 with 
1 % (w/v) BSA in 
PBS 
o/n at 4°C 1 hr at rt o/n at 4°C 1 hr at rt 
 
Primary antibodies were a kind gift from (-) Dr Jim Ralphs (School of Bioscience, Cardiff University, 
UK) and (~) Prof Daniela Riccardi. BSA: bovine serum albumin. All dilutions were in PBST unless 
otherwise stated. 
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2.3.6.4 Actin filament staining 
 
Actin filament staining was performed in order to assess morphology of the 
surface and deep zones of the model by delineating the cytoskeleton of the cells. In 
all cases results were analysed by confocal microscopy (section 2.3.6.6).  
 
2.3.6.4.1 Surface zone 
 
The 3D co-cultures contain a layer of osteoblasts which could be easily lost 
whilst cryosectioning, therefore analysis of the surface zone was performed on whole 
gel quarters, as opposed to cryosections, as for the deep zone. Day 7 3D collagen co-
cultures were fixed and washed (page 63), cut into quarters and directly placed in the 
middle of a 2 mm thick nylon washer (which served as a well) attached onto a poly-
lysine coated slide.  The gel quarters were stained o/n at 4°C with 5 µM phalloidin 
conjugated with Atto488 (Phalloidin-Atto488). They were then washed in PBST (3 
times in 5 min) and mounted with Fluoroshield™ with DAPI as a nuclear counterstain 
and observed by looking directly down on to the gel surface (page 72). For analysis, 
5 arbitrary regions of the surface zone of each replicate co-culture were observed. 
 
2.3.6.4.2 Deep zone 
 
Hydrophobic rings were drawn around day 7 3D co-culture cryosections 
(page 65), rehydrated (page 65), incubated with 5 µM Phalloidin-Atto488 (1 hr at rt), 
washed and mounted (page 67). For analysis, 4-6 sections of each replicate co-
culture were observed (page 72). 
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2.3.6.5 Cell death 
 
Ethidium homodimer is a membrane-impermeable fluorescent dye that is 
weakly fluorescent unless bound to DNA when it emits red fluorescence (Gaugain et 
al., 1978a, Gaugain et al., 1978b). The dye is generally used for viability assays as 
dead or dying cells have disrupted cell and nuclear membranes and therefore 
ethidium homodimer is able to penetrate and bind to DNA. The dye is not able to do 
this in live cells as their membranes are intact (Glazer et al., 1990). 
 
DAPI is a fluorescent dye that binds strongly to A-T rich regions of double-
stranded DNA and so emitting blue fluorescence. The dye can also bind to A-U rich 
regions in RNA but it is not as strongly fluorescent as when it binds DNA. DAPI is a 
membrane-permeable dye and therefore it can bind to DNA in both dead and live 
cells (Kapuscinski, 1995). 
 
At day 1 and day 7, culture medium was removed and 3D collagen co-
cultures were washed with PBS and then incubated with 1 µM ethidium homodimer 
in serum-free medium for 2 hr at 4°C with gentle agitation. This procedure was done 
to ensure the dye penetrates the depth of the gel whilst slowing down cell 
metabolism of the dye. Co-cultures were then incubated for a further 2.5 hr at 37°C 
in 5 % CO2/95 % air atmosphere and washed o/n at 37°C in 5 % CO2/95 % air 
atmosphere with culture medium containing serum. Positive control co-cultures were 
frozen for 1 hr at -20°C and thawed for 10 min, three times to ensure 100 % death, 
before treating with ethidium homodimer as above.  
 
2.3.6.5.1 Surface zone  
 
For cell death analysis of the surface zone, all 3D collagen co-cultures were 
fixed, washed, cut into quarters (page 63), placed directly into a 2 mm thick nylon 
washer attached onto a poly-lysine coated slide, and mounted (page 67).  For 
analysis, 5 arbitrary regions of the surface zone of each replicate co-culture were 
observed using confocal microscopy (page 72).  
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2.3.6.5.2 Deep zone 
  
For cell death analysis of the deep zone, 3D collagen co-cultures were 
washed with PBS, fixed, infiltrated with diluted OCT compound and cryosectioned 
(page 63). For analysis, 5 random slides of each replicate co-culture were rehydrated 
(page 65) and mounted (page 67). One random section from each slide was observed 
with a fluorescence microscope (page 48). DAPI (blue) labelled nuclei (total number 
of cells) and ethidium homodimer and DAPI (purple) labelled nuclei (number of 
dead cells) were counted across 10 fields of view per section at x20 magnification. 
  
2.3.6.6 Confocal microscopy 
 
Confocal microscopy was performed by Dr Anthony Hayes and Mr Marc 
Isaacs (School of Bioscience, Cardiff University) using a confocal scanning laser 
microscope (page 48). Specimens were observed either directly down onto the 
surface zone (actin filament stain, page 70, and cell death of surface zone, page 71) 
or by observing transverse cryosections (Figure 2.1) (deep zone actin filament stain, 
page 70 and CX43 immunofluorescence, page 67). Samples were scanned using 
appropriate excitation and emission settings for simultaneous recording of DAPI 
(358 Excitation(max), Ex(max), 461 Emission(max), Em(max)) and Phalloidin-Atto488 
(495 Ex(max), 519 Em(max)) for actin filament staining; DAPI and ethidium 
homodimer (590 Ex(max), 617 Em(max)) for cell death, or DAPI and Alexa 594 (590 
Ex(max), 617 Em(max)) for CX43 immunostaining. Specimens were optically sectioned 
using a x63 objective with an arbitrary zoom (surface and deep zone actin filament 
stain, and CX43 immunofluorescence) or x10 objective with a 2.32 zoom (surface 
zone cell death). 5 µm (surface zone) or 0.5 µm (deep zone) step size z-stack optical 
sections through the specimen were reconstructed using confocal software (page 48). 
Maximum intensity models were prepared showing detail of the surface zone or deep 
zone. 
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2.3.7 Protein assays 
 
2.3.7.1 Lactate dehydrogenase assay (LDH) 
 
LDH is an enzyme released naturally by cells into cell culture medium upon 
lysis as a result of cell death. LDH release can also be used to quantify cell number 
by purposely lysing the cultures in question. In this case LDH release is directly 
proportional to cell number. Culture supernatants from 3D MLO-Y4 mono-cultures 
were collected for analysis of LDH release as a result of cell death. For analysis of 
cell number, 3D MLO-Y4 mono-cultures were lysed by adding 200 µl of cell lysis 
buffer (9 % Triton™ X-100 in distilled water), frozen at -80°C for 1 hr, thawed and 
then incubated at 37°C for 45 min. The supernatant of the lysed cultures was then 
collected into a 1.5 ml microfuge and centrifuged (1000 rpm, rt, 5 min) to pellet cell 
debris, the clear lysate kept for analysis. LDH assay was carried out using a CytoTox 
96® Non-Radioactive Cytotoxicity Assay following the manufacturer’s instructions. 
Briefly, 50 µl of experimental samples were added to a 96-well plate followed by 50 
µl of Substrate Mix (CTS). The plate was covered with foil and incubated in the dark 
at rt for 10-30 min according to the reaction. 50 µl of Stop Solution (CTS) was added 
and the plate read at 492 nm wavelength using a plate reader (page 49). If necessary, 
samples were diluted in order to avoid saturation of the assay. Dilutions of samples 
are clearly stated in the relevant experimental chapters.  
 
 
 
 
 
 
 
 
 
 
73 
 
Chapter 2 
2.3.7.2 ELISAs 
 
2.3.7.2.1 PGE2  
 
 PGE2 ELISA was carried out using an Enzo Life Sciences PGE2 kit 
following manufacturer’s instructions. A dilution series of experimental samples 
defined the required dilutions for samples to fit within the standard curve of the 
assay, dilutions are clearly stated in the relevant experimental chapters. All 
experimental samples were within the standard curve. An example of a PGE2 ELISA 
standard curve can be found in page 270. The sensitivity of the assay is 8.26 µl as 
stated by the manufacturer. 
 
Briefly, 100 µl of experimental samples and standards (7.81-1000 pg/ml 
PGE2 in standard diluent) were pipetted into the appropriate wells of the provided 
96-well plate. Blue conjugate (50 µl, blue solution of alkaline phosphatase 
conjugated with PGE2) was added to all wells except the Total Activity (TA) and 
Blank wells. Yellow antibody (50 µl yellow solution of monoclonal antibody to 
PGE2) was added to all wells except the Blank, TA and non-specific binding (NSB) 
wells.  The plate was covered and incubated (o/n, 4ºC). The plate was then emptied, 
and washed 3 times with Wash Solution (400 µl, 5 % Tris buffered saline with 
detergents in distilled water). Blue conjugate (5 µl) was added to the TA wells, pNpp 
Substrate Solution (200 µl, p-nitrophenyl phosphate (pNpp) in buffer) was added to 
all wells, the plate covered and incubated (1 h, 37ºC). Stop Solution (50 µl, trisodium 
phosphate in water) was added to all wells and the plate was read immediately using 
a plate reader (page 49) at 405 nm wavelength with correction between 570 and 590 
nm to correct for optical imperfections in the plate. Absorbance was recorded using 
the provided software (page 49). The standard curve was used to determine PGE2 
concentration of the experimental samples. Data normalisation is clearly stated in the 
relevant experimental chapters.  
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2.3.7.2.2 IL-6  
 
 IL-6 ELISA was carried out using an R&D Systems DuoSet IL-6 ELISA kit, 
a kind gift from Dr Bronwen Evans, following the manufacturer’s instructions. A 
dilution series of experimental samples defined the required dilutions for samples to 
fit within the standard curve of the assay, dilutions are clearly stated in the relevant 
experimental chapters. All experimental samples were within the standard curve 
range. An example of an IL-6 ELISA standard curve can be found in page 270. 
 
Briefly, Capture Antibody (2 µg/ml in PBS of rat anti-mouse IL-6) was used 
to coat a 96-well microplate (100 µl/well, o/n, rt). Wells were aspirated and 
thoroughly washed 3 times with Wash Buffer (400 µl, 0.05 % TWEEN® 20 in PBS, 
pH 7.2-7.4), blocked with Reagent Diluent (300 µl, 1 % BSA in PBS, pH 7.2-7.4, 0.2 
µm filtered), incubated (1 hr, rt) and washed. 100 µl of experimental samples and 
standards (15.62-1000 pg/ml, recombinant mouse IL-6 diluted in Reagent Diluent) 
was added in the appropriate wells, incubated (2 hr, rt), and washed before adding 
Detection Antibody (100 µl, 400 ng/ml biotinylated goat anti-mouse IL-6 diluted in 
Reagent Diluent). The plate was incubated (2 hr, rt) and washed. Streptavidin-HRP 
(100 µl, 1:200 streptavidin conjugated to HRP in Reagent Diluent) was added to each 
well, and the plate incubated in the dark (20 min, rt), and washed. Substrate Solution 
(100 µl, 1:1 mix of Colour Reagent A, H2O2 and Colour Reagent B, 
Tetramethylbenzidine, TMB) was added, and the plate incubated in the dark (20 min, 
rt), before adding Stop Solution (50 µl, 2 N sulphuric acid, H2SO4). The plate was 
read using a plate reader (page 49) at 450 nm wavelength with wavelength correction 
at 540 nm and 570 nm to correct for optical imperfections of the plate. The 
absorbance was recorded using the provided software (page 49). The standard curve 
was used to determine IL-6 concentration of the experimental samples. Data 
normalisation is clearly stated in the relevant experimental chapters.  
 
 
 
 
 
75 
 
Chapter 2 
2.3.7.2.3 PINP 
 
 PINP ELISA was carried out using an Immunodiagnostic systems Rat/Mouse 
PINP EIA kit, a kind gift from Dr Cleo Bonnet, following the manufacturer’s 
instruction. A dilution series of experimental samples defined the required dilutions 
for samples to fit within the standard curve of the assay, dilutions are clearly stated in 
the relevant experimental chapters. All experimental samples were within the 
standard curve range. An example of a PINP ELISA standard curve can be found in 
page 270. The sensitivity of the assay was 0.7 ng/ml as stated by the manufacturer. 
 
Briefly, 50 µl of experimental samples, controls (mouse serum in PBS with 
BSA and 0.025 % sodium azide) and standards (0-77 ng/ml, mouse PINP in PBS 
with mouse and goat serum, BSA and 0.025 % sodium azide) were added to the 
appropriate wells of the 96-well plate provided. 50 µl of PINP Biotin (PINP labelled 
with biotin in PBS with BSA) was added to each well; the plate was covered and 
incubated (1 hr, rt) with shaking (500-700 rpm). The plate was emptied and washed 3 
times with Wash Solution (PBS with Tween). 150 µl of Enzyme Conjugate (avidin-
linked HRP in PBS with protein, enzyme stabilisers and preservative) was added to 
all wells. The plate was then covered, incubated (30 min, rt) and washed. 150 µl of 
TMB Substrate (aqueous formulation of TMB and H2O2) was added to all wells, the 
plate covered and incubated (30 min, rt). 50 µl of Stop Solution (0.5 M hydrochloric 
acid, HCl) was then added and the plate immediately read using a plate reader (page 
49) at 450 nm wavelength with correction at 650 nm wavelength to correct for 
optical imperfections of the plate. The absorbance was recorded using the provided 
software (page 49). The standard curve was used to determine PINP concentration of 
the experimental samples. Data normalisation is clearly stated in the relevant 
experimental chapters.  
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2.3.8 Mechanical loading  
 
2.3.8.1 Manufacturing of loading device 
  
In order to be able to apply strain to the 3D cultures, a 16-well loading plate 
was generated from TECH-SIL 25 Silicone Elastomer (Technovent, Newport, South 
Wales, UK). TECH-SIL 25 (S-25) is a medical-grade silicone with low viscosity. 
200 g of silicone was mixed thoroughly for 2-3 min in a plastic container at a 9:1 
ratio by weight with the platinum catalyst provided. The mixed silicone in the 
container was then placed inside a vacuum chamber (page 49) attached to a vacuum 
pump (page 49) for 10-20 min until all bubbles in the mix disappeared. During this 
process, air was gently let out of the vacuum once or twice by opening the vacuum 
valve and then closing it again in order to help remove bubbles from the mix. The 
silicone mix was then gently poured into the middle of a clean custom-made metal 
mould with its borders previously coated with polyvinyl chloride (PVC) tape. The 
mould was made based upon the dimensions of a standard 48-well tissue culture 
plate in order to fit a 48-well plate lid, and also give 16 wells of 10 mm diameter 
with 150 µm well base thickness. However, the spaces between the wells were filled 
with silicone, and the mould allowed for a series of holes to be made on each side of 
the plate to accommodate hooks for the attachment of the plate to the BOSE loading 
instrument. The mould was overfilled by 10 %, and at this point any remaining 
bubbles were removed with a scalpel. The base of the mould was then pressed down 
and clamped with a G-clamp so that excess silicone seeped out.  The clamped mould 
was then placed into a dry oven at 80°C for a minimum of 1 h to cure the silicone. 
After this, the plate was removed from the mould and immediately wrapped in tin 
foil or lint free tissue paper to avoid dust or dirt sticking to it. The silicone plate was 
then further cured by boiling it at 100°C in distilled water for 3-4 hr. The silicone 
plate was then washed thoroughly with water and detergent and then soaked in 2-3 
changes of tap water per day for 2-3 weeks in order to remove any remaining dirt or 
detergent. The last 2-3 days of soaking were done in distilled water (dH2O). Once 
clean, the plate was autoclaved and was then ready to use. After each use, the plate 
was washed thoroughly with tap water and dH2O but without detergent and 
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autoclaved for re-use. The silicone plate was designed by and manufactured with 
help from Prof Sam Evans (School of Engineering, Cardiff University, UK). 
 
2.3.8.2 Strain measurements 
 
Digital Image Correlation (DIC), based on the use of contrast produced by 
arbitrary speckle patterns, can be used to measure strain (Barranger et al., 2012) in 
the loading plate. DIC compares two digital images of two different mechanical 
states of a particular object: a reference state and a deformed state. A previously 
applied speckle pattern follows the strain of the object, and so the displacement that 
occurs between both reference and deformed state can be measured by matching the 
speckle pattern in small regions of the image (Peters and Ranson, 1982, Chu et al., 
1985).  By using two cameras and matching speckle patterns in each image, the 
position and displacement in three dimensions can be obtained, after calibrating the 
system using a grid of known dimensions to determine the position of the cameras. 
 
The bottom of the plate was covered in a light layer of white Snazaroo face 
paint with a sponge and then a speckle pattern was applied using a sponge and black 
face paint. The patterned was formed by carefully covering the whole bottom of the 
plate in random white and black speckles. The plate was attached using hooks to the 
testing machine vertically (Figure 2.2B) and stretched using a 5 N load cell (Figure 
2.2A) attached to a Servo Hydraulic Testing Machine, which was controlled by an 
MTS FlexTest® GT controller and software (page 49). Images were captured at 2.5 N 
using DIC cameras (page 49) (Figure 2.2C), and the strain was measured with the 
provided software. This method was performed by Prof Sam Evans, Mr John 
McCrory and Miss Hayley Wyatt (School of Engineering, Cardiff University, UK).  
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Figure 2.2 Set-up for strain testing of loading device. A 5N load cell (A) pulls on a 
string attached to the 16-well silicone plate (B) causing strain in each individual 
well. The strain is detected by the cameras (C) filming the speckle pattern on the 
bottom of the plate.  
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2.3.8.3 Mechanical loading of 3D collagen mono- and co-cultures 
 
Mechanical loading using the developed silicone loading device (page 77) 
was performed on 3D collagen osteocyte mono-cultures, or on 3D collagen 
osteocyte-osteoblast co-cultures.  
 
3D osteocyte mono-cultures were prepared and cultured in the silicone plate 
(page 77) by embedding MLO-Y4 cells in type I collagen gels (page 52). 800 µl of 
DMEM GlutaMAX™ supplemented with 100 U/ml penicillin, 100 µg/ml 
streptomycin and 5 % DFBS was added on top of the 3D collagen MLO-Y4 mono-
cultures and they were then incubated o/n at 37°C in 5 % CO2/95 % air atmosphere 
for 24, 48 or 72hr without changing culture medium prior to load, or 7 days where 
culture medium was changed every 2-3 days and prior to loading. 
 
 3D collagen co-cultures were prepared and cultured in the silicone loading 
device (page 77) for 7 days (page 52).  At day 7, cultures were treated for 1 h with 
either AMPA/KA antagonist NBQX (200 µM in DMEM 5% DFBS), A2A antagonist 
SCH 442416 (1 µM in DMEM 5% DFBS), or with standard culture medium 
(DMEM 5% DFBS) for untreated cultures. Antagonist carriers, PBS for NBQX or 
dimethyl sulfoxide (DMSO) for SCH 442416, were present in all cultures. 3D 
collagen co-cultures were mechanically loaded in the presence of antagonists. 
 
In both cases, the silicone plate was attached to a BOSE ElectroForce® 
loading instrument (page 49) by a custom-made device in order to stretch the plate 
on one side only causing cyclic compression and tension forces at the same time but 
in perpendicular directions in all wells. A 250 N load cell was used to apply a 
loading regime of 5 min, 10 Hz, 2.5 N to the 3D collagen cultures. Loading was 
controlled using the provided software (page 49). The time points at which cultures 
were terminated post-load are clearly stated in the appropriate experimental chapters 
of this thesis. 
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2.4 Statistics 
 
 Statistical tests were performed using Minitab (page 49). Data points >2 
standard deviations away from the mean were considered outliers and not included in 
analyses. All data were tested for normality (Anderson-Darling test) and equal 
variances (Barlett’s test) in order to fulfil the assumptions of the statistical tests used. 
If these assumptions were violated, data were transformed or non-parametric tests 
were used. Transformations are clearly stated in the relevant results sections. 
Differences were deemed significant if P<0.05. 
 
Some results are presented graphically using boxplots showing the smallest 
sample and the largest sample as whiskers (Figure 2.3A and B), the lower quartile 
and the upper quartile (25 % of the data presented is lower or higher than 
interquartile range respectively) (Figure 2.3 C and D), the interquartile range (range 
of data between the lower and upper quartiles, represented by a box) (Figure 2.3E) 
and the median (line across middle of data set) (Figure 2.3 F). If the median line is 
not central and/or the whiskers are of different lengths, the data may not be normally 
distributed. Boxplots can also detect outliers, usually shown by an asterisk (Figure 
2.3G) (Rubin, 2010, Peck et al., 2012). 
 
The number of independent experiments, and replicates per experiment (n), 
for each method is clearly stated in the relevant materials and methods and figure 
legends of this thesis. Independent experiments were set up so that each 3D culture 
replicate was derived from the same pool of cells. However, because each culture 
replicate was plated in different wells within a plate and all subsequent 
manipulations (e.g. surface osteoblasts, antagonist treatments and loading) were 
performed independently in each culture, it cannot be assumed that all cells behaved 
in the same manner, even if derived from the same pool. Therefore, when performing 
all statistical analyses in this thesis, raw data was used from each culture replicate 
within each independent experiment. An example of an experimental design can be 
found in Figure 2.4. 
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Figure 2.4 Example of a boxplot. A) Smallest sample whisker. B) Largest sample 
whisker. C) Lower quartile showing 25 % of data is lower than 0.45. D) Upper quartile 
showing 25 % of data is higher than 0.8. E) Interquartile range. F) Median indicating 
the middle of the data set. G) An outlier from the dataset. H) A non-central median line 
indicating data are not normally distributed. 
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Figure 2.5 Example of experimental design. Diagram showing a single independent experiment of 3 replicates per condition for both control and 
loaded plates. For repetition of independent experiments the same design as the initial experiment was used. 
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3. Characterisation of a novel 3D in vitro osteocyte-osteoblast co-culture model 
 
3.1 Background  
 
Normal mechanical loading potently induces bone formation via effects of 
loading on osteocytes, which transmit the signal to osteoblasts, increasing their 
activity and so leading to bone formation (Heino et al., 2004, Taylor et al., 2007, 
Rhee et al., 2011, Zarrinkalam et al., 2012). Current in vitro mechanical loading 
models do not reflect the interactions of the cells within bone, with most focusing on 
mechanical loading of osteoblasts in monolayers (Wang et al., 2011, Xiao et al., 
2011, Li et al., 2012c) (page 30). Furthermore, although interesting findings have 
been obtained from the available 3D in vitro bone models (section 1.4.2.3.2), none 
elucidate the osteocyte-osteoblast interactions that regulate mechanically-induced 
bone formation (Kurata et al., 2006, Tortelli and Cancedda, 2009, Tortelli et al., 
2009, Papadimitropoulos et al., 2011a, Papadimitropoulos et al., 2011b, Barthelemi 
et al., 2012). This highlights a major gap in the understanding of bone 
mechanotransduction. In order to address this issue, a 3D osteocyte-osteoblast co-
culture model was developed by Mason et al. using the mouse osteocyte-like cell line 
MLO-Y4  and a human osteoblast cell line (MG63 and SaOS-2) (Mason D., 2009, 
Mason et al., 2009). However, this model has the disadvantage that it uses cell lines 
from different species, which could affect the interactions between osteocytes and 
osteoblasts. 
 
3.1.1 Aims 
 
 The experiments in this chapter aimed to develop and characterise a novel 
mouse 3D in vitro osteocyte-osteoblast co-culture model suitable for investigating 
osteocyte-osteoblast interactions and mechanotransduction. Viability, morphology 
and phenotype of the cells within the model, and the ability of the osteocytes to form 
a network within the 3D model, were assessed. 
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3.2 Materials and Methods 
 
 The 3D co-culture model was adapted from Mason et al. (Mason D., 2009, 
Mason et al., 2009), to incorporate cell lines representing osteocytes and osteoblasts 
from the same species, in this case, mouse. For all experiments in this chapter, 3D 
collagen co-cultures from 3 independent experiments of n=3 per experiment, unless 
otherwise stated, were prepared and cultured for 1 or 7 days as outlined in page 52. 
 
3.2.1 3D osteocyte-osteoblast co-culture model 
  
At day 7, 3D co-cultures were fixed, infiltrated and cryosectioned (page 63), 
immunostaining for type I collagen was performed to reveal the 3D collagen gel and 
counterstaining with DAPI revealed the presence of cell nuclei (page 67 and Table 
2.4). 
 
3.2.2 Cell death 
 
In situ cell death assays for both surface and deep zones of the model were 
carried out as described in section page 70 at day 1 and day 7. Percentage death was 
quantified as a proportion of total cell number and statistically analysed using 
General Linear Model (GLM) for crossed factors (page 81). Pairwise comparisons 
where P≤0.05 were recorded. GLM is used to test hypotheses by taking into account 
all of its contributing factors in a linear combination, whilst also accounting for error 
contribution. The hypotheses tested may be univariate (involving one variable) or 
multivariate (involving two or more variables). 
 
3.2.3 Morphology  
 
 Monolayer cultures of MC3T3-E1(14) (page 50) and MLO-Y4 (page 50) 
cells and 3D co-cultures (page 52) were observed and imaged daily over 7 days using 
an inverse light microscope (page 63). At day 7, 3D co-cultures were fixed, 
infiltrated and cryosectioned (page 63). Cryosections of all replicates were stained 
with Phalloidin-Atto488 for actin filament labelling (page 70). 
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3.2.4 mRNA expression  
 
Total RNA from the surface and deep zones of day 7 3D co-cultures was 
extracted, reverse transcribed and cDNA integrity checked by RT-PCR of 18S rRNA 
or amplified for SOST (pages 52-55). mRNA levels were quantified by relative RT-
qPCRs for E11, COL1A1, ALP, OCN, Runx2 and SV40 large T-antigen; 18S rRNA, 
GAPDH and HPRT1 were amplified as RGs. For all templates, amplifications were 
carried out on cDNA diluted 1:10, in DEPC water, for all genes except SV40 large 
T-antigen and HPRT1 (page 55). Primer details are outlined in pages 56, 58 and 
Table 2.1). RT-qPCR data were normalised to the optimal RF using NormFinder as 
in page 57. Data for each GOI were calibrated to the highest expresser, expressed as 
REU (page 58) and statistically analysed using GLM for crossed factors (page 81). 
Pairwise comparisons where P≤0.05 were recorded. RT-qPCR products were 
resolved by agarose gel electrophoresis (page 55). Data are from 3 independent 
experiments of n=4 per experiment for both the surface and deep zones. 
 
3.2.5 Protein expression 
 
At day 7, 3D co-cultures were fixed, infiltrated and cryosectioned (page 63). 
4-6 cryosections per culture were immunostained for E11 (page 65 and Table 2.3), 
SV40 large T-antigen or CX43 (page 67 and Table 2.4).  
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3.3 Results 
 
3.3.1 3D osteocyte-osteoblast co-culture model 
 
MLO-Y4 osteocyte-like cells embedded within a 3D type I collagen gel 
overlaid with MC3T3-E1(14) osteoblasts (Figure 3.1A) and maintained for 7 days 
revealed a single osteoblast surface cell layer and osteocytes embedded throughout 
the depth of the type I collagen gel (Figure 3.1B). This confirmed the original 
organisation of the 3D co-culture is maintained for up to 7 days in culture. 
  
3.3.2 Cell death  
  
3.3.2.1 Surface zone 
 
Confocal images of the surface zone across 5 arbitrary fields of view were 
taken at x10 magnification with a 2.32 zoom for all 9 replicates. At both day 1 
(Figure 3.2A) and day 7 (Figure 3.2B), viability of MC3T3-E1(14) mouse osteoblast-
like cells was 100 %. Freeze-thaw controls showed 100 % death of the surface zone 
of the model (Figure 3.2C).  
 
3.3.2.2 Deep zone  
 
 10 arbitrary fields of view from 5 random transverse cryosections from all 9 
replicates were used for quantification of cell death as a proportion of total cell 
number (Figure 3.3E) at x20 magnification. At day 1 (Figure 3.3A) and day 7 (Figure 
3.3B) a mixture of live and dead MLO-Y4 cells was observed. Live osteocytes had a 
blue nucleus and dendritic morphology, whereas a purple nucleus and rounded 
morphology was observed for dead cells. Some live MLO-Y4 cells also had red 
staining in their cytoplasm but not their nucleus (Figures 3.3A and B). Freeze-thaw 
controls showed 100 % osteocyte death (Figure 3.3C). Across the 3 independent 
experiments, an average of 16.13 ±3.16 % osteocyte cell death was observed at day 1 
and 13.85 ±2.35 % at day 7 (Figure 3.3D) as a proportion of total number of 
osteocytes at day 1 and day 7, respectively. MLO-Y4 cell death within 3D co-
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cultures was not significantly different between day 1 and day 7, however a 
significant difference was observed between replicate experiments (GLM, P=0.002) 
(pairwise comparisons: day 1 experiment 1 vs. 3, P=0.0069 and experiment 2 vs. 3, 
P=0.004; day 7 experiment 1 vs. 2, P=0.0414) with means ± standard errors ranging 
from; 20.62 ±2.28 % (experiment 1), 17.32 ±1.43 % (experiment 2) and 10.04 ±1.14 
%  (experiment 3) at day 1; and 18.08 ±1.86 % (experiment 1), 9.35 ±1.39 % 
(experiment 2) and 13.48 ±1.41 % (experiment 3) at day 7, and an  interaction 
between both  factors (day and experiment) was observed (GLM, P=0.018). A 
significant difference was seen in total cell number between day 1 and day 7 (GLM, 
P=0.003 of log10 data) and between replicate experiments (GLM, P=0.00001 of 
log10 data). At day 1, total cell number was 2-fold higher in experiment 3 when 
compared to experiment 1 (GLM, P=0.0089 of log10 data),  and 1.5-fold higher 
when compared to experiment 2 (GLM, P=0.0187 of log10 data). At day 7, total cell 
number was 1.7-fold higher in experiment 3 when compared to experiment 1 (GLM, 
P=0.0494 of log10 data) (Figure 3.3E). 
 
3.3.3 Morphology 
 
3.3.3.1 Surface zone 
 
MC3T3-E1(14) cells in a 3D co-culture (Figure 3.4C) had a similar ovoid or 
pyriform morphology to those in monolayer cultures (Figure 3.4A). The osteoblasts 
formed a thin pavement-like single cell layer on top of the 3D co-cultures which 
were difficult to image under the inverse light microscope (Figure 3.4C). However, 
when labelled for actin filaments (Figure 3.4E), the osteoblast layer and cell 
morphology were clearer. The osteoblasts were seen projecting stress fibres 
throughout their cell bodies. Actin filament labelling also showed similar osteoblast 
morphology after a 7 day culture period (Figure 3.4E). 
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3.3.3.2 Deep zone  
 
MLO-Y4 cells in 3D co-cultures (Figure 3.4D) had a similar dendritic 
morphology to those in monolayer cultures (Figure 3.4B) across the collagen gel. At 
day 7, osteocytes showed their typical dendritic morphology and connections 
between neighbouring osteocytes as revealed by actin filament staining (Figure 
3.4F). 
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Figure 3.1 Novel 3D osteocyte-osteoblast co-culture model. A) Diagram of the 3D in vitro model indicating the surface and deep zone, and 
positions of the osteoblasts and osteocytes. B) Fluorescence microscope image of a 3D co-culture transverse cryosection immunostained to reveal 
the 3D type I collagen gel (Alexa594) and cell nuclei (DAPI). The image shows a single cell layer of cells on top of the collagen gel and cells 
embedded within the gel (SZ: surface zone; DZ: deep zone). Scale bar: 100 µm (B). Image was taken at an arbitrary field of view and is 
representative of 3 independent experiments of n=3 per experiment. Controls performed by omitting (PBST) or substituting (IgG) the primary 
antibody, showed no labelling (page 271). 
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Figure 3.2 Osteoblast viability on the surface of the 3D co-culture (red: ethidium homodimer, blue: DAPI, purple: combination of both dyes). A) 
Confocal microscope image of an arbitraty field of view showing only live (blue nuclei) osteoblasts at day 1 and at day 7 (B). Some live osteoblasts 
show red staining in their cytoplasm but not their nucleus at both time points. C) Confocal microscope image of an arbitrary field of view from a 
freeze-thaw control where all osteoblasts are dead. Images are taken at the level of the surface zone and are representative of 3 independent 
experiments, n=3 per experiment, 5 arbitrary fields of view per replicate. Scale bars: 50 µm (A, B and C).  (x10 magnification with a 2.32 zoom).  
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Figure 3.3 Osteocyte viability in 3D co-cultures (red: ethidium homodimer; blue: 
DAPI, purple: combination of both dyes). A) Fluorescence microscope image of an 
arbitrary field of view showing a mixture of live (blue nuclei) and dead (purple 
nuclei) osteocytes at day 1 and at day 7 (B). Some live osteocytes also show red 
staining in the cytoplasm but not their nucleus. C) Fluorescence microscope image of 
an arbitrary field of view from a freeze-thaw control where all osteoblasts and 
osteocytes are dead (SZ: surface zone, DZ: deep zone). D) Boxplot of percentage cell 
death as a proportion of total number of cells at day 1 and day 7. E) Boxplot showing 
total cell number counted for each replicate experiment at day 1 and day 7 in each 
independent experiment. For total cell number, signifcant differences obtained by 
GLM of log10 data between day 1 and day 7 denoted by **P<0.01. Significant 
differences from pairwise comparisons, within each day, between independent 
experiments are shown by ‘a’, with respect to experiment 2, and ‘b’, with respect to 
experiment 3. Images are taken from 3D co-culture transverse cryosections and are 
representative of 3 independent experiments, n=3 per experiment, 5 sections per 
replicate, 10 arbitrary fields of view per section. (x20 magnification, Scale bars: 100 
µm A, B and C). 
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Figure 3.4 Osteoblast and osteocyte morphology in the 3D co-cultures. A) Inverse 
light microscope image of MC3T3-E1(14) cells in monolayer with a typical array of 
osteoblastic morphologies, mainly ovoid or pyriform. B) Inverse light microscope 
image of MLO-Y4 cells in monolayer with a typical dendritic morphology. C) 
Inverse light microscope image taken from the surface zone of the 3D model. A 
confluent monolayer of osteoblasts is observed. D) Inverse light microscope image 
of MLO-Y4 cells halfway through the depth of a 3D co-culture showing a similar 
dendritic morphology to that seen in monolayer cultures. E)  Confocal microscope 
image looking down onto the surface zone of a 3D co-culture at day 7. Osteoblasts 
were stained to reveal actin filaments (Phalloidin-Atto488) and cell nuclei (DAPI). 
Image shows a pavement-like osteoblast monolayer, with individual osteoblasts 
containing well-developed stress fibres, and therefore maintenance of MC3T3-
E1(14) morphology. F) Confocal microscope image of a 3D co-culture transverse 
cryosection at day 7. Osteocytes were stained to reveal actin filaments (Phalloidin-
Atto488) and cell nuclei (DAPI). Image shows connections between neighbouring 
osteocytes and with dendritic morphology, therefore maintenance of MLO-Y4 
morphology. Images are arbitrary fields of view representative of 3 independent 
experiments, n=3 per experiment. (Scale bars: 200 µm (A), 50 µm (B), 200 µm (C), 
50 µm (D), 50 µm (E) and 10 µm (F) respectively). 
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3.3.4 mRNA expression 
 
Low quantities of total RNA were obtained from the surface zone of the 
model, and therefore, the A260/A230 (0.06-6.69) and the A260/A280 (1.09-3.19) surface 
zone ratios were generally suboptimal (page 54) indicating presence of contaminants. 
However, concentration absorbances close to the NanoDrop detection limit (2 ng/µl) 
are less accurate. Therefore, cDNA for the surface zone was generated by reverse 
transcribing the maximum volume of RNA permitted in the reaction. This approach 
was also taken with deep zone RNA for consistency (page 54). The range of total 
RNA reverse transcribed varied between 17-1655.80 ng for the surface zone and 
108.80-1817.30 ng for the deep zone.  
 
mRNA expression was assessed in both surface and deep zones of day 7 3D 
collagen co-cultures by relative RT-qPCR using primers against osteoblast and 
osteocyte phenotypic markers. Data were expressed in REU and normalised to 
GAPDH, which was ranked as the most stable RG through NormFinder as it had the 
lowest stability value and inter- and intragroup variation (page 57, Table 3.1 and 
Figure 3.5). SOST expression was determined by RT-PCR. Data were from 3 
independent experiments of n=4 for both surface and deep zones. However, an 
outlier was detected in the surface zone samples for all genes except COL1A1 where 
3 outliers were detected in the surface zone samples. Therefore, data analysed were 
from 3 independent experiments where n=3 for the surface zone and n=4 for the deep 
zone, except COL1A1 (2 independent experiments). 
 
All mRNAs were detected in both zones of the co-culture (Figure 3.6A) 
except for SOST (Figure 3.6B). No significant difference in expression was detected 
between zones of the model for E11 (surface zone, 0.264 ±0.072 REU; deep zone, 
0.361 ±0.087 REU) (Figure 3.7A), OCN (surface zone, 0.212 ±0.076 REU; deep 
zone, 0.269 ±0.080 REU) (Figure 3.7D) and Runx2 (surface zone, 0.275 ±0.083 
REU; deep zone, 0.157 ±0.025) (Figure 3.7E). However, the surface zone of the 
model showed a significantly higher expression of COL1A1 (0.168 ±0.085 REU) 
compared to the deep zone (0.028 ±0.007 REU) (GLM, P=0.0001 of log10 data) 
(Figure 3.7B). In contrast, the deep zone (0.366 ±0.075 REU) of the 3D co-culture 
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showed a significantly higher ALP expression than the surface zone (0.185 ±0.047 
REU) (GLM, P=0.001 of ranked data) (Figure 3.7C). Quantification of the SV40 
large T-antigen, only expressed by MLO-Y4 cells (deep zone), was performed to 
indicate levels of MLO-Y4 RNA cross-contamination in the surface zone (MC3T3-
E1(14)) of the model. SV40 large T-antigen expression was significantly lower in the 
surface zone (0.102 ±0.018 REU) of the model compared to the deep zone (0.315 
±0.079 REU) (GLM, P=0.005 of log10 data) (Figure 3.7F). This indicates a 3-fold 
decrease in SV40 large T-antigen mRNA expression in the surface zone. 
 
Whilst all genes showed a significant difference in expression between 
replicate experiments (GLM, E11 P=0.0001 of log10 data, OCN P=0.0001 of log10 
data, Runx2 P=0.013 of ranked data, COL1A1 P=0.0001 of log10 data, ALP 
P=0.0001 of ranked data, SV40 large T-antigen P=0.002 of log10 data) (pairwise 
comparisons: surface zone E11 experiment 1 vs. 3, P=0.0099 and experiment 2 vs. 3, 
P=0.0097, OCN experiment 1 vs. 2, P=0.0011, Runx2 experiment 2 vs. 3, P=0.044, 
ALP  experiment 1 vs. 3, P=0.0009; deep zone E11 experiment 1 vs. 3, P=0.0094 
and experiment 2 vs. 3, P=0.047, OCN experiment 1 vs. 2, P=0.0057 and 
experiment 1 vs. 3, P=0.0046, COL1A1 experiment 1 vs. 2, P=0.001, ALP 
experiment 1 vs. 2, P=0.0281 and experiment 1 vs. 3, P=0.0009, SV40 large T-
antigen deep zone experiment 1 vs. 3, P=0.0030) the trend within each experiment 
was generally consistent, except for Runx2 experiment 3. 
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Table 3.1 NormFinder outputs. Stability values, inter- and intragroup variation outputs for 
all 3 candidate reference genes. 
  
Figure 3.5 Determination of the most stable reference gene through NormFinder. Graph 
shows the intergroup variation for all candidate reference genes in all replicates. Standard 
error of the mean was calculated from the average intragroup variation in all replicates. (3 
independent experiments, n=3 for surface and 4 for deep zones). 
 
Gene Stability value Intergroup variation Intragroup variation 
    Surface zone Deep zone Surface zone Deep zone 
18S rRNA 0.603 0.477 -0.477 0.000 0.435 
GAPDH 0.398 0.376 -0.376 0.000 0.012 
HPRT1 1.192 -0.853 0.853 0.015 5.851 
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Figure 3.6 Gene expression in 3D co-cultures after 7 days. A) Gel electrophoresis 
of RT-qPCR products shows expression of E11 (118 bp), COL1A1 (140 bp), ALP 
(132 bp), Runx2 (120 bp) and OCN (153 bp) in both surface and deep zones of the 
model. B) Gel electrophoresis showing expression of SOST (112 bp) by RT-PCR 
in mouse femur (positive control), but absence of expression in the surface and 
deep zones of the model. Negative controls (blank) were clean for all reactions. 
Gels are representative of 2 (COL1A1) or 3 (others) independent experiments, n=3 
for surface and 4 for deep zones. 
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Figure 3.7 Quantification of gene expression in the 3D co-culture after 7 days by relative RT-qPCR. Boxplots of E11 (A), COL1A1 (B), ALP (C), 
OCN (D), Runx2 (E) and SV40 large T antigen (F) expressed as REU and normalised to GAPDH expression. Significant differences obtained by 
GLM of log10 data (E11, COL1A1, OCN and SV40) or ranked data (ALP and Runx2) between surface and deep zones denoted by **P<0.01, 
***P<0.0001. Significant differences from pairwise comparisons, within each zone, between independent experiments denoted by ‘a’ with respect 
to experiment 1, and ‘b’ with respect to experiment 2. (2 (COL1A1) or 3 (others) independent experiments, n=3 for surface and 4 for deep zones). 
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3.3.5 Protein expression  
  
In all cases, presented data are representative of day 7, 3D co-cultures from 3 
independent experiments where n=3. 4-6 cryosections of all 9 replicates were 
observed. IgG controls showed no immunoreaction (Figure 3.8G-L). 
 
3.3.5.1 Surface zone 
 
Osteoblasts in 3D co-cultures showed strong uniform immunolabelling for 
the dendricity marker E11 (Figure 3.8A), in agreement with gene expression results. 
Abundant CX43 immunostaining was also observed in these cells in the cell 
membrane and cytoplasm when cultured in 3D co-cultures (Figure 3.8C). As 
expected, no immunostaining of SV40 large T-antigen was detected in the surface 
zone of the 3D model (Figure 3.8E). 
 
3.3.5.2 Deep zone  
 
Osteocytes in 3D co-cultures showed E11 (Figure 3.8B) and connexin 43 
(Figure 3.8D) immunostaining. CX43 was detected, in high abundance, along the 
processes, as well as within the cytoplasm, around the nucleus of the osteocytes 
(Figure 3.8D) and also in junctions between cells (Figure 3.8D inset). Connections 
between MLO-Y4 cells in 3D co-cultures were also observed in images where actin 
filaments were labelled (Figure 3.4F). Nuclear SV40 large T-antigen 
immunolabelling was also detected in the deep zone of the model, however 
osteocytes showed varying strengths of SV40 large T-antigen staining (Figure 3.8F). 
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Figure 3.8 Protein expression in 3D co-cultures after 7 days by immunostaining (SZ: 
surface zone, DZ: deep zone). A) Light microscope image revealing immunostaining 
for the dendricity marker E11 in both osteoblasts (SZ) and osteocytes (DZ). B) Light 
microscope image showing E11 immunostaining in the osteocytes highlighting their 
morphology. C) Confocal microscope image showing CX43 (Dylight594) 
immunolabelling and cell nuclei stain (DAPI) in the osteoblasts and osteocytes (D). 
Image reveals abundant quantities of CX43 present in the cytoplasm and cell 
membranes of both cell types, around the nucleus of the osteocytes, and connections 
between embedded osteocytes (D, inset). E) Fluorescence microscope image shows 
immunolabelling for SV40 large T-antigen (Dylight594) and cell nuclei stain (DAPI) 
in osteocytes only, represented by the purple colour (combination of both dyes). 
However, the image reveals no SV40 large T-antigen immunostaining in the 
osteoblasts. F) Fluorescence microscope image showing varying degrees of SV40 
large T-antigen immunostaining in the osteocytes. In all cases, controls performed by 
omitting (PBST: E11 (H), CX43 (J), SV40 large T-antigen (L)) or substituting (IgG: 
E11 (G), CX43 (I), SV40 large T-antigen (K)) the primary antibody, showed no 
labelling. Images are arbitrary fields of view taken from 3D co-culture transverse 
cryosections representative of 3 independent experiments, n=3 per experiment. Scale 
bars: 50 µm (A), 50 µm (B), 20 µm (C), 20 µm (D), 10 µm (inset), 50 µm (E), 50 µm 
(F), 200 µm (G), 200 µm (H), 10 µm (I), 10 µm (J), 100 µm (K), 100 µm (L). 
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3.4 Discussion 
 
A novel in vitro 3D mouse osteocyte-osteoblast co-culture model has been 
morphologically and phenotypically characterised. The model is a two-phase culture 
system where osteocytes were first embedded within collagen gels and left in culture 
overnight before osteoblasts were added the following day (Figure 3.1).  In this 
model, cells were viable, expressed appropriate phenotypic markers and connected to 
neighbouring cells (Figure 3.9). For all quantitative data presented, there appeared to 
be a significant difference between independent experiments. The reasons for this are 
discussed at the end of the discussion 
 
The model was developed as an all mouse adaptation of a previously 
published 3D human osteoblast-mouse osteocyte co-culture model (Mason D., 2009, 
Mason et al., 2009). The model developed by Mason et al. (Mason D., 2009, Mason 
et al., 2009), has been fully characterised (article awaiting re-submission). However, 
the main disadvantage of this model is the use of two different species of cells: 
human osteoblasts (MG63) and mouse osteocytes (MLO-Y4) which does not 
represent an in vivo situation. Likewise, the osteocyte-osteoblast interactions 
observed may be influenced by the difference in species between cell types. A 
further disadvantage of using MG63 cells is that they are a heterogeneous 
osteosarcoma-derived cell line which is arrested at the pre-osteoblast state. Whereas, 
MC3T3-E1 cells are a non-cancer cell line which can be differentiated from 
immature to mature osteoblast. Furthermore, MC3T3-E1 subclones, such as MC3T3-
E1(14), provide homogeneous cell populations (Czekanska et al., 2012). 
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and express signalling components. 
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3.4.1 Cell viability 
 
3.4.1.1 Surface zone 
  
In the 3D co-cultures, MC3T3-E1(14) mouse osteoblasts were 100 % viable 
(Figure 3.2). The most likely explanation is that osteoblasts behave like a monolayer 
of cells with dead osteoblasts detaching from the top of the collagen gel and being 
replaced by new osteoblasts to maintain the single cell layer on the co-culture 
(personal observation). 
 
3.4.1.2 Deep zone 
 
In the 3D co-culture, MLO-Y4 mouse osteocyte-like cells displayed an 
average of 16.13 ±3.16 % death after 1 day of culture and an average of 13.85 ±2.35 
% death after 7 days of culture (Figure 3.3A-D). It has previously been reported that 
osteocytic death, common in normal human bone (Noble et al., 1997), increases with 
age from less than 1 % at birth up to 75 % by 80 years old (Frost, 1960, Mullender et 
al., 1996, Tomkinson et al., 1997).  Assuming there is a linear relationship between 
age and osteocyte death, 20 % death would occur by 21 years of age. Thus the 16.13 
±3.16 % osteocyte viability observed in the 3D model appears consistent with in vivo 
viabilities.  
 
Furthermore, osteocyte cell death rates at day 1 were not significantly 
different from those at day 7 (Figure 3.3D). Although this could suggest that cell 
death was caused by the experimental set up, the method used to quantify cell death 
does not take into account cell proliferation, which could mask any further cell death.  
 
In vivo, most cells undergoing cell death are destroyed by neighbouring or 
phagocytic cells (Gregory and Pound, 2011). However, this is only subject to the 
accessibility of the cells in question. In bone, osteocytes are embedded within a 
mineralised matrix and so are inaccessible, unless during osteoclastic resorption. 
Consistent with this hypothesis, in vivo, dead osteocytes can be detected within their 
lacunae (Tomkinson et al., 1998, Weinstein et al., 2000). In in vitro 3D cultures it is 
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difficult to determine whether all dead cells remain embedded within the 3D matrix. 
However, in the 3D co-culture a similar percentage osteocyte cell death was 
observed at day 1 and day 7. This observation suggests that the dead osteocytes 
present at day 1 did not disintegrate, but like in vivo, remained encased within the 
matrix. Osteocyte death has been shown to be common in both healthy and unhealthy 
bone and to trigger bone resorption (page 13), suggesting that the 3D co-culture 
model could also be modified to study bone resorption and remodelling in 
physiological and pathophysiological conditions, by adding osteoclasts. 
 
3.4.2 Morphology 
 
3.4.2.1 Surface zone 
 
In the 3D co-culture model, MC3T3-E1(14) cells displayed a range of 
osteoblastic morphologies, mainly ovoid and pyriform with stress fibres, which were 
maintained for 7 days (Figure 3.4A, C and E). They also formed a pavement-like 
monolayer on top of the 3D culture (Figure 3.4E). In vivo, osteoblasts range in shape, 
they can be ovoid, rectangular, columnar, cuboidal or pyriform (Bourne, 1972). 
Osteoblasts have been shown to be situated on top of the bone matrix containing 
osteocytes (Gegenbaur, 1864 as cited in (Bourne, 1972)) forming a pavement-like or 
‘overlapping roof tiles’ monolayer on top of the bone surface (Bidder, 1906 as cited 
in (Bourne, 1972), (Sudo et al., 1983)) and their position is essential for osteocyte-
osteoblast interactions which ultimately lead to the regulation of bone matrix 
formation (Heino et al., 2004, Taylor et al., 2007, Rhee et al., 2011, Zarrinkalam et 
al., 2012). In vitro, monolayer cultures of MC3T3-E1(14) cells show a fibroblastic 
morphology during their logarithmic growth phase. However, when confluent they 
assume a pyriform shape with prominent stress-fibres across their cell bodies (Sudo 
et al., 1983, Murshid et al., 2007). Therefore, osteoblasts morphology in the 3D co-
culture is consistent with in vivo and in vitro observations. 
 
 
 
 
108 
 
Chapter 3 
3.4.2.2 Deep zone 
 
In the 3D co-culture model, MLO-Y4 cells maintain their osteocytic 
morphology throughout all gel depths for 7 days and appear to connect to each other 
(Figure 3.4B, D and F). In vivo, osteocytes present a dendritic morphology, which 
allows communication with neighbouring osteocytes. This forms an extensive 
network known as LCS (Doty, 1981, Menton et al., 1984, Palumbo et al., 1990, 
Bonewald, 1999, Plotkin et al., 2002), which permits metabolic traffic and exchange 
in the mineralised environment of the bone matrix. In vitro, monolayer cultures of 
MLO-Y4 cells display a two-dimensional dendritic morphology, which becomes 
three-dimensional in 3D collagen cultures (Kato et al., 1997, Murshid et al., 2007). 
Thus, the osteocyte morphology in the 3D co-cultures is consistent with in vivo and 
in vitro observations, indicating that these cells have the morphological 
characteristics necessary for network formation throughout the 3D co-culture. 
 
3.4.3 mRNA expression 
 
In the 3D co-culture model, surface zone cells showed a significantly higher 
expression of COL1A1 compared to the deep zone of the model (Figure 3.7B). This 
correlates with in vivo and in vitro data which showed both osteoblasts (Collin et al., 
1992, Zhou et al., 1994, Shi et al., 1996, Wang et al., 1999),  and osteocytes express 
COL1A1 however, osteocytes express COL1A1 at lower levels (Sun et al., 1995, 
Kato et al., 1997). Interestingly, deep zone cells within the 3D co-cultures were 
found to express significantly higher levels of ALP compared to the surface zone of 
the model (Figure 3.7C). Osteoblasts have been shown to express ALP both in vivo 
and in vitro (Takuwa et al., 1991, Collin et al., 1992, Whyte, 1994, Zhou et al., 1994, 
Wang et al., 1999). However, previous in vivo and in vitro data has shown that 
osteocytes express low levels of ALP (Dodds et al., 1993, Mikuni-Takagaki et al., 
1995, Kato et al., 1997). This suggests that under appropriate conditions the MLO-
Y4 cells within the 3D model may be able to mineralise the collagen matrix within 
which they are embedded.  
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OCN and Runx2 are also expressed in both the surface and deep zones of the 
model (Figure 3.7D and E respectively).  This correlates with both in vivo and in 
vitro studies which showed both osteoblasts and osteocytes express OCN  
(osteoblasts: (Collin et al., 1992, Zhou et al., 1994); osteocytes: (Mason et al., 1996, 
Kato et al., 1997)) and Runx2 in osteoblasts in vivo and in vitro (Ducy et al., 1997, 
Komori et al., 1997, Otto et al., 1997, Gilbert et al., 2002, Choi et al., 2005) and in 
osteocytes in vitro (Fujita et al., 2001). Both surface osteoblasts and embedded 
osteocytes were also shown to express E11 when cultured in 3D co-cultures (Figure 
3.7A). E11 is an early osteocyte marker (Wetterwald et al., 1996, Schulze et al., 
1999, Hadjiargyrou et al., 2001, Zhang et al., 2006) which has also been detected in 
mature osteoblasts and osteoblasts undergoing bone matrix synthesis (Nose et al., 
1990, Wetterwald et al., 1996, Hadjiargyrou et al., 2001, Zhang et al., 2006, Jahn et 
al., 2010). The fact that there is E11 expression in the surface zone of the model 
suggests that the osteoblasts may be not only sending out projections to connect with 
neighbouring osteoblasts and/or embedded osteocytes, but also be attempting to 
differentiate into osteocytes.  
 
SOST was not detected in either zones of the model (Figure 3.6B). In bone in 
vivo, SOST is exclusively expressed by mature osteocytes (van Bezooijen et al., 
2004, Poole et al., 2005, van Bezooijen et al., 2005, Li et al., 2008). Whilst some 
studies have reported the expression of SOST in osteocytes (Bellido et al., 2005, 
Papanicolaou et al., 2009, Woo et al., 2011) and osteoblasts (Galea et al., 2011, Yu et 
al., 2011) in vitro, the MLO-Y4 (Papanicolaou et al., 2009, Yang et al., 2009) and 
MC3T3-E1 (Papanicolaou et al., 2009) cell lines do not express SOST. This finding 
is consistent with the idea that MLO-Y4 cells are not mature osteocytes and lack a 
mineralised environment in culture (Yang et al., 2009). 
 
There are several matters to take into account when analysing gene 
expression in this 3D co-culture. According to the minimum information for 
publication of quantitative real-time PCR experiments (MIQE) guidelines, in order to 
perform RT-qPCR, ideally, the mass of RNA reverse transcribed should be equal for 
all samples in order to reduce variance when comparing, in this case, between 
surface and deep zone mRNA expression (Gu and Publicover, 2000, Kalariti et al., 
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2004). However, due to the low and variable amounts of total RNA extracted from 
the surface zone samples, this is not possible as there would be a high risk of not 
detecting low expression genes. Nevertheless, normalisation to the most stable RG 
accounts for differences in quality and quantity of the reverse transcribed RNA used 
in the reaction. 
 
Another matter to take into account is the possibility of RNA cross-
contamination between zones due to the extraction protocol. The fact that there is 
expression of SV40 large T-antigen in the surface zone (Figure 3.7F), albeit at lower 
levels, suggests that there are small levels of RNA cross-contamination from the 
osteocytes. MLO-Y4 cells express SV40 large T-antigen as they were initially 
isolated from transgenic mice expressing the SV40 large T-antigen oncogene under 
the control of the OCN promoter (Kato et al., 1997) (page 50). However, MC3T3-
E1(14) are a spontaneously immortalised cell line and therefore do not express  SV40 
large T-antigen (Wang et al., 1999) (page 50). There is not a gene that is only 
expressed by the osteoblasts in the model, therefore RNA cross-contamination from 
the surface zone into the deep zone of the model could not be quantified. However, 
light microscope images of toluidine blue stained transverse cryosections where 
MC3T3-E1(14) cells were cultured on top of empty 3D collagen gels for 7 days, 
showed no invasion of the osteoblasts (page 272). This contradicts previous data 
which showed the human osteoblast cell line MG63 invading empty 3D collagen gels 
and the invasion being controlled by embedding MLO-Y4 cells in the 3D gel (Mason 
D., 2009, Mason et al., 2009). However, the invasion of empty collagen gels by 
MG63 cells may be due to their cancer phenotype, as they are osteosarcoma-derived, 
and the lack of contact-inhibition, which leads to uncontrolled proliferation 
(Czekanska et al., 2012). Therefore, the fact that MC3T3-E1(14) cells do not invade 
empty 3D collagen gels, and that there are low levels of MLO-Y4 RNA present in 
the surface zone preparation, suggests limited cross-contamination between zones.  
 
Significant differences in gene expression observed between replicate 
experiments should also be taken into consideration. Relative RT-qPCR was used as 
the quantification method by normalising to GAPDH, selected as the most stable RG. 
Therefore, any intra- and/or intergroup variation in individual replicates should be 
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accounted for and so there should no difference between independent experiments. 
However, this is not the case and this is addressed at the end of the discussion. 
 
Finally, even though there are significant differences in expression of 
COL1A1, ALP and SV40 large T-antigen between surface and deep zones, the actual 
amount of expression of each gene, in terms of mRNA copy number, is not known. 
Thus the changes seen could be between relatively low levels. This is because 
relative RT-qPCR was performed. To be able to quantify copy numbers of each gene 
absolute RT-qPCR should be carried out. This method would particularly be useful 
to assess the extent of osteocyte RNA cross-contamination by determining the exact 
amount SV40 large T-antigen mRNA present in the two zones.  
 
3.4.4 Protein expression 
 
3.4.4.1 Surface zone 
 
In the 3D co-culture, osteoblasts showed immunolabelling for E11, 
supporting gene expression data (page 109), and CX43 protein throughout osteoblast 
cytoplasm and cell membrane (Figure 3.8A and C), suggesting that the surface 
osteoblasts are indeed connecting to neighbouring cells through projections that have 
the potential to be functional. Osteoblasts have been previously shown to express 
E11 and the gap junction CX43 protein, in vivo and in vitro (Wetterwald et al., 1996, 
Lecanda et al., 2000, Hadjiargyrou et al., 2001, Yamaguchi and Ma, 2003, Zhang et 
al., 2006, Taylor et al., 2007). The fact that osteoblasts synthesise E11 protein is not 
surprising. Previous studies have shown that osteoblasts have cytoplasmic processes 
connecting them to neighbouring cells (Spuler, 1899 as cited in (Bourne, 1972), 
(Wetterwald et al., 1996, Schulze et al., 1999)). Additionally, MC3T3-E1 cells have 
been shown to have prominent stress fibres that stretch across their cell bodies into 
small cytoplasmic processes (Murshid et al., 2007). Furthermore, these connections 
between osteoblasts and neighbouring cells are mainly through CX43. This gap 
junction is not only the most abundant in bone, but also has an important role in 
skeletal development and function (Stains and Civitelli, 2005, Rhee et al.). No SV40 
large T-antigen immunostaining was observed in the surface zone of the model even 
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after 7 days of co-culture (Figure 3.8E); as it is only MLO-Y4 cells that express this 
protein within the 3D model (Kato et al., 1997). This shows that no osteocytes have 
migrated to the surface zone of the 3D co-culture and that this zone is solely 
composed of osteoblasts. 
 
3.4.4.2 Deep zone 
 
In the 3D co-culture, MLO-Y4 cells showed expression of E11, in agreement 
with gene expression data (page 112), and CX43 protein (Figure 3.8A-D). Confocal 
images of osteocytes in 3D co-cultures showed presence of CX43 throughout the 
cytoplasm, osteocytic processes and around the nucleus (Figure 3.8C and D). 
Osteocytes, like osteoblasts, have been shown to express proteins for E11 
(Wetterwald et al., 1996, Hadjiargyrou et al., 2001, Zhang et al., 2006) and CX43 
both in vivo and in vitro (Kato et al., 1997, Cheng et al., 2001b, Taylor et al., 2007). 
Both of these proteins are key in osteocyte morphology and function. E11 helps 
maintain osteocyte dendricity (Zhang et al., 2006) whereas CX43 not only allows the 
formation of the LCS within the bone matrix, but also permits connection of 
osteocytes to surface osteoblasts, as shown in vitro by Yellowley et al. and Taylor et 
al. (Shalhoub et al., 2006, Taylor et al., 2007). Most importantly, CX43 has been 
shown to contribute to bone remodelling and formation (Bivi et al., 2012). This is 
further evidence that osteocytes within the 3D co-culture are potentially able to form 
a network similar to the LCS, as well as connect to the osteoblasts on the surface. 
 
In the 3D co-culture, osteocytes showed nuclear expression of SV40 large T-
antigen as they were immortalised by the overexpression of the SV40 large T-antigen 
(Figure 3.8E and F) (page 50) (Kato et al., 1997). Although the nuclear localisation 
of SV40 large T-antigen in MLO-Y4 cells has not previously been shown, it has been 
demonstrated in other cells (Haddaway et al., 2007, Ralston and Layfield, 2012). 
SV40 large T-antigen is considered an oncogene, due to its ability to arrest cell cycle 
and apoptosis, leading to uncontrolled proliferation (reviewed in (Barker and 
Gardner, 1974, Siris, 1994, Langston et al., 2007). Thus, the proliferation of the 
MLO-Y4 cell line is driven by the expression of the SV40 large T-antigen. In day 7 
3D co-cultures, osteocytes showed varying strengths of SV40 large T-antigen 
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immunostaining suggesting not all embedded osteocytes may be undergoing 
proliferation (Figure 3.8F), and those which are may have a low proliferation rate. 
Cells staining for SV40 large T-antigen, regardless of strength of staining, were only 
observed embedded within the 3D collagen gel. This observation supports evidence 
of no osteoblast invasion into the deep zone of 3D gel or of osteocytes into the 
surface zone (pages 109 and 272).  
 
3.4.5 Differences between replicate experiments 
 
 As previously mentioned, for all quantitative data presented, a significant 
difference was observed between independent experiments. This difference could be 
due to variability in setting up the 3D co-cultures. Total cell number was 
significantly different between replicate experiments (Figure 3.3E) and also some 
differences were observed between individual replicates within each experiment 
(page 273). The total cell number fold differences seen when comparing experiment 
3 with either experiment 1 or 2 at day 1 or 7, suggests that when cells were mixed 
well within the collagen solution before polymerising the gels, some gels had more 
cells than others. Another possible explanation is that because of the variance in cell 
density, there would be a change in behaviour of the cells in the 3D co-culture and as 
a consequence osteocyte-osteoblast interactions would have differed between 
replicate co-cultures and between independent experiments. Thus, differences in cell 
densities and, consequently, differences in osteocyte-osteoblast interactions, could 
have affected the overall percentage death and gene expression across replicate 
experiments. 
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3.5 Conclusion 
 
The mouse osteocyte-osteoblast 3D co-culture model characterised in this 
chapter provides a 3D platform to study the osteocyte control of osteoblast activity as 
a result of mechanical loading, something other current 3D models do not provide 
(Kurata et al., 2006, Murshid et al., 2007, Atkins et al., 2009). The next challenge is 
to determine whether this model is functional and can be used to investigate 
physiological mechanical stimuli and the resulting signalling that regulates osteocyte 
control of osteoblast activity.  
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4. Expression of adenosine, calcium-sensing and glutamate signalling 
components in the 3D co-culture model 
 
4.1 Background 
 
 The adenosine, calcium-sensing, and glutamate signalling pathways have 
been shown to influence bone biology (page 36), as seen in KO animals involving 
signalling components of these pathways. Briefly, for the adenosine signalling 
pathway, the A1 KO model had increased bone volume and small osteoclasts (Kara et 
al., 2010b), the A2A KO mouse displayed increased bone resorption and osteoclast 
activity (Mediero et al., 2012), and the A2B KO model exhibited decreased bone 
density (Carroll et al., 2012) (pages 37-38). Furthermore, CaSR KO mice displayed 
growth retardation, small skeletons and several fractures (Chang et al., 2008a) (page 
38). In addition, for the glutamate signalling pathway, the NMDAR1 KO model 
exhibited a thin bone structure and poor mineralisation (Skerry, 2008b), and the 
VGLUT1 KO model displayed a decrease in bone mass and an increase in osteoclast 
resorption (Morimoto et al., 2006) (pages 41-42)  
 
All adenosine receptors have been found to be expressed in primary 
osteoblasts and osteoblast cell lines. However, currently there are no studies on the 
expression of these receptors in osteocytes (Evans and Ham, 2012) (page 36). CaSR 
has been found to be expressed in osteoblasts and osteocytes (page 38). Glutamate 
receptors NMDARs and AMPARs together with transporters EAATs are expressed 
in both osteoblasts and osteocytes, however, receptors KAs and mGluRs have only 
been shown to be expressed in osteoblasts (Brakspear and Mason, 2012) (page 40). 
Interestingly, receptors A1, A2A and CaSR have been shown to heterodimerise with 
mGluR1 and/or 5 in the CNS (page 43). Furthermore, both glutamate and ATP have 
been implicated in mechanotransduction (page 36). ATP has a short half-life and is 
quickly broken down to smaller products such as adenosine, suggesting that 
adenosine may also be a mechanical signal. However the role of the adenosine, CaSR 
and glutamate signalling pathways in mechanically-induced bone formation is not 
fully understood.  
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4.1.1 Aims 
 
The experiments in this chapter aimed to determine the expression of 
signalling components of the adenosine, calcium-sensing and glutamate signalling 
pathways within the novel 3D osteocyte-osteoblast co-culture model. This study 
provided a platform for the investigation of the roles of these pathways in bone 
biology. The mRNA and protein expression of the all of the adenosine receptors, 
CaSR and a range of the glutamate receptors and transporters was selected according 
to previous data linking them to bone remodelling, mechanical loading or to the 
adenosine or CaSR pathways (pages 40 and 43). 
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4.2 Materials and Methods 
 
For all experiments in this chapter, 3D collagen co-cultures were prepared 
and cultured for 7 days as described in page 52. 
 
4.2.1 mRNA expression  
 
Total RNA from the surface and deep zones of day 7 3D co-cultures was 
extracted, reverse transcribed, cDNA integrity checked by RT-PCR of 18S rRNA 
and then amplified for A1, A2A, A2B and A3 adenosine receptors, CaSR, or 
AMPAR2, KA1, mGluR1, mGluR5 glutamate receptors and GLAST1 and EAAC1 
glutamate transporters (pages 52-55). Primer details are outlined in page 58 and 
Table 2.2.  Data presented are representative from 3 independent experiments of n=4 
for both surface and deep zones.  
 
4.2.2 Protein expression 
 
At day 7, 3D co-cultures were fixed, infiltrated and cryosectioned (page 63). 
Cryosections were immunostained for adenosine receptors (A1, A2A, A2B, A3), 
glutamate receptors (AMPAR2, KA1, mGluR1), and glutamate transporters 
(GLAST1, EAAC1) (page 65 and Table 2.3), or CaSR (page 67 and Table 2.4). Data 
presented are representative of 3 independent experiments of n=1 per experiment and 
4-6 cryosections per gel. 
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4.3 Results 
 
4.3.1 mRNA expression 
 
Adenosine receptors A2A and A2B (Figure 4.1A) and glutamate transporter 
GLAST1 (Figure 4.1C) mRNAs were detected in both surface and deep zones, 
whereas, glutamate receptors AMPAR2 and KA1 were only detected in the deep 
zone of the model (Figure 4.1C). However, mRNAs for adenosine receptors A1 and 
A3 (Figure 4.1A), CaSR (Figure 4.1B), glutamate receptor mGluR1 and 5 (page 273) 
and transporter EAAC1 (Figure 4.1C) could not be detected in either zone of the 
model . In all experiments and primer combinations RT-PCR negative controls did 
not amplify any products. 
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Figure 4.1. RT-PCR expression of adenosine, calcium-sensing and glutamate 
signalling components in day 7 3D co-cultures. Gel electrophoresis shows RT-PCR 
products for all adenosine receptors (A), CaSR (B) and glutamate receptors 
(AMPA2, KA1 and mGluR1) and transporters (GLAST1 and EAAC1) (C) in 
osteoblasts (surface) and osteocytes (deep). Mouse brain cDNA was the positive 
control for all RT-PCRs except CaSR, where mouse kidney cDNA was used. 
Negative controls did not yield any products. Gels are representative of 3 
independent experiments, n=4 for both surface and deep zones. 
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4.3.2 Protein expression 
 
Both osteoblasts and osteocytes in 3D co-cultures showed strong uniform 
immunolabelling for the adenosine receptor A2A (Figures 4.2C and D) and for CaSR 
(Figures 4.3A and B). Immunolabelling for the glutamate receptor KA1 (Figures 
4.4C and D) and transporter GLAST1 (Figures 4.4G and H) was also observed in 
both osteoblasts and osteocytes.  However, adenosine receptors A1 (Figures 4.2A and 
B), A2B (Figures 4.2E and F) and A3 (Figures 4.2G and H); and glutamate receptors 
AMPAR2 (Figures 4.4A and B) and mGluR1 (Figures 4.4E and F); and glutamate 
transporter EAAC1 (Figures 4.4I and J) were not detected in either zone of the model 
with the antibodies used. Negative controls where primary antibodies were omitted 
(PBST) or substituted with non-immune immunoglobulins (IgG) did not reveal 
immunolabelling (Figures 4.3C and D, and 4.4K-T), except for adenosine receptor 
controls where non-specific background staining is observed (Figures 4.2I and J). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
122 
 
D 
F 
H 
3D CO-CULTURE OSTEOCYTES 
A 1
 
A 2
A 
A 2
B
 
A 3
 
C
O
N
TR
O
LS
 
B A 
C D 
E F 
G H 
I J 
SZ 
DZ 
SZ 
DZ 
SZ 
DZ 
SZ 
DZ 
SZ 
DZ 
IGG PBST 
SZ 
DZ 
123 
                Chapter 4      
Figure 4.2 Adenosine receptors protein expression in day 7 3D co-cultures detected 
by immunostaining.  Light microscope images from transverse cryosections of 3D 
co-cultures immunolabelled for adenosine receptor A1 (A and B), A2A (C and D), 
A2B (E and F), and A3 (G and H) in osteoblasts (SZ) and osteocytes (DZ). Controls 
where primary antibodies were omitted (PBST) or substituted with non-immune 
immunoglobulins (IgG) showed non-specific background staining (I and J). Scale 
bars: 50 µm. Images are arbitrary fields of view representative of 3 independent 
experiments, n=1 per experiment. 
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Figure 4.3 CaSR protein expression in day 7 3D co-cultures detected by immunostaining 
(red: CaSR, blue: DAPI).  Fluorescence microscope images of transverse cryosections of 
3D co-cultures immunolabelled for CaSR (A and B) in osteoblasts (SZ) and osteocytes 
(DZ).  Controls where primary antibodies were omitted (PBST) or substituted with non-
immune immunoglobulins (IgG) showed no labelling (C and D). Scale bars: 50 µm, 50 µm, 
100 µm, 100 µm. Images are arbitrary fields of view representative of 3 independent 
experiments, n=1 per experiment. 
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Figure 4.4 Glutamate receptors and transporters protein expression in day 7 3D co-
cultures detected by immunostaining.  Light microscope images of transverse 
cryosections of 3D co-cultures immunolabelled for AMPAR2 (A and B), KA1 (C 
and D), mGluR1 (E and F), GLAST1 (G and H), and EAAC1 (I and J), in osteoblasts 
(SZ) and osteocytes (DZ).  Controls where primary antibodies were omitted (PBST: 
AMPA2 (L), KA1 (N), mGluR1 (P), GLAST1 (R), EAAC1 (T)) or substituted with 
non-immune immunoglobulins (IgG: AMPA2 (K), KA1 (M), mGluR1 (O), GLAST1 
(Q), EAAC1 (S)) showed no labelling. Scale bars: 50 µm. Images are arbitrary fields 
of view representative of 3 independent experiments, n=1 per experiment. 
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4.4 Discussion 
 
Various adenosine, calcium-sensing and glutamate signalling component 
mRNAs and proteins were detected by RT-PCR and immunolabelling respectively 
(Table 4.1). 
 
Table 4.1 3D co-culture mRNA and protein expression of signalling components. 
 
+ present; - absent; NI not investigated. 
 
It is important to note that to confirm the absence of protein expression of 
some of these receptors, immunostaining must be repeated with different antibodies 
to those used in this thesis and with a positive control alongside. Furthermore, 
quantification of these proteins in the 3D model by western blotting in surface 
osteoblasts and deep osteocytes should also be carried out. Nevertheless, these results 
provide an expression prolife of adenosine, calcium-sensing and glutamate signalling 
components within the 3D co-culture model. 
 
 
 
 
 
Signalling Pathway Receptor/Transporter mRNA Protein 
  Surface Zone Deep Zone Surface Zone Deep Zone 
Adenosine 
A1 - - - - 
A2A + + + + 
A2B + + - - 
A3 - - - - 
Calcium-sensing CaSR - - + + 
Glutamate 
AMPAR2 - + - - 
KA1 - + + + 
mGluR1 - - - - 
mGluR5 - - NI NI 
GLAST1 + + + + 
EAAC1 - - - - 
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4.4.1 mRNA expression 
 
In the 3D co-culture model, surface osteoblasts and deep osteocytes 
expressed mRNAs for adenosine receptors A2A and A2B, and glutamate transporter 
GLAST1, after 7 days of culture (Figure 4.1A and C). Glutamate receptors AMPAR2 
and KA1 were only expressed in the deep zone osteocytes (Figure 4.1C). Adenosine 
receptors A1 and A3, CaSR, glutamate receptors mGluR1 and 5, and glutamate 
transporter EAAC1 were not expressed in the 3D model (Figure 4.1A-C) (Table 4.1).  
 
To date, studies on the mRNA expression of adenosine receptors are scarce 
and in vitro (page 36). Osteoblasts have been previously shown to express mRNA for 
adenosine receptors A1, A2A and A2B, but not for A3, in MG63 human osteoblast-
like cells (Russell et al., 2007).  In the 3D co-culture, surface osteoblasts express A2A 
and A2B receptors, but no A3; consistent with MG63 data. However, the lack of A1 
mRNA expression in 3D co-culture surface osteoblasts contradicts previous findings. 
This difference in expression could be due a difference in species as MG63 cells are 
a human osteoblast cell line. Other explanations include low gene expression, and the 
fact that previous studies were done on cells in monolayer, and not in a 3D co-
culture, both of which are discussed later in this section.  
 
No data have been published yet on the mRNA expression of adenosine 
receptors in osteocytes in vivo or in vitro (Evans and Ham, 2012). Therefore, this 
thesis reports, for the first time, the expression of adenosine receptors A2A and A2B, 
and absence of A1 and A3 mRNA in MLO-Y4 osteocyte-like cells when cultured in 
3D co-cultures. 
 
CaSR mRNA has previously been found to be expressed in osteoblasts in 
vivo in rat and bovine bone (Chang et al., 1999) and in rat and human undecalcified 
bone (Dvorak et al., 2004), and in vitro in rat calvarial osteoblasts (Chattopadhyay et 
al., 2004) and in several osteogenic cell lines (Yamaguchi et al., 1998b, Yamaguchi 
et al., 2001) including MC3T3-E1 cells (Yamaguchi et al., 1998a). In osteocytes, 
expression of CaSR mRNA has been previously shown in vivo (Chang et al., 1999, 
Dvorak et al., 2004), however, the absence of CaSR mRNA in MLO-Y4 osteocyte-
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like cells reported here is the first investigation of CaSR mRNA expression in 
osteocytes in vitro. The fact that no CaSR mRNA could be detected in the 3D co-
culture surface MC3T3-E1(14) cells contradicts previous findings. CaSR is a G-
protein coupled receptor and many of this type of receptors are highly difficult to 
detect at the mRNA level as they are scarce (Yang et al., 1999, Sarramegna et al., 
2003, Hansen et al., 2007). Indeed, expression of CaSR mRNA has been shown to be 
controversial in vascular smooth muscle cells (VSMCs) with some studies showing 
expression (Smajilovic et al., 2006, Molostvov et al., 2007) and others failing to 
detect CaSR mRNA (Farzaneh-Far et al., 2000, Shalhoub et al., 2006). This issue 
could also be the case in osteoblasts and osteocytes, accounting for the inability to 
detect it in the surface and deep zones of the 3D model. Further reasons for the 
inability to detect CaSR mRNA in the 3D co-culture are discussed at the end of this 
section. 
 
As reviewed in (Kalariti et al., 2004, Brakspear and Mason, 2012), of the 
selected receptors and transporters, osteoblasts have been shown to express in vivo 
mRNA for glutamate transporter GLAST1 (Mason et al., 1997). In vitro, studies 
have demonstrated that osteoblasts also express mRNAs for GLAST1 in rat primary 
osteoblasts (Takarada et al., 2004), human osteoblast-like cell lines MG63 (Kalariti 
et al., 2004) and SaOS-2 (Huggett et al., 2002), EAAC1 in rat primary osteoblasts 
(Takarada et al., 2004); glutamate receptors KA1 in rat calvarial osteoblasts (Hinoi et 
al., 2002), and mGluR1 in rat femoral osteoblasts and MG63 cells (Gu and 
Publicover, 2000, Kalariti et al., 2004) and 5 in MG63 cells (Kalariti et al., 2004). 
However, to date, there are no reports on the expression of AMPAR2 mRNA in 
osteoblasts in vivo, whereas in vitro Hinoi et al reported absence of AMPAR2 in rat 
calvarial osteoblasts (Hinoi et al., 2002). Surface osteoblasts in 3D co-cultures 
express GLAST1 mRNA but no AMPAR2 mRNA was detected, consistent with 
published data. However, surface osteoblasts showed no expression of mRNAs for 
EAAC1, KA1 or mGluR1 or 5, contradicting previous studies. Whilst this may 
reflect rare transcripts for the receptors, this is unlikely for EAAC1 which is 
relatively abundant (Brakspear, 2010).  
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Osteocytes have previously been found to express GLAST1 mRNA in vivo in 
rat bone (Mason et al., 1997) and in vitro in MLO-Y4 cells (Huggett et al., 2002), 
consistent with 3D co-culture data for osteocytes, which also express GLAST1. This 
thesis reports for the first time expression of AMPAR2 and KA1, and absence of 
expression of EAAC1, and mGluR1 and 5 mRNA in osteocytes in vitro.   
 
The differences in mRNA expression of some genes between previous studies 
and the 3D co-culture surface osteoblasts could be due low amounts of RNA and low 
abundance mRNA expression genes by RT-PCR. Alternatively, expression of some 
of these genes in the surface osteoblasts may be inhibited by the presence of 
embedded osteocytes, which would suggest a direct effect of osteocytes on osteoblast 
behaviour. This hypothesis could be tested by culturing M3CT3-E1(14) osteoblasts 
on empty gels and in 3D co-cultures with a different cell type embedded in the 
collagen gel, then assessing mRNA expression. Indeed, regulation of osteoblast 
phenotype, through the expression of COL1A1, in 3D co-cultures with osteocytes 
has already been shown in the human-mouse 3D co-culture model by Mason et al. 
(Mason et al., 2009, Mason D., 2009), suggesting this could also be the case in the all 
mouse 3D model.  
 
An explanation for the differences in gene expression, for the embedded 
osteocytes, is the fact that all previous in vitro studies have been performed in 
monolayer cultures of cells. Embedding cells within a 3D matrix has been shown to 
alter gene expression (Boukhechba et al., 2009, Kozlowski et al., 2009). 
 
4.4.2 Protein expression 
 
In the 3D co-culture model, both osteoblasts and osteocytes expressed A2A 
(Figure 4.2C and D), CaSR (Figure 4.3A and B), KA1 and GLAST1 proteins (Figure 
4.4C-D and G-H respectively), but A1 (Figure 4.2A and B), A2B (Figure 4.2E and F), 
A3 (Figure 4.2G and H), AMPAR2 (Figure 4.4A and B), mGluR1 (Figure 4.4E and 
F) or EAAC1 (Figure 4.4I and J) were not detected (Table 4.1).  
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Osteoblasts have been shown to express protein for all adenosine receptors in 
human primary osteoblasts (Costa et al., 2011), A1, A2A and A2B, but not for A3, in 
MG63 human osteoblast-like cells (Russell et al., 2007). In the 3D co-culture, 
surface osteoblasts stained for A2A receptor, consistent with previous studies and 
mRNA data (page 130). However, none of the other receptors were detected 
contradicting previous data. The difference in expression with previous studies could 
be due a difference in species as MG63 cells are a human osteoblast cell line. The 
lack of A2B protein in the 3D co-culture contradicts previous studies and mRNA 
expression data (page 130). This finding could be due to the degradation of A2B 
protein and therefore not being detected by immunostaining, or because the mRNA 
produced is not being translated to protein. However, even though the absence of A1 
and A3 protein in surface osteoblasts contradicts previous findings, it is consistent 
with mRNA data (page 130), suggesting that A1 and A3 receptors are not present in 
MC3T3-E1(14) cells when cultured in 3D co-cultures.  
 
Since protein expression of adenosine receptors has not previously been 
reported for osteocytes in vitro or in vivo (Evans and Ham, 2012), this is the first 
observation of A2A protein expression, and absence of A1, A2B and A3 protein in 
MLO-Y4 osteocyte-like cells in 3D co-cultures. 
 
CaSR protein is expressed in osteoblasts in vivo in rat and bovine bone 
(Chang et al., 1999), and in vitro in rat calvarial osteoblasts (Chattopadhyay et al., 
2004) and in various osteoblast-like cell lines (Yamaguchi et al., 1998b, Yamaguchi 
et al., 2001) including MC3T3-E1 cells (Yamaguchi et al., 1998a). This is consistent 
with 3D co-culture surface osteoblasts data. CaSR protein expression has only been 
shown in vivo in rat, human and bovine osteocytes (Chang et al., 1999, Dvorak et al., 
2004) with no in vitro studies in osteocytes or osteocyte-like cell lines. Thus, this 
thesis reports, for the first time, immunolabelling of CaSR protein in embedded 
MLO-Y4 cells, consistent with in vivo data. Interestingly, the presence of CaSR 
protein in the 3D model contradicts CaSR mRNA expression data obtained from 
surface osteoblasts and deep osteocytes, possibly reflecting rare and/or unstable 
CaSR mRNA (Smajilovic et al., 2006, Molostvov et al., 2007). 
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As reviewed in (Brakspear and Mason, 2012, Cowan et al., 2012), of the 
selected receptors and transporters, osteoblasts and osteocytes have been shown to 
express, in vivo, protein for glutamate transporters GLAST1 (Mason et al., 1997) and 
EAAC1 in rat bone (Bonnet, Williams and Mason, unpublished data).  In vitro, 
GLAST1 and EAAC1 proteins are expressed in human osteoblast-like cell lines 
(Brakspear, 2010) with EAAC1 protein also being present in human primary 
osteoblasts (Brakspear, 2010), but there are no reports of expression in mouse 
osteoblasts in vitro. GLAST1 protein is abundant in MLO-Y4 osteocyte-like cells 
(Huggett et al., 2002), but there are no reports of EAAC1 protein in these cells. 3D 
co-culture surface osteoblasts and embedded osteocytes stained for GLAST1 protein, 
consistent with mRNA data (page 130), in vivo data for osteoblasts and both in vivo 
and in vitro data for osteocytes. Furthermore, it is reported for the first time the 
presence of GLAST1 protein in MC3T3-E1 mouse osteoblasts in vitro. Absence of 
EAAC1 protein in the 3D co-culture, although consistent with mRNA data (page 
130), contradicts previous in vivo and in vitro studies.  
 
AMPAR2 protein is expressed by osteoblasts in vivo in human and rat bone 
(Bonnet, Williams and Mason unpublished data, (Szczesniak et al., 2005)). However, 
there is contradicting evidence in osteocytes in vivo, where Bonnet et al. reported 
AMPAR2 protein in osteocytes (Bonnet, Williams and Mason unpublished data), 
whereas, Szczesniak et al. showed absence of AMPAR2 in these cells (Szczesniak et 
al., 2005). Both studies used rat bone, but there were differences in terms of rat 
strains, age and sex, which could account for the contradicting results. In vitro, 
AMPAR2 protein was not expressed in rat primary osteoblasts (Szczesniak et al., 
2005), but studies on in vitro osteocyte expression of AMPAR2 protein have not yet 
been carried out. The absence of AMPAR2 protein in 3D co-culture osteoblasts is 
consistent with mRNA data (page 130) and in vitro studies, but not with in vivo data. 
Absence of AMPAR2 protein in 3D co-culture osteocytes contradicts mRNA 
expression data (page 130), but is consistent with the in vivo studies, and also is a 
novel in vitro finding. These differences in expression could be ascribed to the low 
amount of protein being produced, or because the mRNA produced is not being 
translated to protein.  
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Finally, no studies have reported the presence of KA1 or mGluR1 protein in 
osteoblasts or osteocytes in vivo or in vitro. Therefore, this thesis shows, for the first 
time, presence of KA1 and absence of mGluR1 protein in mouse osteoblasts and 
osteocytes in vitro. Immunostaining for KA1 in surface osteoblasts contradicts the 
absence of KA1 mRNA in the surface zone of the model (page 130). 
 
 4.5 Conclusion 
 
 In conclusion, a concise profile of expression of adenosine, calcium-sensing 
and glutamate receptors and transporters was developed. Components of each of the 
three signalling pathways are expressed in one or both zones of the 3D co-culture 
(Table 4.1). The lack of expression of mGluR1 and 5 means that the 
heterodimerisation between A1 and mGluR1, A2A and mGluR5, or CaSR and 
mGluR1 or 5 (section 4.1) cannot be investigated. However, it is probable that there 
is functional adenosine signalling, involving receptor A2A and possibly receptor A2B, 
glutamate signalling involving transporter GLAST1 and receptor KA1, and possibly 
receptor AMPAR2, and also CaSR signalling within the 3D model. This sets a 
platform for further investigation of the roles of adenosine, calcium and glutamate in 
mechanically-induced bone formation.  
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5. Development of a novel loading device for mechanical loading of 3D osteocyte 
cultures 
 
5.1 Background 
 
Currently, many mechanical loading devices exist which allow the 
application of osteogenic loads in vitro  (Brown, 2000) . However, most of these are 
custom-made devices which range in complexity, accuracy and consistency of 
loading and are not commercially available (page 30). Commercially available bone 
loading instruments include BOSE ElectroForce®, FlexCell® and ZETOS. These 
devices can be used to load in vivo, ex vivo or 2D and 3D in vitro cultures. For 
instance, BOSE ElectroForce® can be used to apply tension, compression, bending, 
and shear loads of up to 450 N and frequencies between 0.00001-300 Hz in vivo 
(Macione et al., 2011), ex vivo (Price et al., 2011, Xiao et al., 2011) and 3D in vitro 
cultures (Sittichockechaiwut et al., 2009), but not to 2D cell cultures. Although 
BOSE ElectroForce® systems have the right specifications to mechanically load the 
3D model, they can only load one specimen at a time and its set-up would disrupt the 
surface osteoblast layer of the 3D model (page 30).  
 
FlexCell® is only applicable to ex vivo and 2D or 3D in vitro cultures, and can 
be used to apply tension, compression or fluid flow with forces of up to 62 N and 
frequencies between 0.01-5 Hz. FlexCell® has the advantage of being able to load 6 
specimens at a time for compression and up to 24 for tension loads. However, the 
frequency range of FlexCell® is not suitable for physiological osteogenic loads which 
require a minimum frequency of 10 Hz (Rubin et al., 2001a, Fritton et al., 2000) 
(page 30). Furthermore, the FlexCell® compression system cannot be used to apply a 
defined force or strain as it does not have a load cell and functions by using a piston 
and compressed air to apply forces, which could be affected by, for example, 
changes in temperature or atmospheric pressure.  
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Finally, ZETOS systems have only been validated for ex vivo specimens and 
the set-up would disrupt the surface osteoblast layer. Therefore this system would not 
be appropriate for the loading of the 3D co-culture model (Davies et al., 2006, 
Endres et al., 2009, Aw et al., 2012) (page 30).  
 
For the mechanical loading of the 3D co-culture model, a device that applies 
physiological osteogenic mechanical stimuli without disrupting the osteoblast layer 
or the 3D collagen gel itself, as this is not very stiff, is essential. Also, it must have 
the ability to load numerous 3D co-cultures at the same time, maintaining equal 
strains across cultures. Currently there are no loading devices which are suitable for 
the 3D co-culture model developed in this thesis.  
 
5.1.1 Aims 
  
The experiments in this chapter aimed to develop a novel mechanical loading 
device suitable for the application of forces to the 3D co-culture model. The 
performance of the device was assessed by validating strain measurements using DIC 
and assessing responses of embedded osteocytes to physiological loads in 3D mono-
cultures. The effect of culture time prior to load (time pre-load) on the osteocyte 
responses, and the effect of load on specific signalling pathways (Chapter 4) were 
also investigated.  
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5.2 Materials and methods  
 
 For all experiments in this chapter, 3D collagen osteocyte mono-cultures 
were prepared, cultured in a flexible multi-well plate (page 77) and mechanically 
loaded (5 min, 10 Hz, 2.5 N) using a BOSE ElectroForce® loading instrument (page 
77). For all experiments, medium was not changed before mechanical stimulation, 
except in the 7 days pre-load culture time experiment where medium was changed 
immediately before load. Data presented are from 3D osteocyte mono-cultures and as 
in Table 5.1, unless otherwise stated. Control (non-loaded) cultures underwent all 
manipulations, such as movements in and out of incubators and to and from loading 
instrument, except mechanical loading.  
      
 
 
 
5.2.1 Mechanical loading device 
 
A 16-well loading plate was manufactured from solid silicone so that the 
wells of the plate were of the same dimensions (10 mm diameter) as a standard 48-
well tissue culture plate but with a 150 µm thick base to allow microscopic 
observation of the cells. The plate was also manufactured to fit a 48-well plate lid 
(page 77). The spaces between the wells were filled with silicone and a series of 
holes were made on each side of the plate to accommodate hooks, which enabled the 
BOSE loading instrument to stretch the plate causing cyclic compression and tension 
forces at the same time, but in perpendicular directions in all wells (pages 77 and 80).  
 
 
Time pre-load No of experiments N
o of culture replicates 
 (control and loaded) 
24 hr (pilot) 1 2 
24 hr 2 3 
48 hr 1 3 
72 hr 1 3 
7 days 1 3 
Table 5.1 Source of data presented 
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Strain measurements were carried out by applying a speckle pattern to the 
base of the plate, which was then stretched at 2.5 N using a 5 N load cell attached to 
a Servo Hydraulic Testing Machine. Images were captured using DIC cameras and 
strains measured with the software provided (page 78).  
 
For loading 3D cultures, the silicone plate was attached to a BOSE 
ElectroForce® loading instrument by a custom-made device. A 250 N load cell was 
used to apply a cyclic loading regime of 5 min, 10 Hz, 2.5 N to the 3D cultures (page 
80).  
 
5.2.2 Cell death/number 
 
LDH assays were carried out at all time-points post-load with medium or 
culture lysates from 3D osteocyte mono-cultures (control and loaded) cultured for 
24, 48 or 72 hr or 7 days pre-load to assess cell death and cell number respectively 
(page 73). For all experimental samples, the assay was carried out on media/lysates 
diluted in culture medium or lysis buffer (respectively) as indicated in Table 5.2. 
LDH absorbance values obtained from culture lysates (cell number) were expressed 
as a percentage of the average of 0 hr control cultures except the 7 days experiment 
where the average of 0.5 hr control cultures was used. LDH absorbance values from 
culture lysates were also used to normalise PGE2 and IL-6 ELISA data. 
  
5.2.3 PGE2 release 
 
 PGE2 ELISAs were carried out (page 74) on media from control and loaded 
3D osteocyte mono-cultures cultured for 24 hr pre-load  at 0 (immediately after 
load), 0.5, 1, 3, 6, 12 and 24 hr post-load (1 pilot experiment, n=2) and then at 0.5 hr 
post-load in a further 2 independent experiments (n=3). Control and loaded 3D 
osteocyte mono-cultures cultured for 48 hr, 72 hr and 7 days pre-load were also 
analysed 0.5 hr post-load (1 independent experiment, n=3). For all experimental 
samples, the assay was carried out on media diluted in standard diluent as indicated 
in Table 5.2. Data from all experiments were normalised to cell number (page 139) 
except the pilot experiment, which was not normalised. The average release of 0.5 hr 
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control samples was subtracted from all values as medium was not changed before 
mechanical stimulation, except in the 7 days pre-load culture time experiment where 
medium was changed before mechanical stimulation. Raw data for all assays can be 
found in page 275. 
 
5.2.4 mRNA expression 
 
Total RNA was harvested at 3 and 24 hr post-load from control and loaded 
osteocytes cultured in 3D collagen gels for 24, 48, 72 hr or 7 days pre-load. RNA 
was extracted, reverse transcribed and cDNA integrity checked by RT-PCR of 18S 
rRNA (pages 52-55). Relative RT-qPCR for A2A, A2B, AMPAR2, GLAST1, KA1, 
E11 and RANKL, and 18S rRNA, GAPDH and HPRT1 as RGs, was carried out 
(pages 55-56, 58, Tables 2.1 and 2.2).  For all templates, amplifications were carried 
out on cDNA diluted in DEPC water as indicated in Table 5.2. RT-qPCR data were 
normalised to the correct RG using NormFinder (page 57). Data for each GOI were 
calibrated to the average ∆CT of the unloaded samples at each time point and 
expressed as REU (page 58). 
 
5.2.5 IL-6 release 
 
IL-6 ELISAs were carried out (page 75) on medium from control and loaded 
3D osteocyte mono-cultures cultured for 24 hr pre-load at 0.5, 1, 3, 6, 12 and 24 hr 
post-load (1 pilot experiment, n=2) and then at 0 (immediately after load), 0.5, 6 and 
24 hr post-load in a further 2 experiments (n=3). Control and loaded 3D osteocyte 
mono-cultures cultured for 48 hr and 72 hr pre-load were also analysed at 0 
(immediately after load), 0.5, 6 and 24 hr post-load (1 independent experiment, n=3). 
For all experimental samples, the assay was carried out on media diluted in reagent 
diluent as indicated in Table 5.2. Data from all experiments were normalised to cell 
number (page 139), except the pilot experiment which was not normalised, and the 
average release of 0 hr control samples was subtracted from all values as medium 
was not changed before mechanical stimulation. Raw data for all assays can be found 
in page 279. 
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Table 5.2 Experimental sample dilutions used. 
-: not diluted (neat); NI: not investigated. 
 
5.2.6 Statistics 
 
Data were statistically analysed using GLM for crossed factors or one-way 
Analysis of Variance (ANOVA) with Tukey-Kramer post-hoc test for parametric 
data. When transformation did not make data parametric Kruskal-Wallis with Mann-
Whitney post hoc tests were used (page 81). Pairwise comparisons where P≤0.05 
were recorded.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time pre-load No of experiments LDH Media LDH Lysates RT-qPCR PGE2 IL-6 
24 hr (pilot) 1 - NI - 1:64 - 
24 hr 2 - 1:4 - 1:64 - 
48 hr 1 - - - 1:16 1:10 
72 hr 1 - - - 1:16 1;10 
7 days 1 - 1:4 - 1:40 NI 
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5.3 Results 
 
5.3.1 Novel loading plate 
 
 A 16-well loading plate was generated from solid silicone (Figure 5.1B) so 
that it was deformable and optically transparent to allow microscopic observation of 
the cells, and was manufactured to the dimensions of a 48-well tissue culture plate 
(Figure 5.1A). Before loading 3D cultures, the strain that occurs within each empty 
well when 2.5 N of force is applied to the silicone plate, was measured using DIC. 
Strain testing showed that there is a large variability in strains across wells (from 
approximately 3000 µε to 6000 µε), with some wells demonstrating inward welling 
(Figure 5.1C). Furthermore, strain variability was also observed in between wells 
ranging from approximately 500 to 3500 µε (Figure 5.1C). However, 9 out of the 16 
wells had strains of 4000-4500 µε (Figure 5.1C).  
 
When applying a cyclic loading regime of 5 min, 10 Hz, 2.5 N to the 3D 
cultures, the provided software showed that the force was maintained at a 2.5 N peak 
and a smooth sine-wave was produced during each loading cycle applied, indicating 
negligible loading variance and a reproducible loading regime (Figure 5.3).  
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A 
B 
C 
* 
* 
* 
* 
* 
* 
Figure 5.1 A novel mechanical loading device. A) A standard 48-well tissue culture plate. 
B) 16-well silicone loading plate with holes for its attachment to a BOSE loading 
instrument. C) Heat map generated by DIC showing strains occurring in each well of the 
loading device when 2.5 N of force is applied. Inward welling (*) is also observed in some 
wells. 
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Figure 5.2 Mechanical loading of 3D cultures. The silicone loading plate (C) is attached to a BOSE ElectroForce® loading instrument with a 
custom-made device (A) which contains pins holding the plate in place and small rollers to allow the plate to move during loading (B). *: load 
cell; arrows: direction of stretching of the plate.  
A B 
C 
* 
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* 
Figure 5.3 Example of mechanical loading control performed with WinTest® Software 4.1 with TuneIQ control optimisation (BOSE). Image is a 
screen-shot of the output observed whilst performing a 5 min, 10 Hz, 2.5 N cyclic loading regime (*) using the silicone plate and custom-made 
adaptor on a BOSE ElectroForce® loading instrument. A 2.5 N force peak (circle) and a smooth sine-wave were observed during each loading 
regime. 
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5.3.2 Cell death/number 
 
LDH release into the medium as a result of cell death was measured at all 
time-points post-load in all experiments. LDH was not detected indicating no 
measurable cell death as a result of mechanical loading (raw data can be found in 
page 284). 
 
To assess cell number, LDH release from culture lysates was measured at all 
time-points in all experiments, except for the 24 hr pre-load pilot experiment. Data 
were expressed as a percentage of the average of 0 hr control cultures for all values 
in all experiments except the 7 days pre-load experiment where the average of 0.5 hr 
control cultures was used. The effect of load and time pre-load on cell number was 
assessed at 0.5, 6 and 24 hr post-load. At 0.5 hr post-load there was a significant 
effect of load (GLM, P=0.027 of log10 data) but no effect of time pre-load, and 
pairwise comparisons at each pre-load time were not significant (Figure 5.4A). At 6 
hr post-load there was a significant effect of time pre-load (GLM, P=0.0015 of 
ranked data) but no effect of load (Figure 5.4B). Cell number was significantly 
higher in loaded osteocytes cultured for 72 hr pre-load compared to loaded 
osteocytes cultured for 24 hr pre-load (24 hr loaded 93.02 ±2.53 %, 72 hr loaded 
152.60 ±12.03 %; P=0.0266) (Figure 5.4B). At 24 hr post-load there was a 
significant effect of time pre-load (GLM, P=0.0001) but no effect of load (Figure 
5.4C). Cell number was significantly higher in loaded osteocytes cultured for 72 hr 
pre-load compared to those cultured for 24 hr or 48 hr pre-load (24 hr loaded 102.53 
±4.05 %, 48 hr 104.32 ±8.93 %, 72 hr 182.08 ±5.51 %; 24 hr vs. 72 hr P=0.0011, 48 
hr vs. 72 hr P=0.0055) (Figure 5.4C).  
 
Data from osteocytes cultured for 48 and 72 hr pre-load were combined and 
re-analysed at 0.5, 6 and 24 hr post-load, and showed no significant effect of load or 
time post-load on cell number (control; 0.5 hr 128.80 ±17.87 %, 6 hr 105.78 ±9.51 
%, 72 hr 122.18 ±15.06 %; loaded: 0.5 hr 91.17 ±4.61 %, 6 hr 125.21 ±13.46 %, 24 
hr 143.20 ±18.01 %) (Figure 5.4D). When osteocytes were cultured for 7 days prior 
to mechanical stimuli, there was also no significant effect of load on 3D osteocyte 
mono-cultures (control 100 ±2.41 %, loaded 99.65 ±1.48 %) (Figure 5.4E). 
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Figure 5.4 Cell number in mechanically-loaded 3D osteocyte mono-cultures by LDH assay. Graphs showing cell number categorised by time of culture 
(A-C), combined 48-72 hr cultures (D) and 7 day cultures (E) at 0.5, 6 and 24 hr post-load unless other time-points are indicated. Data were expressed as 
a percentage of the average of 0 hr control cultures (A-D) or the average of 0.5 hr control cultures (E). *P<0.05, ***P<0.001 as obtained by GLM (C), 
GLM of log10 data (A) or ranked data (B). Significant differences as obtained by GLM pairwise comparisons denoted by ‘a’ with respect to 24 hr loaded 
cultures (B-C) and ‘b’ with respect to 48 hr loaded cultures (C). Data presented are from (A-C) 1 (48-72 hr cultures) or 2 (24 hr cultures) independent 
experiments, n=3; (D) 2 independent experiments, n=3 and (E) 1 independent experiment, n=3.  
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5.3.3 PGE2 release 
 
 A pilot experiment (1 independent experiment, n=2) was carried out in order 
to determine when and whether PGE2 is released from 3D osteocyte mono-cultures 
after being mechanically stimulated using the loading device. In this experiment, 
where 3D osteocyte mono-cultures were cultured for 24 hr prior to loading, there was 
a significant effect of load (GLM, P=0.040) but not time post-load (Figure 5.5A), 
and pairwise comparisons of control vs. loaded at each time-point were not 
significant (Figure 5.5B). Although not significantly different in this pilot 
experiment, mean PGE2 release increased approximately 4-fold at 0.5 hr post-load 
(control 1206.55 ± 37.32 pg/ml/OD492 nm; loaded 4632.91 ±1773.78 pg/ml/OD492 nm) 
in loaded cultures (Figure 5.5B).  
 
This experiment was then repeated twice measuring PGE2 release at 0.5 hr 
post-load only and normalising data to cell number (page 139). At 0.5 hr post-load, 
there was a significant effect of load (GLM, P=0.002 of ranked data), time pre-load 
(GLM, P=0.0275 of ranked data) and an interaction between both factors (GLM, 
P=0.033 of ranked data). PGE2 was barely detectable in 3D osteocyte mono-cultures 
cultured for 24 hr pre-load and so mean PGE2 was significantly higher in loaded 
osteocytes cultured for 48 hr prior to loading (24 hr: loaded -246.47 ±216.99 
pg/ml/OD492 nm; 48 hr: loaded 36120.75 ±13357.06 pg/ml/OD492 nm, P=0.0249) 
(Figure 5.5C), and although not significant, those cultured for 72 hr pre-load also 
revealed  a load-induced increase in mean PGE2 (control 0 ±4661.30 pg/ml/OD492 
nm; loaded 15896.88 ±2361.87 pg/ml/OD492 nm) (Figure 5.5C). Since osteocytes 
cultured for 48 and 72 hr pre-load increased PGE2 release in response to loading, 
these data were combined and re-analysed.  
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 Following loading, PGE2 release significantly increased at 0.5 hr post-load in 
3D mono-cultures cultured for 48-72 hr prior to loading (control 0 ±2505.57 
pg/ml/OD492 nm; loaded 26008.81 ±7566.25 pg/ml/OD492 nm) (one-way ANOVA, 
P=0.0001 of ranked data) (Figure 5.5D). When cultured for 7 days prior to 
mechanical stimuli, 3D osteocyte mono-cultures also showed a significant increase in 
PGE2 release 0.5 hr post-load in loaded cultures compared to control cultures 
(control 1195.40 ±109.72 pg/ml/OD492 nm; loaded 3152.26 ±435.20 pg/ml/OD492 nm) 
(one-way ANOVA, P=0.041) (Figure 5.5E). 
 
. 
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Figure 5.5 PGE2 release in mechanically-loaded 3D osteocyte mono-cultures by ELISA. Graphs showing PGE2 release in a pilot experiment of 24 hr cultures 
(A-B), categorised by time of culture (C), combined 48-72 hr cultures (D) and 7 day cultures (E) at 0.5 hr post-load unless other time-points are indicated. 
Data was normalised to the absorbance (OD492 nm) of LDH lysates (cell number) (C-E). *P<0.05 as obtained by GLM (A), GLM of ranked data (C) or one-
way ANOVA (E). ***P<0.001 as obtained by one-way ANOVA of ranked data (D). Significant differences as obtained by GLM pairwise comparisons denoted 
by ‘a’ with respect to 24 hr loaded cultures (C). Data presented are from (A) 1 independent experiment, n=2 or 3; (B) 1 (48-72 hr cultures) or 2 (24 hr cultures) 
independent experiments, n=3; (C) 2 independent experiments, n=3 and (D) 1 independent experiment, n=2 or 3.  
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5.3.4 mRNA expression 
 
A pilot experiment (1 independent experiment, n=2) was carried out in order 
to determine A2A, A2B, AMPAR2, GLAST1, KA1, E11 and RANKL mRNA 
expression by relative RT-qPCR at 3 and 24 hr post-load in control and loaded 3D 
osteocyte mono-cultures after being mechanically stimulated using the loading 
device. Data were expressed in REU and normalised to the geometric mean of 
GAPDH and HPRT1 as selected by NormFinder (page 57). In this experiment, 
mRNAs for A2A, A2B, E11 and RANKL were detected in 3D osteocyte control and 
loaded mono-cultures (Figure 5.6A-D) but GLAST1, AMPAR2 and KA1 mRNAs 
were not detected. Although not significantly different, loading increased A2A 
mRNA expression 1.5-fold after 3 hr (control 1.000 ± 0.0364 REU; loaded 1.512 ± 
0.162 REU) (Figure 5.6A). A2B mRNA expression was significantly increased in 
loaded cultures (3 hr: control 1.000 ± 0.039 REU, loaded 1.302 ± 0.068 REU; 24 hr: 
control 1.000 ± 0.007 REU, loaded 1.368 ± 0.163 REU) (effect of load GLM, 
P=0.021) (Figure 5.6B).  E11 mRNA expression was also significantly increased by 
load (GLM, P=0.002) at both 3 and 24 hr (3 hr: control 1.000 ± 0.033 REU, loaded 
1.248 ± 0.048 REU, P=0.460; 24 hr: control 1.000 ± 0.004 REU, loaded 1.383 ± 
0.060 REU, P=0.0101) (Figure 5.6.C). RANKL mRNA expression decreased by half 
24 hr post-load (control 1.026 ± 0.230 REU; loaded 0.615 ± 0.161 REU) (Figure 
5.6D) in loaded cultures as a result of loading. 
 
This experiment was then repeated twice and data was compared to that 
observed in 3D osteocyte mono-cultures cultured for 48 or 72 hr prior to load (Figure 
5.7). No significant differences were observed between osteocytes cultured for 24, 48 
or 72 hr pre-load in A2A mRNA expression 3 hr post-load (Figure 5.7A), A2B 
(Figures 5.7C and D) and E11 (Figure 5.7E and F) 3 or 24 hr post-load, or in 
RANKL mRNA expression 24 hr post-load (Figure 5.7H). However, there was a 
significant effect of time pre-load (GLM, P=0.013) and load (GLM, P=0.035) in 
A2A mRNA expression 24 hr post-load; and an interaction was observed between 
both factors (GLM, P=0.016). In loaded cultures, A2A mRNA expression was 
significantly higher in osteocytes cultured for 72 hr pre-load when compared to those 
cultured for 24 and 48 hr pre-load (24 hr loaded 1.11 ±0.062 REU; 48 hr loaded 
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0.895 ±0.146 REU; 72 hr loaded 1.651 ±0.175 REU) (pairwise comparisons: 24 hr 
loaded vs. 72 hr loaded P=0.0186; 48 hr loaded vs. 72 hr loaded P=0.0037) (Figure 
5.7B). There was also a significant effect of time pre-load in RANKL mRNA 
expression at 3 hr post-load as a result of culture time (GLM, P=0.018 of ranked 
data). However, no significant effects of load were observed. RANKL mRNA 
expression was significantly higher in osteocytes cultured for 48 hr pre-load 
compared to those cultured for 24 hr pre-load (24 hr loaded 0.908 ±0.125 REU; 48 hr 
loaded 2.072 ±0.095 REU, P=0.0353) (Figure 5.7G). Since loading-induced 
increases in PGE2 release only appeared to occur when osteocytes were cultured for 
48 hr or greater pre-load, mRNA data was re-analysed, combining experiments 
where 3D osteocyte mono-cultures were cultured for a minimum of 48 hr prior to 
mechanical loading. 
 
  No significant effect of load or time was observed in A2A or A2B mRNA 
expression at 3 or 24 hr post-load in 3D mono-cultures cultured for 48-72 hr prior to 
loading (Figures 5.8A and B). However, there was a trend of load increasing mean 
A2A expression at both 3 and 24 hr post-load (3 hr: control 1.007 ±0.056 REU, 
loaded 1.190 ±0.125 REU; 24 hr: control 1.014 ±0.077 REU, loaded 1.273 ±0.197 
REU), although this was a small increase. Load significantly decreased E11 mRNA 
expression (3 hr: control 1.001 ±0.015 REU, loaded 0.937 ±0.030 REU; 24 hr: 
control 1.022 ±0.096 REU, loaded 0.819 ±0.050 REU) (GLM, P=0.018 of ranked 
data), however pairwise comparisons were not significant (Figure 5.8C). 
Furthermore, there was a significant effect of time on RANKL mRNA expression in 
loaded cultures (GLM, P=0.022). RANKL mRNA expression increased at 3 hr post-
load but decreased to control levels at 24 hr post-load (3 hr loaded 1.688 ±0.181 
REU; 24 hr loaded 1.027 ±0.220 REU, P=0.0486) (Figure 5.8D). 
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In osteocytes cultured for 7 day pre-load, mRNA expression was analysed at 
3 hr post-load only. Data were expressed in REU and normalised to GAPDH as 
selected by NormFinder (page 57).  A2A mRNA expression was doubled in loaded 
cultures (control 1.019 ±0.144 REU; loaded 2.128 ±0.379 REU) (one-way ANOVA, 
P=0.052) (Figure 5.9A) and E11 increased 1.3-fold (control 1.002 ±0.049 REU; 
loaded 1.336 ±0.101 REU) (one-way ANOVA, P=0.041) (Figure 5.9C) when 
compared to control cultures. There was no significant effect of load in A2B (Figure 
5.9B) and RANKL mRNA expression (Figure 5.9D), although a 1.8-fold increase in 
RANKL expression was observed (control, 1.020 ±0.141 REU; loaded, 2.126 ±0.430 
REU).  
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Figure 5.6 Quantification of mRNA expression in mechanically-loaded 3D osteocyte mono-
cultures from a pilot experiment by relative RT-qPCR. Graphs of A2A (A), A2B (B), E11 (C) and 
RANKL (D) expression in cultures incubated for 24 hr prior to load. Data expressed as REU 
and normalised to the geometric mean of GAPDH and HPRT1 expression. Significant 
differences as obtained by GLM between control and loaded cultures are denoted by *P<0.05, 
**P<0.01. Significant differences as obtained by GLM pairwise comparisons denoted by ‘a’ 
with respect to 3 hr control, and ‘b’ with respect to 24 hr control. (1 independent experiment, 
n=2). 
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Figure 5.7 Quantification of mRNA expression in mechanically-loaded 3D osteocyte 
mono-cultures by relative RT-qPCR categorised by time of culture prior to load. Graphs of 
A2A (A-B), A2B (C-D), E11 (E-F) and RANKL (G-H) mRNA expression at 24, 48 and 72 hr 
culture time pre-load. Data were recorded 3 and 24 hr post-load and are expressed as REU 
and normalised to the geometric mean of GAPDH and HPRT1. Significant differences as 
obtained by GLM between culture times are denoted by *P<0.05,  **P<0.01. Significant 
differences as obtained by GLM pairwise comparisons denoted by ‘a’ with respect to 24 hr 
loaded, and ‘b’ with respect to 72 hr loaded. (1 (48 and 72 hr) or 2 (24 hr) independent 
experiments, n=3). 
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Figure 5.8 Quantification of mRNA expression in mechanically-loaded 3D osteocyte mono-
cultures cultured for 48-72 hr  prior to load by relative RT- qPCR. Graphs of A2A (A), A2B (B), 
E11 (C) and RANKL (D) mRNA expression. Data were taken at 3 and 24 hr after loading and 
are expressed as REU and normalised to the geometric mean of GAPDH and HPRT1. 
Significant differences as obtained by GLM are denoted by *P<0.05. Significant differences 
as obtained by GLM pairwise comparisons denoted by ‘a’ with respect to 3 hr loaded. (2 
independent experiments, n=3). 
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Figure 5.9 Quantification of mRNA expression in mechanically-loaded 3D osteocyte mono-
cultures cultured for 7 days prior to load by relative RT-qPCR. Graphs of A2A (A), A2B (B), 
E11 (C) and RANKL (D) mRNA expression. Data were taken at 3 hr post-load and 
expressed as REU and normalised to GAPDH expression. Significant differences as 
obtained by one-way ANOVA are denoted by *P<0.05. (1 independent experiment, n=3). 
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5.3.5 IL-6 release 
 In the pilot experiment of 3D osteocyte mono-cultures cultured for 24 hr prior 
to loading, there was a significant effect of load (GLM, P=0.00001) (Figure 5.10A) 
but not time, however pairwise comparisons at each time-point were not significant 
(Figure 5.10B). This experiment was then repeated twice at 0 (immediately after 
loading), 0.5, 6 and 24 hr post-load, and data was compared to that observed in 3D 
osteocyte mono-cultures cultured for 48 or 72 hr prior to load (Figure 5.10 C-E) and 
expressed relative to the average of 0 hr control samples.  
 At 0.5 hr post-load, there was a significant effect of loading (GLM, P=0.038 
of ranked data) and time pre-load (GLM, P=0.009 of ranked data) on IL-6 release 
(Figure 5.10C). Although there was a significant effect of load on the whole data set 
which appeared to increase mean IL-6 at 48 and 72 hr time pre-load, within 
individual time-points there were no significant effects of load. IL-6 release was 
significantly greater at 0.5 hr in osteocytes cultured for 48 hr prior to loading 
compared to those cultured for 24 hr pre-load (24 hr: control 134.17 ±51.37 
pg/ml/OD492 nm, loaded 107.46 ±19.69 pg/ml/OD492 nm; 48 hr: control 3989.93 
±2153.05 pg/ml/OD492 nm, loaded 6524.92 ±1498.27 pg/ml/OD492 nm) (GLM, 
P=0.0134 of ranked data) (Figure 5.10C). At 6 hr post-load, there was an effect of 
time pre-load (GLM, P=0.00001 of ranked data) but no effect of load on IL-6 
release. IL-6 release from osteocytes cultured for 24 hr pre-load was significantly 
different when compared to those cultured for 48 hr and 72 hr pre-load (GLM, 
P=0.00001 of ranked data for both 24 hr vs. 48 hr and 24 hr vs. 72 hr) (Figure 
5.10D). IL-6 significantly increased in control osteocytes cultured for 48 and 72 hr 
pre-load when compared to control osteocytes cultured for 24 hr pre-load (24 hr 
control 214.10 ±37.12 pg/ml/OD492 nm; 48 hr control 7935.85 ±3110.22 pg/ml/OD492 
nm; 72 hr control 8898.65 ±3849.85 pg/ml/OD492 nm, P=0.0001 for both pairwise 
comparisons); and in loaded cultures at 48 hr when compared to 24 hr loaded 
cultures (24 hr loaded 252.51 ±27.09 pg/ml/OD492 nm; 48 hr loaded 7036.81 ±898.95 
pg/ml/OD492 nm, P=0.0004) (Figure 5.10D). Finally, at 24 hr post-load, there was an 
effect of time pre-load (GLM, P=0.00001 of ranked data) but no effect of load on IL-
6 release. IL-6 release was significantly increased in control osteocytes cultured for 
48 and 72 hr pre-load when compared to control osteocytes cultured 24 hr pre-load 
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(24 hr control 263.51 ±42.28 pg/ml/OD492 nm; 48 hr control 12351.79 ±3993.19 
pg/ml/OD492 nm; 72 hr control 7192.60 ±3387.89 pg/ml/OD492 nm) (pairwise 
comparisons: 24 hr control vs. 48 hr control P=0.0094; 24 hr control vs. 72 hr 
control P=0.0326); and in loaded osteocytes cultured for 48 hr pre-load when 
compared to those cultured for 24 hr pre-load (24 hr loaded 299.57 ±73.13 
pg/ml/OD492 nm; 48 hr loaded 6506.72 ±1864.32 pg/ml/OD492 nm) (pairwise 
comparisons: 24 hr loaded vs. 48 hr loaded P=0.0399) (Figure 5.10E). Since IL-6 
release was much lower in osteocytes cultured for 24 hr pre-load and PGE2 responses 
to loading were increased in osteocytes cultured for 48 hr or greater pre-load, these 
data were combined for 3D osteocyte mono-cultures cultured for a minimum of 48 hr 
prior to mechanical loading. 
 
 One-way ANOVAs were used to analyse 48-72 hr time pre-load data as 
transformation did not make data parametric when using GLM. Therefore the only 
comparisons made were between control and loaded cultures at the individual time-
points. Although there was no significant effect of load on IL-6 release in 3D mono-
cultures cultured for 48-72 hr prior to loading (Figure 5.10F), a trend of decreased 
mean IL-6 release as a result of load was observed at 6 and 24 hr post-load, but not at 
0.5 hr post-load.  
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Figure 5.10 IL-6 release in mechanically-loaded 3D osteocyte mono-cultures by 
ELISA. Graphs showing IL-6 release in a pilot experiment of cultures incubated for 24 
hr prior to load (A-B), categorised by time of culture  pre-load (C-E) and combined 
48-72 hr pre-load cultures (F) at time-points indicated post-load. Data were normalised 
to total cell number (C-F). *P<0.05, ***P<0.001 as obtained by GLM of ranked data. 
Significant differences as obtained by GLM pairwise comparisons denoted by ‘a’ with 
respect to  24 hr control cultures, and ‘b’ with respect to 24 hr loaded cultures (D-E). 
Data presented are from (A) 1 independent experiment, n=2 or 3; (B-D) 1 (48-72 hr 
cultures) or 2 (24 hr cultures) independent experiments, n=2 or 3; (E) 2 independent 
experiments, n=3. 
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5.4 Discussion  
 
 A novel mechanical loading device was developed in order to facilitate the 
application of mechanical stimuli to the 3D co-culture model (Figure 5.1A and B). 
The ability of the device to induce a cellular response was assessed by loading 
osteocytes, the mechanosensing cell in bone, in 3D type I collagen gels. The work in 
this chapter aimed to test the loading device and characterise the osteocyte response. 
A summary of the results shown can be seen in Figure 5.11. It is important to 
mention that the results presented in this chapter from the 24 hr pilot experiment and 
7 day pre-load cultures are each derived from single experiments (n=2 or 3) and 
therefore all trends observed should be discussed with caution. In order to increase 
the reliability of the results presented, these experiments should be repeated. 
Nevertheless, the data presented give an indication of the load responses from 3D 
collagen embedded osteocytes using a novel loading device. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
161 
 
Figure 5.11 Summary of results. Embedded osteocytes were 
shown to respond to physiological loads by releasing PGE2, and 
this loading response was maintained if the embedded osteocytes 
were cultured for a minimum of 48 hr and up to 7 days prior to 
mechanical stimuli. Culture time pre-load appeared to have an 
effect on E11 mRNA expression as a result of loading. 
Furthermore, the adenosine receptor A2A was shown to be 
mechanically regulated. 
LOAD LOAD 
↑ PGE2  (1.8-fold) 
↓ IL-6 (2-fold) ↑ PGE2 (2.6-fold) 
Time pre-load 
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5.4.1 Mechanical loading device 
 
A 16-well silicone plate was developed where the wells were of the same 
dimensions as a standard 48-well tissue culture plate but with thinner bottoms 
(Figure 5.1A and B). The silicone plate accommodates hooks to stretch the plate, 
therefore when stretched it causes compression and tension forces at the same time 
but in perpendicular directions (Figure 5.2). This silicone plate was attached to the 
BOSE ElectroForce® 3200 loading instrument and the loading regime (5 min, 10 Hz, 
2.5 N) was based on previous publications showing that a short period of  10 Hz, 
4000-4500 µε  loading is physiological and osteogenic (Hillam and Skerry, 1995, 
Mason et al., 1996, Rubin et al., 2001a). The loading device was designed so that 
when stretched, a uniform strain would be produced in every well causing 
compression and tension forces at the same time but in perpendicular directions. 
Furthermore, it was shown that when 2.5 N is applied to the silicone plate, the wells 
experience strains of approximately 4000-4500 µε (Figure 5.1C). However, there 
was variability in strain across wells. The majority of the wells showed 4000-4500 
µε when loaded at 2.5 N (Figure 5.1C), which has been shown to be a high 
osteogenic strain in rats in vivo (Mason et al., 1996). Some wells experienced inward 
welling during strain testing, which resulted in higher strains being recorded, with 
the highest being approximately 6000 µε, but other wells showed lower strains, 
between 3000-3500 µε (Figure 5.1C). In an ideal situation, all wells would 
experience the same strain, and that strain would be physiological and osteogenic 
(4000-4500 µε), as if wells were to experience different strains it could lead to a 
variation in load response across repeats within an independent experiment. 
Furthermore, even though some of the strain values measured are lower than 
physiological strains (3000-3500 µε), they are still within the peak strain values 
observed in vertebrates which range from 2000-3500 µε (Rubin and Lanyon, 1984a, 
Rubin and Lanyon, 1984b, Rubin et al., 1990). However, wells with strains recorded 
at 6000 µε are exposed to pathophysiological strains. 
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Inward welling was probably caused by the fact that the base of the wells are 
thin and without a 3D gel inside the well, the base is flexible and can bend inwards 
when the plate is stretched. The base of the plate could be made thicker which may 
help resolve the inward welling, however a previous prototype of this silicone plate 
was made with a thicker base and it interfered with microscopic observation of the 
cells as it was not transparent enough. A compromise between thickness and 
transparency of the base of the plate should be found in order to address the inward 
welling. However, if this compromise is not possible, a thicker base should be 
prioritised over transparency, as observation of the cells in culture could be done 
using other microscopy techniques.   
 
The strain testing performed was carried out on an empty plate. Therefore, 
testing the silicone plate with 3D cultures may prevent inward welling and variable 
strains, and thus give a more accurate reading of the strains occurring within each 
well when 2.5 N of force is applied. This method was previously tested by applying a 
speckle pattern on the surface of 3D collagen gels within the silicone plate. However, 
the speckles were too big for the surface area to be analysed by the DIC cameras and 
the 3D gels were also found to reflect the light of the cameras, interfering with the 
readings. This method should be optimised by taking into account the 3 main 
requirements for speckle patters: image contrast, randomness of the pattern and 
attachment of the pattern to the surface of the specimen (Ning et al., 2011). The 
incorporation of toner into the 3D gels before polymerisation within the silicone 
plate may be a possible solution (Sutton et al., 2009). The toner would give a smaller 
speckle pattern which would be detectable by the DIC cameras. However, the natural 
pink colour of the 3D gels may not produce enough contrast for the cameras to detect 
the individual speckles. Furthermore, the light reflective properties of the 3D gels 
may not be able to be addressed. Application of the speckle pattern to the base of the 
silicone plate, with 3D collagen gels in the wells, may be a better solution. It is vital 
to accurately measure strains within the developed loading device and further work 
should be carried out to improve this methodology, as previously mentioned, if the 
strains across wells are truly variable, it could lead to a variation in load response 
across experimental repeats. For example, osteocytes within 3D gels in wells which 
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experience higher strains may release more PGE2 than those in wells suffering lower 
strains.  
 
Currently, there are two devices similar to the one developed in this thesis, 
based on a silicone plate format (Neidlinger-Wilke et al., 2005, Tata et al., 2011). 
Tata et al developed a silicone plate in a six-well plate format to mechanically load 
VSMCs in monolayers, whereas the device developed by Neidlinger-Wilke et al is a 
single-well silicone plate which was designed to load 3D collagen cultures of 
intervertebral disc cells. Both devices were used to apply cyclic mechanical stimuli 
by stretching in a similar fashion to the device developed in this thesis (Neidlinger-
Wilke et al., 2005, Tata et al., 2011). The loading regimes applied using these plates 
(Neidlinger-Wilke et al., 24 hr, 0.1 Hz, 10,000 µε; Tata et al., 6-72 hr, 1 Hz, 10-20% 
strain) (Neidlinger-Wilke et al., 2005, Tata et al., 2011) are indeed very different to 
the regime used in this thesis and used frequencies below osteogenic values (Mason 
et al., 1996, Rubin et al., 2001a). Both published devices were not designed to fit a 
commercially available loading instrument and therefore require their own custom-
made loading apparatus (Neidlinger-Wilke et al., 2005). Furthermore, Neidlinger-
Wilke et al did not publish strain test data and Tata et al assessed the strain field at 
the bottom surface of the wells using finite element (FE) modelling, but did not 
directly measure strains to validate this FE model by using DIC, or any other 
methods (Neidlinger-Wilke et al., 2005, Tata et al., 2011). Thus the strains applied 
with the published models are not validated, nor have been shown to be uniform.  
 
Although further work must be done in order to fully characterise the loading 
device developed in this thesis and ensure the application of uniform strains, the 
strain measurements obtained by DIC gave an initial indication that 2.5 N of force 
may result in physiological osteogenic strains. Furthermore, the device can be 
successfully used with a BOSE ElectroForce® loading instrument and allows the 
application of mechanical stimuli to 16 3D collagen co-cultures at the same time, a 
higher number of specimens than the published or commercially available devices.  
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5.4.2 Cell death/number 
 
 In 3D osteocyte mono-cultures, under the stated experimental conditions, 
there was no detectable cell death as a result of mechanical loading at any time pre-
load or post-load time. However, cell number was found to be significantly higher in 
osteocytes cultured for 72 hr pre-load compared to those cultured for 24 and 48 hr 
pre-load (Figure 5.4B and C). These data suggest that there may be an increase in 
proliferation or a decrease in cell death within the first 24 hr of culturing osteocytes 
in 3D gels. Therefore, 3D osteocyte mono-cultures should be cultured for at least 48 
hr prior to loading.  
 
 In osteocytes cultured for 48-72 hr and 7 day pre-load, there was no 
significant effect of loading on cell number (Figure 5.4D and E), correlating with cell 
death data. Previous in vivo (Noble et al., 2003, Plotkin et al., 2005, Kulkarni et al., 
2012) and in vitro (Bakker et al., 2004, Tan et al., 2006, Tan et al., 2008) studies 
have shown that loading reduces osteocyte cell death. Furthermore, in vitro studies 
have shown that loading increases osteoblast number (Kaspar et al., 2000, Pavlin et 
al., 2000, Kaspar et al., 2002, Ignatius et al., 2005, Jackson et al., 2006). These in 
vitro studies contradict 3D osteocyte mono-culture data. However, this could be 
explained by the fact that osteoblasts were cultured in monolayers and subjected to 
stretching or fluid flow loading regimes of 0.5 or 1 Hz and  approximately 1000 or 
10000 µε, for a minimum of 0.5 hr each day for the duration of their experiments 
(Kaspar et al., 2000, Kaspar et al., 2002, Ignatius et al., 2005, Jackson et al., 2006); 
whereas, the 3D osteocyte mono-cultures in this thesis were exposed to a single 
loading regime of 5 min, 10 Hz, 2.5 N (4000-4500 µε). To date there appear to be no 
studies on the effect of load on osteocyte cell number in vitro.  
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5.4.3 PGE2 release 
 
In 3D osteocyte mono-cultures, load induced PGE2 release at 0.5 hr post-load 
was found to be significantly higher in osteocytes cultured for 48 hr pre-load when 
compared to those cultured for 24 hr pre-load (Figure 5.5C). Although not 
significant, there was also a higher release of PGE2 in osteocytes cultured for 72 hr 
pre-load than those cultured for 24 hr pre-load (Figure 5.5C). These data suggest 
mechanical loading responses from embedded osteocytes using the developed 
silicone plate, are more reliable after the osteocytes have been cultured in 3D 
collagen gels for at least 48 hr prior to loading. This could be because the osteocytes 
may take over 24 hr to form dendrites and develop an osteocytic phenotype within 
the 3D collagen gels. Of particular importance is the expression of functional CX43 
gap junctions, which have been previously shown to be involved in the release of 
PGE2 from osteocytes in vitro (Jiang and Cherian, 2003, Cherian et al., 2005).  
 
In osteocytes cultured for 24 hr pre-load from a pilot experiment, there was a 
significant increase in PGE2 release at all time-points post-load, in particular at 0.5 
hr post-load, though not significant (Figure 5.5A and B). In osteocytes cultured for 
48-72 hr pre-load there was a significant increase in PGE2 release 0.5 hr post-load, 
consistent with the pilot data (Figure 5.5D). This significant increase at 0.5 hr post-
load was also observed in loaded osteocytes cultured for 7 days pre-load (Figure 
5.5E). Previous in vitro studies have shown that mechanically-loaded osteocytes in 
monolayer increase PGE2 release (Cheng et al., 2001a, Jiang and Cheng, 2001, Saini 
et al., 2011, Li et al., 2012b), as early as 0.5 hr post-load (Cheng et al., 2001a), 
consistent with the data presented here. No previous studies have investigated 
osteocyte response to load in 3D. Thus the combination of MLO-Y4 cells in 3D 
collagen gels with the new loading device has shown load-induced PGE2 release by 
these cells for the first time. It is important to note that PGE2 release resulting from 
load appeared to be 10 times lower in loaded osteocytes cultured for 7 days pre-load 
(3152.26 ±435.20 pg/ml/OD492 nm) compared to loaded osteocytes cultured 48-72 hr 
pre-load (26008.81 ±7566.25 pg/ml/OD492 nm). However, without normalisation to 
cell number, loaded osteocytes cultured for 48-72 hr pre-load released 3087.11 
±727.17 pg/ml whereas loaded osteocytes cultured for 7 day pre-load released 
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2076.96 ±307.44 pg/ml, suggesting that the difference observed in normalised values 
is due to a difference in total cell number between 48-72 hr and 7 days time pre-load.  
 
Nevertheless, it can be concluded that in the 3D model, osteocytes are able to 
respond to mechanical stimuli when embedded in 3D collagen gels, but the extent of 
the response is affected by time pre-load time. 
 
5.4.4 mRNA expression 
 
 Although for most genes analysed there was no significant difference in 
mRNA expression between 3D osteocytes cultured for 24, 48 and 72 hr pre-load, 
some differences were observed in A2A expression 24 hr post-load (Figure 5.7B) and 
in RANKL expression 3 hr post load (Figure 5.7G).  This suggests that generally 
culture time has no effect on the osteocyte response to load at the mRNA level. The 
differences observed could be due to the phenotype state of the 3D osteocyte mono-
culture. A2A mRNA expression was higher 24 hr post-load in osteocytes cultured for 
72 hr pre-load than in those cultured for 24 or 48 hr pre-load (Figure 5.7B), and 
RANKL mRNA expression 3 hr post-load was higher in osteocytes cultured for 48 hr 
pre-load than in those cultured for 24 hr pre-load (Figure 5.7G). As previously 
hypothesised (page 166), the embedded osteocytes may take over 24 hr to develop an 
osteocytic phenotype, and form dendrites with connections to neighbouring cells 
within the 3D collagen gels. 
 
In osteocytes cultured for 24 hr pre-load from a pilot experiment, there was 
no significant effect of load on A2A mRNA expression, although an increase in A2A 
expression was observed at 3 hr post-load (Figure 5.6A). However, mechanical 
stimuli significantly increased A2B mRNA expression in loaded cultures (Figure 
5.6B). In osteocytes cultured for 48-72 hr pre-load there was no significant effect of 
load in A2A (Figure 5.8A), consistent with preliminary data, or A2B mRNA 
expression (Figure 5.8B), contradicting preliminary data. However, mean A2A 
mRNA expression increased by approximately 1.2-fold in loaded cultures at both 3 
and 24 hr post-load, consistent with pilot data. There was also a significant 2-fold 
increase in A2A mRNA expression observed in 3D osteocyte mono-cultures cultured 
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for 7 days pre-load (Figure 5.9A).  Thus A2A mRNA expression appears to increase 
in response to mechanical load in 3D osteocyte mono-cultures. The lack of load 
effect on A2B mRNA expression was also observed in osteocytes cultured for 7 days 
pre-load (Figure 5.9B). There are no in vivo or in vitro studies on the effect of 
mechanical stimuli on the expression of adenosine receptors in bone and this is the 
first report of mechanical regulation of A2A expression in osteocytes in vitro.  
 
In osteocytes cultured for 24 hr pre-load from a pilot experiment, mechanical 
loading significantly increased E11 mRNA expression at both 3 and 24 hr post-load 
(Figure 5.6C). In 48-72 hr 3D mono-cultures, mechanical loading significantly 
decreased E11 mRNA expression by 1.15-fold at both 3 and 24 hr post-load (Figure 
5.8C), contradicting preliminary data. However, a significant increase in E11 
expression of 1.3-fold was observed in 7 day loaded cultures 3 hr post-load (Figure 
5.9C). Previous in vitro studies have shown that E11 mRNA expression in MLO-Y4 
monolayers increased 2 hr after exposure to fluid shear (Yang et al., 2004, Zhang et 
al., 2006), which contradicts 48-72 hr time pre-load data, but is consistent with 
observations from osteocytes cultured for 7 days pre-load.  However, all previous 
studies were carried out in monolayer cultures, suggesting that in order for E11 
mRNA expression to increase as a result of load, osteocytes embedded in a 3D 
matrix may require a longer culture time prior to mechanical stimuli. This 
observation also suggests that embedded osteocytes cultured for 24 hr pre-load may 
not respond adequately to mechanical stimuli because of a lack of dendritic process 
extension, which is dependent on E11 expression, and therefore connection to 
neighbouring cells. Furthermore, this observation supports the previous hypothesis 
that osteocytes may take over 24 hr to settle down in the 3D gels, potentially 
affecting the expression of functional CX43 gap junctions (page 166). 
 
In osteocytes cultured for 24 hr pre-load from a pilot experiment, although 
not significant, mean RANKL mRNA expression decreased by half 24 hr post-load 
(Figure 5.6D). In 3D mono-cultures cultured for 48-72 hr pre-load, although there 
was no load effect on RANKL mRNA, time post-load significantly decreased 
RANKL mRNA expression in both control and loaded cultures (Figure 5.8D). 
Furthermore, there was no significant effect of load or time post-load in RANKL 
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mRNA expression in loaded osteocytes cultured for 7 days pre-load (Figure 5.9D). 
However there was a 1.8-fold increase 3 hr post-load in loaded osteocytes cultured 
for 7 days pre-load. Previous in vitro studies have shown that RANKL mRNA 
expression increases in MLO-Y4 cells in monolayers soon after mechanical load by 
fluid flow (You et al., 2008, Kulkarni et al., 2010), contradicting preliminary and 48-
72 hr time pre-load data, but consistent with 7 days time pre-load observations. This 
suggests a pre-load culture time of 7 days is beneficial, consistent with E11 data.  
 
 Interestingly, neither 24 hr, 48-72 hr nor 7 day time pre-load control and 
loaded cultures expressed detectable levels of GLAST1, AMPAR2 or KA1. These 
data contradicts previous observations that showed expression of all 3 genes in 3D 
co-culture embedded osteocytes (Chapter 4). Although there are no previous studies 
on the mechanical regulation of AMPAR2 or KA1 mRNA expression in osteoblasts 
or osteocytes, GLAST1 was found to be mechanically-regulated in loaded osteocytes 
in vivo (Mason et al., 1997). However, the same regulation has not yet been shown in 
vitro. The data presented suggests that the presence of osteoblasts may be essential 
for the expression of GLAST1, AMPAR2 and KA1 in osteocytes embedded in a 3D 
matrix. This could be tested by culturing 3D co-cultures and osteocyte mono-cultures 
at the same time and quantifying these mRNAs under each condition. If loaded, the 
mechanical regulation of GLAST1 in embedded osteocytes could also be tested.  
 
 It is important to note that although significant differences in the mRNA 
expression between control and loaded cultures were observed, some of these 
differences involved small fold changes. Therefore, the sensitivity of the relative RT-
qPCR assay used should be considered. It has been previously been shown that, in 
general, sensitivity of RT-qPCR assays depend on the handling and purity of the 
RNA, the reverse transcription step, and the qPCR assay itself (Bustin et al., 2009). 
Even performing absolute qPCR, which could be considered to be a more accurate 
method than relative qPCR, has been shown to only be sensitive enough to detect a 
minimum of 3 gene copies (Bustin et al., 2009). Therefore, even though the small 
differences in mRNA expression as a result of load were found to be statistically 
significant in this chapter, these should be considered with caution and confirmed by 
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assays which are known to be highly sensitive to small changes, such as digital PCR 
(Vogelstein and Kinzler, 1999, Dube et al., 2008, Schmittgen and Livak, 2008). 
 
5.4.5 IL-6 release 
 
 In 3D osteocyte mono-cultures, IL-6 release at 0.5, 6 and 24 hr post-load as a 
result of loading was found to be significantly higher in osteocytes cultured for 48 hr 
and 72 hr pre-load when compared to those cultured for 24 hr pre-load (Figure 
5.10C-E). These data give further evidence that mechanical loading responses from 
embedded osteocytes using the developed silicone plate are more reliable after at 
least 48 hr incubation prior to mechanical stimuli. 
 
In 3D osteocyte mono-cultures cultured for 24 hr pre-load from a pilot 
experiment, there was a decrease in IL-6 release at all time-points post-load (Figure 
5.10A and B). Although not significant, mean IL-6 release was reduced to 
approximately one half of control values at 6 and 24 hr post-load, but not at 0.5 hr 
post-load, in osteocytes cultured for 48-72 hr pre-load (Figure 5.10F), consistent with 
preliminary data. To date there are no in vivo or in vitro studies on the effects of 
mechanical loading on IL-6 release from osteocytes, however a previous in vitro 
study has shown that osteoblasts in monolayers exposed to compression highly 
increase their IL-6 synthesis (Sanchez et al., 2009).  
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5.5 Conclusion 
 
 In conclusion, a novel loading device, designed to apply uniform strain in a 
multi-well plate format, induced release of PGE2 in 3D osteocyte mono-cultures in 
response to loads of 5 min, 10 Hz, 2.5 N. The device can be attached to a 
commercially available loading rig and be used to mechanically stimulate 16 3D co-
cultures or mono-cultures at the same time. Validation of strain by DIC revealed that 
although there is strain variability across wells ranging from 3000 to 6000 µε, 9 out 
of 16 wells were exposed to 4000-4500 µε, although further work should be done to 
validate the loading device. Furthermore, it was shown for the first time that 
osteocytes within 3D gels exposed to cyclic strains using the developed loading 
device, increased PGE2 release, and A2A and E11 mRNA expression, and decreased 
IL-6 synthesis. These responses were found to be dependent on culturing osteocytes 
within gels for at least 48 hr prior to load. Although some of these experiments must 
be repeated in order to confirm the observations reported, it was demonstrated that 
the silicone plate provides a platform for the study of mechanically-induced bone 
formation and signalling in the 3D co-culture model. 
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6. The effect of mechanical loading on osteogenesis in the 3D co-culture model 
and the role of glutamate and adenosine receptors in this process 
 
6.1 Background 
 
In previous chapters of this thesis it was shown that within the 3D co-culture 
model, adenosine receptors A2A and A2B, CaSR and the glutamate transporter 
GLAST1 and receptors KA1 and AMPAR2 are expressed, indicating their potential 
for functional signalling (Chapter 4). Furthermore, it was also shown that osteocytes 
embedded in 3D type I collagen gels respond to mechanical stimuli (Chapter 5).  
 
Currently, there is only one published osteocyte-osteoblast co-culture model 
(Taylor et al., 2007). Although this is a 2D model, it has been used to investigate the 
effects on osteoblasts of mechanically-induced signals from osteocytes by exposing 
monolayer osteocytes to fluid flow whilst shielding the osteoblasts (Taylor et al., 
2007). Taylor et al showed that functional gap junction connections between 
osteoblasts and osteocytes, and the MAPK/ERK1/2 intracellular signalling pathway, 
are essential for the response of osteoblasts (proliferation and ALP activity) to 
osteocyte mechanical signals (Taylor et al., 2007). Such signals from osteocytes have 
previously been shown to include IGF-1 and related proteins (Reijnders et al., 2007a, 
Reijnders et al., 2007b), NO (Fox et al., 1996, Zaman et al., 1999), BMP2 (Rawadi et 
al., 2003), SOST (Winkler et al., 2003, van Bezooijen et al., 2004, Poole et al., 2005, 
van Bezooijen et al., 2005, Lowik and van Bezooijen, 2006, van Bezooijen et al., 
2007), and PGE2 (Klein-Nulend et al., 1995b, Ajubi et al., 1996, Ajubi et al., 1999). 
 
Previous studies have implicated adenosine, calcium-sensing and glutamate 
mediated signalling in osteogenesis. Several in vivo studies showed that KO animals 
of some of the receptors involved display a bone phenotype (Morimoto et al., 2006, 
Chang et al., 2008b, Skerry, 2008b, Kara et al., 2010b, Carroll et al., 2012, Mediero 
et al., 2012) (pages 36, 38 and 40). In vitro studies have also associated these 
pathways with bone cell biology (pages 36, 38 and 40). However, to date, only 
glutamate (Spencer and Genever, 2003, Mason, 2004) and ATP (Genetos et al., 
2005, Li et al., 2005b, Genetos et al., 2007, Riddle et al., 2007, Liu et al., 2008) have 
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been implicated in mechanotransduction, with GLAST1, being mechanically 
regulated in osteocytes (Mason et al., 1997), and NMDA, AMPA and KA receptors 
in osteoclasts and bone lining cells (Szczesniak et al., 2005) (page 40) ATP was 
released as a result of mechanical stimuli from both osteoblasts (Pavlin et al., 2000, 
Romanello et al., 2001, Li et al., 2005b) and osteocytes (Genetos et al., 2007) (page 
36). However, mechanically-induced glutamate signalling has only been 
hypothesised (Mason, 2004), and although ATP has a short half-life with one of its 
metabolites being adenosine, the role of adenosine itself in mechanically-induced 
signalling has not yet been investigated.  
 
6.1.1 Aims 
  
 This chapter aimed to determine whether mechanical loading of the 3D co-
culture model induced osteogenesis. The roles of glutamate and adenosine in 
mechanotransduction were also investigated by studying the effects of NBQX, an 
AMPA/KA receptor antagonist, and SCH 442416, an A2A receptor antagonist, on the 
3D co-culture responses to mechanical stimuli. 
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6.2 Materials and Methods 
 
For all experiments in this chapter, 3D co-cultures were prepared, cultured for 
7 days, and pre-treated with AMPA/KA (NBQX, 200 µM in DMEM 5% DFBS) or 
A2A (SCH 442416, 1µM in DMEM 5% DFBS) antagonists for 1 hr before being 
mechanically-loaded (5 min, 10 Hz, 2.5 N) in the presence of antagonists (page 80). 
Antagonist carriers, PBS for NBQX and DMSO for SCH 442416 were present in all 
cultures (page 80). The antagonist medium was removed 30 min post-load, retained, 
and replaced with standard culture medium. 3D co-cultures were cultured for a 
further 1 or 5 days post-load. Indicators of bone formation, COL1A1 and ALP 
mRNA and PINP release; as well as indicators of load response, A2A mRNA 
expression and PGE2 release, were measured. Control (non-loaded) cultures 
underwent all manipulations, such as medium changes, movements in and out of 
incubators and to and from loading instrument, except for mechanical loading. Data 
presented are as in Table 6.1.  
 
Table 6.1 Source of data presented from control and loaded cultures. 
 
 
  
Analysed Treatment Time post-load 
N° of 
experiments 
N° of culture 
replicates  
(control and loaded) 
Statistical 
test used 
mRNA 
A2A DZ Untreated Day 1 1 2 Untreated one-way ANOVA 
COL1A1 SZ 
Untreated 
NBQX 
 SCH 442416 
Day 1 1 
2 Untreated 
3 NBQX 
3 SCH 442416 
GLM 
ALP SZ 
Untreated 
NBQX 
 SCH 442416 
Day 1 1 
2 Untreated 
3 NBQX 
3 SCH 442416 
GLM 
Microplate 
assays 
LDH 
Released 
from 
whole co-
culture 
Untreated 
NBQX, 
SCH 442416 
Day 1 
Day 5 1 
2 Untreated 
3 NBQX 
3 SCH 442416 
- 
DNA 
SZ  
and  
DZ 
Untreated 
NBQX, 
SCH 442416 
0.5 hr 
Day 1 
Day 5 
1 
3 Untreated 
3 NBQX 
3 SCH 442416 
0.5 hr: 
one-way 
ANOVA 
 
Day 1  
and  
Day 5: 
GLM 
PGE2 
Released 
from 
whole co-
culture 
Untreated 0.5 hr 1 3 Untreated one-way ANOVA 
PINP 
Released 
from 
whole co-
culture 
Untreated 
NBQX 
 SCH 442416 
Day 1 
Day 5 1 
2 Untreated 
3 NBQX 
3 SCH 442416 
GLM 
SZ: surface zone (osteoblasts); DZ: deep zone (osteocytes); -: No statistical test performed. 
NOTE: one-way ANOVAs were performed with Tukey-Kramer post-hoc test; GLMs were for crossed 
factors and pairwise comparisons where P≤0.05 were recorded. 
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6.2.1 Cell death/number 
 
LDH assays were carried out at day 1 and day 5 post-load with medium from 
untreated and NBQX or SCH 442416 treated 3D co-cultures (control and loaded) to 
assess cell death (page 73).  
 
DNA quantification assays were carried out at all time-points post-load with 
total DNA extracted from both surface and deep zones of untreated and NBQX or 
SCH 442416 treated 3D co-cultures (control and loaded) (pages 53-54). Total ng of 
DNA from surface and deep zones from each 3D co-culture were added to give total 
ng of DNA per 3D co-culture and then used to normalise PGE2 and PINP ELISA 
data, and calculate cell number per 3D co-culture assuming there is 5.8 µg of DNA 
per 1x106 mouse diploid cells. Cell number data were expressed as a percentage of 
the average of 0.5 hr control cultures for all values. Raw data can be found in page 
290. 
 
6.2.2 PGE2 release  
 
PGE2 ELISA was carried out (page 74) on medium harvested at 0.5 hr post-
load from untreated 3D co-cultures (control and loaded) only. Data were normalised 
to total DNA content (pages 53-54) and analysed as in Table 6.1. Raw data can be 
found in page 290. 
 
6.2.3 mRNA expression  
 
Total RNA from the surface and deep zones of day 1 post-load 3D co-
cultures was extracted separately, reverse transcribed and cDNA integrity checked by 
RT-PCR of 18S rRNA (pages 52-55). Relative RT-qPCRs for COL1A1 and ALP in 
the surface zone of all cultures, A2A in the deep zone of untreated cultures only; and 
18S rRNA, GAPDH and HPRT1, as RGs were carried out (page 55). Primer details 
are outlined in pages 56 and 58 and Tables 2.1 and 2.2. RT-qPCR data were 
normalised to the optimal RG using NormFinder as in page 57. Data for each GOI 
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were calibrated to the average ∆Ct of the untreated control cultures and expressed as 
REU (page 58).  Data was analysed as in Table 6.1. 
 
6.2.4 PINP release 
 
PINP ELISA was carried out (page 76) on medium harvested at day 1 and 5 
post-load from treated and untreated 3D co-cultures (control and loaded). Data was 
normalised to total DNA content (pages 53-54) and statistically analysed as in Table 
6.1 
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6.3 Results 
 
In all cases, data were as in Table 6.1. However, 2 repeats of day 5 3D co-
cultures had to be removed from the experiment due to a suspected infection. 
Therefore, day 5 data analysed were from 1 independent experiment where n=3 for 
SCH 442416 control and loaded, and n=2 NBQX and untreated control and loaded. 
 
6.3.1 Cell death/number 
 
LDH release into the medium as a result of cell death was measured in all 
cultures and at day 1 and day 5 post-load. No LDH was detected indicating no 
measurable cell death as a result of mechanical loading or antagonist treatment (raw 
data can be found in page 284). 
 
 Total ng of DNA were measured at all time-points and treatments to assess 
cell number. Data were expressed as a percentage of the average of 0.5 hr control 
cultures for all values. The effect of load, time post-load and treatment on cell 
number was assessed in untreated cultures only at 0.5 hr post-load (Figure 6.1A), and 
in all cultures at day 1 and 5 (Figure 6.1B) post-load. However, no significant effects 
of any of these factors were observed (0.5 hr: untreated control 100 ±13.89 % and 
loaded 145.43 ±61.55 %; day 1: untreated control 94.97 ±9.88 % and loaded; 85.85 
±2.81 %, NBQX control 114.45 ±34.98 % and loaded 87.05 ±5.18 %; SCH 442416 
control 129.45 ±40.66 % and loaded 81.89 ±2.75 %; day 5: untreated control 84.44 
±4.78 % and loaded 79.67 ±2.12 %; NBQX control 79.96 ±2.26 % and loaded 78.69 
±0.13 %; SCH 442416 control 91.24 ±5.12 % and loaded 82.93 ±5.88 %). 
 
6.3.2 PGE2 release 
 
Whilst mean PGE2 release appeared to decrease 0.5 hr after loading (Figure 
6.2), a significant difference was not observed between untreated control and loaded 
cultures (control, 0.031 ±0.005 pg/ml/ng DNA; loaded, 0.023 ±0.006 pg/ml/ng 
DNA) (one-way ANOVA, P=0.371). 
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Figure 6.1 Cell number in mechanically-loaded 3D co-cultures by DNA 
quantification. Graphs showing cell number at 0.5 hr post-load (A) and day 1 
and 5 post-load (B). Data were expressed as a percentage of the average of 0.5 hr 
control cultures (A and B). Data presented are from 1 independent experiment, 
n=3 (A), or 1 independent experiment, n=3 NBQX day 1, SCH 442416 days 1 
and 5, and n=2 NBQX and day 5 and untreated control and loaded cultures days 
1 and 5 (B). 
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Figure 6.2 PGE2 release in untreated mechanically-loaded 3D co-cultures 
by ELISA. Boxplot of PGE2 release from untreated 3D co-cultures 0.5 hr 
post-load normalised to total ng of DNA. (1 independent experiment, n=3 
control and loaded). 
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6.3.3 mRNA expression 
 
 mRNA expression was assessed by relative RT-qPCR in the surface zone of 
day 1 control and loaded cultures in the presence or absence of NBQX or SCH 
442416 using primers against COL1A1 and ALP, and in the deep zone of day 1 
untreated control and loaded cultures using primers against A2A.  Data were 
expressed in REU and normalised to either GAPDH for the surface zone, or the 
geometric mean of GAPDH and HPRT1 for the deep zone (NormFinder used to 
calculate most stable RG) (page 57). 
 
 Mechanical loading did not have a significant effect on embedded osteocyte 
A2A mRNA expression (control 1.006 ±0.111 REU; loaded 1.047 ±0.227 REU) 
(Figure 6.3A), or osteoblast COL1A1 (control 1 ±0.003 REU; loaded 0.902 ±0.087 
REU) (Figure 6.3B) or ALP (control 1 ±0 REU; loaded 1.566 ±0.607 REU) (Figure 
6.3C) mRNA expression in untreated cultures. However, mean ALP mRNA 
expression appeared to increase by 1.5-fold as a result of loading.  
 
 Treatment with NBQX did not have a significant effect on COL1A1 (control 
1.186 ±0.236 REU; loaded 1.217 ±0.299 REU) (Figure 6.3B) or ALP (control 0.928 
±0.047 REU; loaded NBQX 3.457 ±1.469 REU) (Figure 6.3C) mRNA expression on 
loaded surface osteoblasts. However, NBQX treatment seemed to increase mean 
ALP mRNA expression in loaded cultures by 3.7-fold.  
 
 Treatment with SCH 442416 did not have a significant effect on COL1A1 
(control 1.252 ±0.270 REU; loaded 0.956 ±0.224 REU) (Figure 6.3B) or ALP 
(control 0.683 ±0.166 REU; loaded 2.417 ±1.392 REU) (Figure 6.3C) mRNA 
expression on loaded surface osteoblasts. However, SCH 442416 treatment had a 
similar effect to that observed with NBQX on mean ALP mRNA expression as it 
appeared to increase by 3.5-fold in loaded cultures treated with the A2A antagonist. 
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Figure 6.3 Quantification of gene expression in mechanically-loaded 3D co-cultures at day 1 post-load by relative RT-qPCR. Boxplots of A2A (A) in the deep 
zone, and COL1A1 (B) and ALP (C) in the surface zone, expressed as REU and normalised to the geometric mean of GAPDH and HPRT1 expression for A2A, 
or GAPDH expression for COL1A1 and ALP. Data were from 1 independent experiment, where n=2 deep zone for A2A; and n=3 for NBQX and SCH 442416 
treated control and loaded cultures, n=2 untreated control and loaded cultures). 
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6.3.4 PINP release  
 
Mechanical loading and day had a significant effect on PINP release (GLM, 
load: P=0.002; day: P=0.005). Whilst antagonist treatment had no significant effect 
on PINP synthesis, an interaction between antagonist treatment and load was 
observed (GLM, P=0.033). Although there was a significant effect of day on the 
whole data set which appeared to increase mean PINP release at day 5, pairwise 
comparisons were not significant. 
 
PINP release was significantly 1.9-fold higher in untreated loaded 3D co-
cultures when compared to control cultures (GLM, P=0.022) (Figure 6.4A). 
However, no significant differences were observed between untreated control and 
loaded 3D co-cultures at day 1 or 5 (day 1: control 0.0011 ±0.0002 ng/ml/ng DNA 
loaded 0.0017 ±0, ng/ml/ng DNA; day 5: control 0.0008 ±0.0002 ng/ml/ng DNA; 
day 5 0.0019 ±0.0003 ng/ml/ng DNA) (Figure 6.4A).  
 
Treatment with NBQX had no significant effect on PINP synthesis from 
loaded 3D co-cultures at day 1 or 5 (Figure 6.4B). The mean PINP increase at day 1 
and 5 in loaded cultures was not as high as that observed in day 1 or 5 loaded 
untreated cultures (day 1: untreated control 0.0011 ±0.0002 ng/ml/ng DNA, NBQX 
loaded 0.0013 ±0.0002 ng/ml/ng DNA; day 5: untreated control 0.0008 ±0.002 
ng/ml/ng DNA, NBQX loaded 0.0016 ±0 ng/ml/ng DNA), (Figure 6.4B).  At day 1, 
there was no basal effect of NBQX treatment on mean PINP release from control 
cultures (untreated control 0.0011 ±0.0002 ng/ml/ng DNA; NBQX control 0.00106 
±0.0003 ng/ml/ng DNA), however, at day 5, NBQX treatment increased mean PINP 
release by 2-fold, approximately the same levels of those observed in untreated 
mechanically loaded cultures (untreated loaded 0.0019 ±0.0003 ng/ml/ng DNA; 
NBQX control 0.0019 ±0 ng/ml/ng DNA) (Figure 6.4B). 
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Treatment with SCH 442416 had no significant effect on PINP synthesis 
from loaded 3D co-cultures at day 1 or 5 (Figure 6.4C). At day 1, an increase in 
mean PINP levels in loaded cultures was observed (untreated control 0.0011 ±0.0002 
ng/ml/ng DNA; SCH 442416 loaded 0.0014±0.0001 ng/ml/ng DNA); though this 
increase was not as high as that observed in day 1 loaded cultures without SCH 
442416 treatment (Figure 6.4C). Furthermore, at day 1, SCH 442416 treatment 
decreased mean PINP release from control cultures (untreated control 0.0011 
±0.0002 ng/ml/ng DNA; SCH 442416 control 0.0009±0.0002 ng/ml/ng DNA) 
(Figure 6.4C). At day 5, SCH 442416 increased mean PINP release to levels slightly 
higher than those observed in untreated mechanically-loaded cultures, but mean 
PINP levels were significantly higher than those observed in untreated control 
cultures (untreated control 0.0011 ±0.0002 ng/ml/ng DNA; untreated loaded 0.0019 
±0.0003 ng/ml/ng DNA; SCH 442416 loaded 0.0021 ±0.0003 ng/ml/ng DNA; P= 
0.0114) (Figure 6.4C). Furthermore, at day 5, SCH 442416 treatment increased mean 
PINP release from control cultures (untreated control 0.0011 ±0.0002 ng/ml; SCH 
442416 control 0.00154±0.0002 ng/ml) (Figure 6.4C).  
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6.4 Discussion 
 
 The preliminary experiment in this chapter was used to determine whether the 
novel 3D osteocyte-osteoblast co-culture model could be used to investigate 
mechanical loading responses. Furthermore, mechanical signalling was also 
investigated by exposing the co-cultures to mechanical stimuli and to treatment with 
AMPA/KA and A2A antagonists. A summary of the results obtained can be found in 
Figure 6.5. The data presented in this chapter are preliminary as they are obtained 
from 1 independent experiment with replicate numbers of 2 or 3. Thus the trends 
observed should be treated with caution. Nevertheless, the data presented helped 
establish the initial platform for the investigation of mechanically induced bone 
formation in the novel 3D co-culture model, and mechanotransduction through the 
adenosine and glutamate signalling pathways. 
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Figure 6.5 Summary of results. A) A physiological loading regime applied to the 3D co-culture increases synthesis of PINP and ALP mRNA 
expression by the osteoblasts. B) In control cultures, at day 5 post-treatment, inhibition of AMPA/KA receptors induced a similar anabolic 
response to that obtained by mechanical loading (A). C) Mechanical loading and A2A inhibition lead to a doubling of ALP mRNA expression at 
day 1 and a 1.9-fold increase in PINP release at day 5 when compared to untreated control cultures (A). 
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6.4.1 Cell death/number 
 
 In the 3D co-cultures, under the stated experimental conditions, there was no 
detectable cell death as a result of mechanical loading or treatment with NBQX or 
SCH 442416, at any time post-load. There was also no significant difference in cell 
number observed (Figure 6.1). As previously mentioned (page 166), in vitro studies 
have shown that loading increases osteoblast number (Kaspar et al., 2000, Pavlin et 
al., 2000, Kaspar et al., 2002, Ignatius et al., 2005, Jackson et al., 2006), which 
contradict 3D co-culture data. However, this could be because the loading regimes 
used (0.5 or 1 Hz, 1000 or 10000 µε, 0.5 hr minimum per day of culture) (Kaspar et 
al., 2000, Kaspar et al., 2002, Ignatius et al., 2005, Jackson et al., 2006) do not 
involve a short single loading bout of mechanical stimulus.  
 
Human primary osteoblasts (HPOBs) cell number has previously been shown 
to significantly decrease by approximately 19 % and 23 % after 2 and 5 days of 
treatment with  200 µM NBQX (Bonnet, Mason, Williams and Evans unpublished 
data), contradicting 3D co-culture data. However, this could be explained by the fact 
that 3D co-cultures were only incubated with NBQX for 1 hr, whereas Bonnet et al 
used longer incubation times of 2 and 5 days. Furthermore, the decrease in cell 
number observed by Bonnet et al was relatively small.  
 
Treatment with 1 µM SCH 442416 has previously been shown to have no 
effect on the cell number of MSCs differentiating to osteoblasts (Gharibi et al., 
2011), correlating with 3D co-culture data. 
 
6.4.2 PGE2 release 
 
In the 3D co-culture, there was no significant difference in PGE2 release 0.5 
hr after load (Figure 6.2), suggesting no response to mechanical load. This effect 
contradicts previous data which showed a significant load-induced increase in PGE2 
release in 3D osteocyte mono-cultures (Chapter 5), and previous studies showing 
that both osteoblasts (Reich and Frangos, 1993, Nauman et al., 2001, Rubin et al., 
2001b, Ponik and Pavalko, 2004) and osteocytes (Cheng et al., 2001a, Jiang and 
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Cheng, 2001, Saini et al., 2011, Li et al., 2012b) in monolayers in vitro release PGE2 
in response to mechanical stimuli. Overall, PGE2 release was considerably lower 
when osteocytes were in a 3D co-culture (0.023 ±0.006 pg/ml normalised to ng of 
total DNA) compared to that observed in 3D mono-cultures (78.806 ±10.880 pg/ml 
normalised to cell number) (Chapter 5). Even without normalisation, PGE2 release 
from loaded 3D co-cultures (20.053 ±2.453 pg/ml) was still lower than in loaded 7 
day 3D osteocyte mono-cultures (51.924 ±7.686 pg/ml). Furthermore, these values 
are lower than those previously observed in osteocyte monolayer cultures (Cheng et 
al., 2001a, Jiang and Cheng, 2001, Saini et al., 2011, Li et al., 2012b). This reduction 
in PGE2 release could be due to a failure in inducing a mechanical response or due to 
a failure in the assay performing correctly, however the standard curve produced 
indicated the assay worked and that all samples fell within the standard curve 
(standard curve and raw data can be found in page 284). Another reason for the 
reduction in PGE2 release and lack of response to loading could be the presence of 
osteoblasts. To test this hypothesis, 3D osteocyte mono-cultures and 3D co-cultures 
should be exposed to load at the same time and PGE2 release assessed 0.5 hr post-
load.  
 
6.4.3 mRNA expression 
 
 In the 3D co-culture, there was no significant difference in A2A mRNA 
expression between day 1 untreated control and loaded embedded osteocytes (Figure 
6.3A), which could be due to a failure in inducing a mechanical response, consistent 
with PGE2 data. Another explanation could be that the presence of surface 
osteoblasts regulates osteocyte gene expression, which have not previously been 
investigated, and thus reflecting the same effect observed with PGE2 release. In 
order to confirm this osteoblast regulation of osteocyte gene expression, 3D 
osteocyte mono-cultures and 3D co-cultures should be exposed to load at the same 
time and A2A mRNA expression assessed post-load.  
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In day 1 3D co-cultures, mechanical stimuli had no effect on osteoblast 
COL1A1 mRNA expression (Figure 6.3B). Previous in vivo and in vitro studies have 
shown an increase in osteoblast COL1A1 mRNA expression in response to load. On 
one hand, in vivo studies showed osteoblast COL1A1 mRNA expression is not 
altered 24 hr after cyclic compression load, but instead begins to increase 2-4 days 
after loading (Pavlin et al., 2001, Mantila Roosa et al., 2011), consistent with 3D co-
culture data. However, in vitro osteoblast studies have shown an increase in 
COL1A1 expression 24 hr after compression or tension loading (Liu et al., 2005, 
Rath et al., 2008, Lu et al., 2012), contradicting 3D co-culture data. NBQX and SCH 
442416 had no effect on day 1 osteoblast COL1A1 mRNA expression regardless of 
mechanical stimuli (Figure 6.3B). To date there are no studies on the effect of NBQX 
or SCH 442416 on COL1A1 mRNA expression by osteoblasts.  
 
In day 1 3D co-cultures, mechanical stimuli increased ALP mRNA 
expression by surface osteoblasts (Figure 6.3C). In vivo, osteoblasts increase ALP 
mRNA expression 24 hr after being mechanically stimulated (Pavlin et al., 2001), 
which was also observed in vitro in MC3T3-E1 cells (Lu et al., 2012) and is 
consistent with 3D co-culture data. Interestingly, this load-induced increase in ALP 
mRNA expression was further amplified with NBQX or SCH 442416 treatment 
(Figure 6.3C). Furthermore, in the absence of mechanical stimuli, SCH 442416 or 
NBQX treatment had no effect on ALP mRNA expression by surface osteoblasts at 
day 1 (Figure 6.3C). Consistent with this data, SCH 442416 was previously shown to 
have no effect on ALP expression during osteoblast differentiation in vitro (Gharibi 
et al., 2011).  To date, there are no studies on the effects of NBQX on ALP mRNA 
expression in osteoblasts or SCH 442416 on ALP mRNA expression by 
mechanically loaded osteoblasts.  
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6.4.4 PINP release 
  
In untreated 3D co-cultures, mechanical loading significantly increased PINP 
release (Figure 6.4A), suggesting that mechanical loading of 3D co-cultures elicits an 
osteogenic response. These results are consistent with previous studies which 
demonstrated that  osteoblasts in vitro increase ColI synthesis after loading (Yang et 
al., 2012), which contradicts PGE2 and A2A mRNA data, and therefore the theory 
that no mechanical response was induced in this experiment. However, these results 
contradict COL1A1 mRNA expression data from the same cultures, which showed 
no effect of loading on day 1 COL1A1 expression. This could be explained by fact 
that mRNA data was obtained only from day 1 surface osteoblasts whereas protein 
synthesis was measured from the medium of whole 3D co-cultures. Therefore, PINP 
synthesis may not only be from surface osteoblasts, but also from embedded 
osteocytes. Primary osteocytes have been previously shown to produce ECM 
proteins including ColI in vitro (Tata et al., 2011). However MLO-Y4 cells produce 
lower levels of COL1A1 mRNA compared to osteoblasts both in monolayer (Kato et 
al., 1997) and in 3D co-cultures (Chapter 1), but the production of ColI protein from 
these cells in the presence or absence of load has not been previously investigated. 
Therefore, 3D osteocyte mono-cultures and 3D co-cultures should be exposed to load 
at the same time in order to address the hypothesis that PINP release may be from 
both cell types within the 3D co-culture. Furthermore, analysis of COL1A1 mRNA 
expression in loaded embedded osteocytes should also be carried out as it would give 
an indication of how much collagen these cells may be synthesising. Nevertheless, 
this PINP release data has shown that mechanically-induced collagen synthesis can 
be achieved in the 3D co-culture under a physiological and osteogenic loading 
regime (5 min, 10 Hz, 4000-4500 µɛ) (Hillam and Skerry, 1995, Mason et al., 1996, 
Rubin et al., 2001a). 
 
Treatment with NBQX in control cultures induced an increase in PINP which 
was highly similar to that observed in untreated loaded cultures at day 5 post-load 
(Figure 6.4B). This data contradicts previous in vivo studies which have shown that 
mice injected with NBQX have a decreased trabecular thickness (Lin et al., 2008), 
whereas rats injected with AMPA have an increased bone volume (Burford et al., 
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2004), suggesting that activation of AMPA/KA receptors increases bone formation. 
To date, the effects of NBQX on bone formation have not been investigated in vitro 
and therefore these are reported for the first time in this thesis. This data suggests 
that a single dose of NBQX may have the same long-term anabolic effects as 
mechanical stimuli and, therefore, could be considered a novel anabolic target for 
bone disease therapies. Furthermore, this data also provides further evidence for the 
hypothesis that glutamate signalling may have a role in mechanically-induced bone 
formation (Mason, 2004) 
 
On the other hand, treatment with SCH 442416 caused a significant increase 
in PINP release in day 5 loaded cultures compared to untreated control cultures 
(Figure 6.4C). Although not significant, SCH 442416 treatment increased PINP 
release in control cultures. Furthermore, mechanical loading and a single dose of 
SCH 442416 treatment appeared to have, although small, an additive effect on PINP 
release, as PINP levels were higher in loaded SCH 442416 treated cultures than in 
untreated loaded cultures or treated control cultures. To date, the effects of SCH 
442416 on collagen synthesis have not been investigated in osteoblasts. This data 
suggests that SCH 442416 treatment could be considered as a novel anabolic 
therapeutic target for bone diseases, similar to NBQX. Furthermore, it could be 
hypothesised that adenosine signalling may have a role in mechanically-induced 
bone formation. 
 
6.4.5 Data reliability 
 
 As previously mentioned, the results presented in this chapter are 
preliminary, with low replicate numbers, and therefore all trends and significant P-
values observed should be treated with caution. The data were presented in boxplots 
as a way of performing descriptive statistics and to show the data spread (page 81), 
to indicate how reliable the trends observed are. One of the main points of discussion 
is whether a mechanical response was induced in this experiment or not. In this 
experiment there was no significant effect of load in A2A mRNA expression and 
PGE2 release, indicating no mechanical response. According to the data reported in 
Chapter 5, approximately 2.6-fold and 2-fold increases should be observed for PGE2 
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release and A2A mRNA expression, respectively. However, this experiment is based 
on a small data set with a large range in data points for each of the groups compared 
and therefore the trends may not be reliable. Although PGE2 and A2A data may not 
be reliable enough to indicate load responses, this experiment showed a load-induced 
osteogenic response. The disparity between COL1A1 mRNA expression and PINP 
release was also a point of discussion. The boxplot for COL1A1 mRNA expression 
indicates a large range in the REUs measured within each group indicating the data 
may not be reliable, whereas the data range of PINP synthesis is much smaller in 
comparison. The increase in ALP mRNA expression appeared more robust as the 
ALP data range is large in loaded cultures but not in control cultures. In order to 
increase the reliability of the data, this experiment should be repeated with a larger 
replicate number.  
 
6.5 Conclusion 
 
 In conclusion, preliminary data show the 3D co-culture model can be used to 
investigate the osteocyte-osteoblast interactions that lead to mechanically-induced 
osteogenesis in terms of type I collagen synthesis and alkaline phosphatase activity. 
This thesis showed that both NBQX and SCH 442416 increased osteoblast ALP 
mRNA expression in loaded cultures at day 1 and increased PINP release in both 
control and loaded cultures at day 5. These anabolic effects of AMPA/KA and A2A 
antagonists support the hypothesis of functional adenosine and glutamate signalling 
within 3D co-cultures (Chapter 4), and of the potential roles of glutamate and 
adenosine in mechanotransduction (Mason, 2004) (section 6.1) and osteogenesis. 
Although the experiments in this chapter must be repeated in order to verify the 
results obtained, it has tested the platform for the investigation of mechanically-
induced bone formation and mechanotransduction through novel signalling 
pathways. 
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7. General discussion 
 
7.1 Validation of the novel 3D co-culture model 
 
This thesis developed a novel 3D osteocyte-osteoblast co-culture mechanical 
loading model, where osteocytes embedded within type I collagen gels are overlaid 
with osteoblasts. The cells within the model were shown to be viable, at both day 1 
and 7, maintain their morphology and appear to connect to neighbouring cells 
through CX43 (Figure 7.1A). Both osteoblasts and osteocytes were also shown to 
maintain their phenotype, through the expression of appropriate phenotypic markers 
(Figure 7.1A). Osteoblasts expressed higher levels of COL1A1 mRNA than 
osteocytes, whereas osteocytes expressed higher levels of ALP mRNA than 
osteoblasts (Figure 7.1A). Both cell types within the model were also shown to 
express components of the adenosine, calcium-sensing and glutamate signalling 
pathways (Figure 7.1A), previously shown to be of importance in bone biology as 
seen in KO animals involving signalling components of these pathways. Briefly, for 
the adenosine signalling pathway, the A1 KO model had increased bone volume and 
small osteoclasts (Kara et al., 2010b), the A2A KO mouse displayed increased bone 
resorption and osteoclast activity (Mediero et al., 2012), and the A2B KO model 
exhibited decreased bone density (Carroll et al., 2012) (pages 37-38). For  the 
calcium-sensing signalling pathway, CaSR KO mice displayed growth retardation, 
small skeletons and several fractures (Chang et al., 2008a) (page 38). Finally, for the 
glutamate signalling pathway, the NMDAR1 KO model exhibited a thin bone 
structure and poor mineralisation (Skerry, 2008b); and the VGLUT1 KO model 
displayed a decrease in bone mass and an increase in osteoclast resorption 
(Morimoto et al., 2006) (pages 41-42). 
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 Furthermore, the osteocytes within the model were found to respond to 
physiological mechanical loading and some of these responses depended on the 
culture time prior to load (Figure 7.1B). Most importantly, this thesis demonstrated 
that mechanical loading of the 3D co-culture is able to apparently induce an 
osteogenic response by increasing PINP synthesis (Figure 7.1B) as well as regulate 
the mRNA expression of adenosine receptor A2A in embedded osteocytes.  
 
There is a great need for a fully characterised in vitro 3D matrix based bone 
model. The majority of the available 3D models involve culturing cells on scaffolds 
(Tortelli et al., 2009, Barron et al., 2010, Papadimitropoulos et al., 2011b), which 
does not represent the bone environment in vivo where osteocytes, are embedded 
within a matrix (section 1.4.2.3.2). Published models involving embedding 
osteoblasts (Maeno et al., 2005, Murshid et al., 2007), MLO-Y4 (Kurata et al., 2006, 
Murshid et al., 2007) or normal human bone-derived cells (NHBCs) (Atkins et al., 
2009) within a matrix showed maintenance of cell viability (Maeno et al., 2005, 
Kurata et al., 2006), osteocyte cell morphology (Kurata et al., 2006, Murshid et al., 
2007, Atkins et al., 2009), connectivity (Kurata et al., 2006), and gene expression 
(Atkins et al., 2009). However, none of these models have been individually assessed 
in all key areas of viability, morphology, connectivity and gene expression. 
Furthermore, none of the available 3D collagen based cultures involve co-culturing 
osteocytes and osteoblasts, nor they have been exposed to mechanical stimuli. 
Therefore none investigate the important interactions between these cell types which 
lead to mechanically-induced bone formation.  
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A comparison of the 3D co-culture model to previous 3D and 2D in vitro 
models, as well as, to bone in vivo can be found in Table 7.1. This table shows that 
the 3D co-culture model developed in this thesis is better characterised than any 
other current 3D mono-culture and 2D co-culture models, as the majority of these 
previous models show gaps in cell viability data, expression of some bone markers, 
and connectivity of the cells within the model. The 3D co-culture model has 
osteoblast and osteocyte cell viabilities, morphologies, phenotypes and loading and 
osteogenic responses similar to those found in vivo, some of which also correlate 
with previous in vitro monolayer culture data. However, unlike in vivo, there is a lack 
of expression of SOST, an important mechanically-regulated bone formation 
regulator, due to the use of MLO-Y4 cells which do not express SOST. The model 
developed in this thesis has also provided novel information on the expression of 
adenosine, calcium-sensing and glutamate signalling components in bone cells, and 
the effect of mechanical load on their expression (Table 7.1). 
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Figure 7.1 A summary of the results presented in this thesis characterising the novel 
3D co-culture model. A) In a resting state, the osteoblasts and osteocytes were shown 
to have minimal cell death at both day 1 and 7 of culture, as well as maintain their 
phenotype through the expression of bone markers (grey bars), and their connectivity 
through the expression of CX43 (green bar), and express signalling components 
(Table 7.1). B) Embedded osteocytes were shown to respond to physiological loads 
through the release of PGE2, and that this loading response was maintained if the 
embedded osteocytes were cultured for a minimum of 48 hr and up to 7 days prior to 
mechanical stimuli. However, time pre-load appeared to have an effect on E11 
mRNA expression as a result of loading, highlighting that culture time pre-load of 
the osteocytes within the 3D model is of great importance. Furthermore, the 
adenosine receptor A2A was shown to be mechanically regulated and therefore 
identified as a potential novel indicator of load response. Most importantly, although 
as preliminary data, it was shown that a physiological mechanical stimulus applied to 
the 3D co-culture is able to potentially induce an osteogenic response through an 
increase in the synthesis of PINP and ALP mRNA expression by the osteoblasts. 
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In vivo 
(human or rodent) 3D co-culture 3D mono-culture 
2D co-culture 
(Taylor et al., 2007) Monolayer culture 
Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteoctyes 
 
 
Transient cells 
only present as 
osteoblasts 
during bone 
formation. 
 
Humans 
 
After bone 
formation: 
 
50-70 % death 
 
The rest become 
bone lining cells 
or osteocytes 
 
(Parfitt, 1990, 
Jilka et al., 1998) 
Humans 
 
Birth: 
 
1 % 
80 years old: 
 
75 % 
 
(Frost, 1960, 
Mullender et al., 
1996, Tomkinson 
et al., 1997) 
Day 1: 
 
0 % 
 
Day 7: 
 
0 % 
 
 
Day 1: 
 
16.13 ±3.16 
% 
 
Day 7: 
 
13.85 ±2.35 
% 
 
       86 % 
 
embedded in 
type II 
collagen gels 
 
(Maeno et al., 
2005) 
~ 3 dead 
cells/field of 
view 
 
(Kurata et al., 
2006) 
Cells remained 
viable 
(quantification of 
death/viability 
not shown) 
Cells 
remained 
viable 
(quantification 
of 
death/viability 
not shown) 
Primary 
osteoblasts 
 
Day 1 to 4: 
 
~5-8 % 
 
(Gohel et al., 
1999) 
 
Primary 
osteocytes 
 
Day 6: 
 
~ 25 % 
 
(Bakker et al., 
2004) 
 
 
Ovoid 
Pyriform 
Rectangular 
Cuboidal 
Columnar 
 
(Bourne, 1972) 
 
       Dendritic 
 
(Doty et al., 1976, 
Menton et al., 
1984, Palumbo, 
1986) 
 
Ovoid/pyriform 
with stress 
fibres 
Dendritic 
Dendritic 
 
(within 3D 
matrix) 
 
(Murshid et 
al., 2007) 
Dendritic 
 
(Kurata et al., 
2006, Murshid 
et al., 2007, 
Atkins et al., 
2009) 
Confluent 
monolayer 
 
Individual cell 
morphology: 
 
NI 
Dendritic 
MC3T3-E1: 
 
Fibroblastic 
during 
logarithmic 
growth phase, 
pyriform when 
confluent with 
stress fibres 
 
(Sudo et al., 
1983, Murshid et 
al., 2007) 
MLO-Y4: 
 
Dendritic 
 
(Kato et al., 1997) 
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Table 7.1 Comparison of the 3D co-culture model to bone in vivo and published in vitro models. 3D co-culture data is highlighted in red. 
NI: not investigated; ↑:  increased; ↓: decreased; ✓: expressed; X: not expressed 
  
In vivo 
(human or rodent) 3D co-culture 3D mono-culture 
2D co-culture 
(Taylor et al., 2007) Monolayer culture 
Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteoctyes 
  
COL1A1 
 
✓ 
 
(Zhou et al., 
1994) 
✓ 
 
(Sun et al., 
1995) 
✓ ✓ 
 
✓ 
 
(Atkins et al., 
2009) 
NI NI NI 
 
 
✓ 
 
(Collin et al., 
1992, Shi et al., 
1996, Wang et 
al., 1999) 
✓ 
 
(Kato et al., 
1997) 
ALP 
 
✓ 
 
(Whyte, 1994, 
Zhou et al., 
1994) 
 
✓ 
 
(Dodds et al., 
1993) 
✓ 
 
✓ 
 
NI NI NI NI 
 
✓ 
 
(Takuwa et al., 
1991, Collin et 
al., 1992, Wang 
et al., 1999) 
 
✓ 
 
(Mikuni-
Takagaki et al., 
1995, Kato et al., 
1997) 
E11 
✓ 
 
(Wetterwald et 
al., 1996) 
 
 
✓ 
 
(Wetterwald et 
al., 1996, 
Schwab et al., 
1999) 
✓ ✓ 
 
✓ 
 
(Atkins et al., 
2009) 
NI NI NI 
 
✓ 
 
(Nose et al., 
1990, 
Hadjiargyrou et 
al., 2001, Zhang 
et al., 2006, 
Jahn et al., 
2010) 
✓ 
 
(Hadjiargyrou et 
al., 2001, Zhang 
et al., 2006) 
SOST 
 
 
X 
 
(Bezooijen et 
al., 2005, 
Poole et al., 
2005) 
 
 
✓ 
 
(Bezooijen et al., 
2005, Poole et 
al., 2005, Li et 
al., 2008) 
X X 
 
 
✓ 
 
differentiating 
osteoblasts 
(Atkins et al., 
2009) 
NI NI NI 
✓ 
 
UMR 106.01 
 
SaOS-2 
 
(Papanicolaou et 
al., 2009, Galea 
et al., 2011, Yu 
et al., 2011) 
 
X 
 
 
MC3T3-E1 
 
(Papanicolaou et 
al., 2009) 
✓ 
 
Primary 
osteocytes 
MLO-A5 
IDG-SW3 
 
(Bellido et al., 
2005, 
Papanicolaou et 
al., 2009, Woo et 
al., 2011) 
 
X 
 
MLO-Y4 
(Papanicolaou et 
al., 2009, Yang 
et al., 2009) 
Runx2 
✓ 
 
(Ducy et al., 
1997, Komori 
et al., 1997, 
Otto et al., 
1997) 
NI ✓ ✓ 
✓ 
 
(Atkins et al., 
2009) 
NI NI NI 
✓ 
 
(Gilbert et al., 
2002, Choi et al., 
2005) 
✓ 
 
(Fujita et al., 
2001) 
OCN 
✓ 
 
(Zhou et al., 
1994) 
✓ 
 
(Mason et al., 
1996) 
✓ ✓ 
✓ 
 
(Atkins et al., 
2009, Maeno et 
al., 2005) 
NI NI NI 
      ✓ 
 
(Collin et al., 
1992) 
 
✓ 
 
(Kato et al., 
1997) 
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Table 7.1 continued. 
NI: not investigated; ↑:  increased; ↓: decreased; ✓: expressed; X: not expressed 
  
 
 
 
 
 
  
 
In vivo 
(human or rodent) 3D co-culture 3D mono-culture 
2D co-culture 
(Taylor et al., 2007) Monolayer culture 
Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteoctyes 
 
 
E11 
 
 
✓ 
 
(Wetterwald et 
al., 1996, 
Hadjiargyrou 
et al., 2001) 
 
✓ 
 
(Wetterwald et 
al., 1996, 
Hadjiargyrou 
et al., 2001) 
✓ 
 
✓ 
 
NI NI NI NI 
✓ 
 
(Zhang et al., 
2006) 
 
✓ 
 
(Zhang et al., 
2006) 
 
CX43 
✓ 
 
(Lecanda et 
al., 2000) 
 
 
✓ 
 
(Bivi et al., 
2012, Loiselle 
et al., 2013) 
 
✓ 
 
✓ 
 
NI NI 
Functional 
gap junctions 
but not 
specifically 
CX43 
Functional 
gap junctions 
but not 
specifically 
CX43 
✓ 
 
(Yamaguchi and 
Ma, 2003) 
 
✓ 
 
(Kato et al., 
1997, Cheng et 
al., 2001b) 
PR
O
TE
IN
 
PH
EN
O
TY
PE
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NI: not investigated; ↑:  increased; ↓: decreased; ✓: expressed; X: not expressed 
  
 
 
In vivo 
(human or rodent) 3D co-culture 3D mono-culture 
2D co-culture 
(Taylor et al., 2007) Monolayer culture 
Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteoctyes 
 
 
A1 
mRNA 
 
NI 
 
 
NI 
 
 
X 
 
 
X 
 
 
NI 
 
 
NI 
 
 
NI 
 
 
NI 
 
✓ 
 
(Russell et al., 
2007) 
 
NI 
 
Protein NI NI X X NI NI NI NI 
✓ 
 
(Russell et al., 
2007, Costa et 
al., 2011) 
NI 
A2A 
mRNA NI NI ✓ ✓ NI NI NI NI 
✓ 
 
(Russell et al., 
2007) 
NI 
Protein NI NI ✓ ✓ NI NI NI NI 
✓ 
 
(Russell et al., 
2007, Costa et 
al., 2011) 
NI 
A2B 
mRNA NI NI ✓ ✓ NI NI NI NI 
✓ 
 
(Russell et al., 
2007) 
NI 
Protein NI NI X X NI NI NI NI 
✓ 
 
(Russell et al., 
2007, Costa et 
al., 2011) 
NI 
A3 
mRNA NI NI X X NI NI NI NI 
X 
 
(Russell et al., 
2007) 
NI 
Protein NI NI X X NI NI NI NI 
✓ 
 
HPOBs  
(Costa et al., 
2011) 
 
X 
 
MG63 
 (Russell et al., 
2007) 
NI 
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 In vivo 
(human or rodent) 3D co-culture 3D mono-culture 
2D co-culture 
(Taylor et al., 2007) Monolayer culture 
Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteoctyes 
 
 CaSR 
mRNA 
✓ 
 
(Chang et al., 
1999, Dvorak et 
al., 2004) 
 
✓ 
 
(Chang et al., 
1999, Dvorak 
et al., 2004) 
 
X 
 
X 
 NI NI NI NI 
 
✓ 
 
(Chattopadhyay 
et al., 2004, 
Yamaguchi et 
al., 1998a, 
Yamaguchi et 
al., 1998b, 
Yamaguchi et 
al., 2001) 
NI 
Protein 
✓ 
 
(Chang et al., 
1999, Dvorak et 
al., 2004) 
 
✓ 
 
(Chang et al., 
1999, Dvorak 
et al., 2004) 
 
✓ ✓ NI NI NI NI 
 
✓ 
 
(Chattopadhyay 
et al., 2004, 
Yamaguchi et 
al., 1998a, 
Yamaguchi et 
al., 1998b, 
Yamaguchi et 
al., 2001) 
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NI: not investigated; ↑:  increased; ↓: decreased; ✓: expressed; X: not expressed 
  
 
 
 In vivo 
(human or rodent) 3D co-culture 3D mono-culture 
2D co-culture 
(Taylor et al., 2007) Monolayer culture 
Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteoctyes 
 
 
AMPAR2 
mRNA NI NI X ✓ NI NI NI NI 
 
 
 
X 
 
(Hinoi et al., 
2002) 
 
NI 
Protein 
✓ 
 
(Bonnet, Mason, 
Williams 
unpublished 
data) 
✓ 
 
(Bonnet, 
Mason, 
Williams 
unpublished 
data) 
 
X 
 
 (Szczesniak 
et al., 2005) 
X X NI NI NI NI 
 
X 
 
(Szczesniak et 
al., 2005) 
NI 
KA1 
mRNA NI  NI 
X 
 
✓ 
 
NI 
 NI NI NI 
✓ 
 
(Hinoi et al., 
2002) 
 
NI 
Protein NI NI ✓ ✓ NI NI NI NI NI NI 
mGluR1 
mRNA NI NI X X NI NI NI NI 
 
✓ 
 
(Gu and 
Publicover, 
2000, Kalariti 
et al., 2004) 
 
NI 
Protein NI NI X X NI NI NI NI NI NI 
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 In vivo 
(human or rodent) 3D co-culture 3D mono-culture 
2D co-culture 
(Taylor et al., 2007) Monolayer culture 
Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteoctyes 
  
GLAST1 
mRNA 
✓ 
 
(Mason et al., 
1997) 
✓ 
 
(Mason et al., 
1997) 
✓ ✓ NI NI NI NI 
✓ 
 
(Huggett et 
al., 2002, 
Kalariti et al., 
2004, 
Takarada et 
al., 2004) 
✓ 
 
(Huggett et al., 
2002) 
 
Protein 
✓ 
 
(Mason et al., 
1997) 
✓ 
 
(Mason et al., 
1997) 
✓ ✓ NI NI NI NI 
✓ 
 
(Brakspear, 
2010) 
✓ 
 
(Huggett et al., 
2002) 
EAAC1 
mRNA 
 
NI 
 
NI X X NI NI NI NI 
✓ 
(Takarada et 
al., 2004) 
NI 
Protein 
✓ 
 
(Bonnet, 
Mason, 
Williams, 
unpublished 
data) 
NI X X NI NI NI NI 
✓ 
 
(Brakspear, 
2010) 
NI S
IG
N
A
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G
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O
M
PO
N
EN
TS
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 In vivo 
(rodent unless otherwise stated) 3D co-culture 3D mono-culture 
2D co-culture 
(Taylor et al., 2007) Monolayer culture 
Osteoblasts Osteocytes  Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteocytes 
 
PGE2 
Released/ 
Synthesised NI 
 
NI 
 
 
3D osteocyte 
mono-culture: 
 
↑ release 
NI NI NI NI 
 
↑ 
release 
 
( Smalt et al., 
1997, Nauman 
et al., 2001, 
Ponik and 
Pavalko, 2004, 
Genetos et al., 
2005) 
↑ 
release 
 
(Cheng et al., 
2001a, Jiang 
and Cheng, 
2001, Saini et 
al., 2011, Li et 
al., 2012) 
3D co-culture: 
 
No significant change 
NO Released/ Synthesised NI 
↑ 
release 
 
(Fox et al., 1996, 
Zaman et al., 
1999) 
3D osteocyte 
mono-culture: 
 
 NI NI NI NI NI 
 
↑ 
release 
 
(McAllister and 
Frangos, 1999, 
Mehrotra et al., 
2006) 
↑ 
release 
 
(Klein-Nulend et 
al., 1995b, Tan 
et al., 2007) 3D co-culture:  
 NI 
SOST mRNA/ Protein NI 
↑ expression 
 
 
(Robling et al., 
2008, Tu et al., 
2012) 
 
3D osteocyte 
 mono-culture: 
 
 NI NI NI NI NI 
 
↓ 
expression 
 
 
(Galea et al., 
2011, Galea et 
al., 2013) 
↑ 
expression 
 
(Wijenayaka et 
al., 2011) 3D co-culture:  
 NI 
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NI: not investigated; ↑:  increased; ↓: decreased; ✓: expressed; X: not expressed 
  
 
 
 In vivo 
(human or rodent) 3D co-culture 3D mono-culture 
2D co-culture 
(Taylor et al., 2007) Monolayer culture 
Osteoblasts Osteocytes  Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteocytes 
 
RANKL 
 mRNA 
↑ expression 
 
with unloading 
 
(Xiong et al., 2011) 
↑ expression 
 
(Nakashima et 
al., 2011, Xiong 
et al., 2011) 
 
3D osteocyte  
mono-culture: 
 
↓expression 
(48-72 hr pre-culture) 
 
No significant change 
(7 days pre-culture) 
 
NI 
 
NI 
 
NI NI 
↑ 
expression 
 
(Mehrotra et al., 
2006, Rucci et al., 
2007, Kreja et al., 
2008) 
↑ 
expression 
 
(You et al., 2008, 
Kulkarni et al., 
2010) 
3D co-culture:  
 
NI 
IL-6 Released/ Synthesised NI NI 
 
3D osteocyte  
mono-culture: 
 
↓ release 
 
NI 
 
NI 
 
NI NI 
↑ release 
 
(Sanchez et al., 
2009) 
NI 
 
3D co-culture: 
 
 NI 
A2A mRNA NI 
 
NI 
 
 
3D osteocyte  
mono-culture: 
 
No significant change 
(48-72 hr pre-culture) 
 
↑ expression 
(7 days pre-culture) 
 
NI 
 
NI 
 
NI NI NI 
 
NI 
 
 
3D co-culture: 
 
↑ expression 
(osteocytes only) 
 
A2B mRNA NI 
 
NI 
 
 
3D osteocyte  
mono-culture: 
 
No significant change 
(48-27 hr and 7 days pre-
culture) 
 
NI 
 
NI 
 
NI NI NI 
 
NI 
 
3D co-culture: 
 
 NI 
M
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N
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A
L 
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A
D
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 In vivo 
 (human or rodent) 3D co-culture 3D mono-culture 
2D co-culture 
(Taylor et al., 2007) Monolayer culture 
Osteoblasts Osteocytes  Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteocytes 
 
AMPAR2 mRNA NI 
 
NI 
 
 
3D osteocyte  
mono-culture: 
 
 X NI 
 
NI 
 
NI NI NI 
 
NI 
  3D co-culture:  
 
NI 
KA1 mRNA NI 
 
NI 
 
 
3D osteocyte  
mono-culture:  
 
X NI 
 
NI 
 
NI NI NI 
 
NI 
  3D co-culture:  
 
NI 
GLAST1 mRNA NI 
 
↓ expression 
 
(Mason et al., 
1997) 
 
3D osteocyte 
 mono-culture:  
 
X NI 
 
NI 
 
NI NI NI 
 
NI 
  3D co-culture:  
 
NI 
E11 mRNA NI NI 
 
3D osteocyte 
 mono-culture: 
 
↓expression 
(48-72 hr pre-culture) 
 
↑ expression 
(7 days pre-culture) 
 
 
NI 
 
NI NI NI NI 
↑ expression 
 
(Yang et al., 2004, 
Zhang et al., 2006) 
 
3D co-culture:  
 
NI 
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 In vivo 
 (human or rodent) 3D co-culture 3D mono-culture 
2D co-culture 
(Taylor et al., 2007) Monolayer culture 
Osteoblasts Osteocytes  Osteoblasts Osteocytes Osteoblasts Osteocytes Osteoblasts Osteocytes 
 
ALP mRNA 
↑ expression 
 
(Pavlin et al., 
2001) 
 
NI 
 
3D osteocyte  
mono-culture:  
 
NI  
NI 
 
NI NI NI 
↑ expression 
 
(Lu et al., 2012) 
 
NI 
3D co-culture: 
 
↑ expression 
(osteoblasts only) 
COL1A1 mRNA 
↑ expression 
 
(Pavlin et al., 
2001, Mantila 
Roosa et al., 
2011) 
NI 
 
3D osteocyte  
mono-culture:  
 
NI  NI 
 
NI NI NI 
↑ expression 
 
(Liu et al., 2005, 
Rath et al., 2008, 
Lu et al., 2012) 
 
NI  
3D co-culture: 
 
No significant change 
(osteoblasts only) 
Pro-
collagen 
I 
Released/ 
Synthesised 
↑ synthesis 
 
(Yang et al., 
2012) 
NI 
 
3D osteocyte  
mono-culture: 
 
 NI NI 
 
NI 
 
NI NI 
↑ synthesis 
 
(Yang et al., 2012) 
NI 
 
3D co-culture:  
 
↑release 
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7.1.1 Limitations of the 3D co-culture model 
 
7.1.1.1 Osteoblast morphology 
 
 Surface osteoblasts were shown to maintain their ovoid/pyriform morphology 
(Table 7.1) and form a confluent monolayer in an ‘overlapping roof tiles’ pattern 
when cultured in 3D co-cultures. However, this morphology could only be 
determined by staining the osteoblasts for actin filaments and using confocal 
microscopy. Observation of individual surface osteoblasts using inverse-light 
microscopy proved difficult due to the fact that MC3T3-E1 cells are not very thick 
(personal observation) and the fact that the 3D gel with embedded osteocytes can be 
seen underneath the osteoblast monolayer. MC3T3-E1 cells could be replaced by 
mouse primary osteoblasts, which may be easier to observe under the light-
microscope as they may be thicker cells.  
 
7.1.1.2 Phenotype 
 
 This thesis showed the expression of a selection of osteocyte phenotypic 
markers, but other markers were not assessed, namely PHEX, MEPE, DMP1 and 
FGF23. MLO-Y4 cells in monolayer have previously been shown to express mRNAs 
for PHEX, MEPE, DMP1 and FGF23 (Bonewald, 2010), and therefore these genes 
should be investigated in the 3D co-culture model in order to further characterise the 
osteocyte phenotype within the model. Moreover, as previously shown MLO-Y4 
cells do not express SOST within the 3D co-culture model, consistent with previous 
monolayer studies (Papanicolaou et al., 2009, Yang et al., 2009, Woo et al., 2011). 
The lack of SOST expression within the 3D co-culture model is not physiological as 
SOST is both mechanically regulated (Robling et al., 2008, Tu et al., 2012) and a key 
regulator of bone formation (Winkler et al., 2003, van Bezooijen et al., 2004, Poole 
et al., 2005, Lowik and van Bezooijen, 2006, van Bezooijen et al., 2007). This 
limitation could be solved by replacing the MLO-Y4 cells with mouse, primary 
osteocytes (Halleux et al., 2012, Nakashima et al., 2011, Stern et al., 2012). 
However, the yield of primary osteocytes after isolation tends to be low and they do 
not proliferate in culture, limiting the number of cells that can be used for 
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experiments. The IDG-SW3 cell line is likely to be the best option to replace the 
MLO-Y4 in the 3D model, as these cells have already been cultured within 3D type I 
collagen gels and are able to differentiate into mature osteocytes which express 
SOST and mineralise (Woo et al., 2011).  
 
7.1.1.3 Connectivity 
 
 Both embedded osteocytes and surface osteoblasts were shown to express 
CX43 (Chapter 3), and osteocytes were shown to contact neighbouring cells. 
However, the functionality of these connections was not shown. Such testing is 
usually carried out by a scrape-loading dye transfer assay. Briefly, using a needle, a 
monolayer of cells is scratched in the presence of two dyes, lucifer yellow which can 
penetrate through gap junction channels and rhodamine dextran which cannot and so 
serves as a tracer dye for the cells originally receiving the dye, the number of cells  
containing lucifer yellow away from the scratch line is then counted (el-Fouly et al., 
1987, Cheng et al., 2001b, Cherian et al., 2003, Xia et al., 2010). Attempts to 
perform this method in the 3D co-culture failed. Therefore a different method, such 
as fluorescence replacement after photobleaching (FRAP), which involves turning 
cells fluorescent using a cell permeable dye and then using a confocal microscope to 
photochemically bleach cells to a sufficient level so that fluorescence recovery can 
be observed without damaging the cell (Kamioka et al., 2007, Ishihara et al., 2008, 
Sugawara et al., 2011, Wang et al., 2013), should be tested to confirm functional 
connectivity between osteocytes and also between these cells and surface osteoblasts. 
 
7.1.1.4 Mineralisation 
 
Although the 3D model is designed to investigate mechanically-induced 
osteogenesis in a similar in vivo physiological environment, it is not mineralised and 
so it would only represent interactions that occur in newly formed osteoid rather than 
mineralised bone. Several previous studies have shown the mineralisation of 3D 
collagen gels is possible with IDG-SW3 cells (Woo et al., 2011) and MC3T3-E1 
cells (Scully et al., 2013a, Scully et al., 2013b) both during differentiation to 
osteocytes, and therefore the 3D co-culture could be mineralised. Mineralisation of 
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the 3D collagen gel would affect the properties of the matrix and cell-ECM 
interactions. For example, it is known from bone in vivo that it is the mineral 
component of bone matrix, which gives bone its load-bearing strength and ability to 
withstand compression (Currey, 1984, Landis, 1995). This change in the 
biomechanical properties of the ECM after mineralisation has also been shown in 
vitro, where the ECM of both 3D collagen gels and monolayer cultures became 
gradually stiffer (Meng et al., 2009, Scully et al., 2013a). Furthermore, ECM 
composition has been shown to affect gene expression (Bissell et al., 1982) and 
osteoblast differentiation, cell number and behaviour (Prideaux et al., 2012, Scully et 
al., 2013a).  Therefore, mineralising the 3D co-culture would make the collagen gels 
stiffer and alter phenotype, further mimicking a physiological environment. 
However, if mineralisation of the 3D co-culture was to be carried out, further 
investigations should be done to test the mechanical properties of the mineralised 3D 
co-cultures as well as the viability and phenotype of the cells within the model and 
assess whether the medium nutrients can still diffuse to all areas of the 3D gel.  
 
7.1.1.5 Experimental variability 
 
A further limitation is that, even though data trends seemed to be constant in 
independent experiments, significant cross-experiment variability was observed on 
several occasions. One explanation for this variability is the way the model is set-up. 
The mixing of the osteocytes within the collagen solution is a crucial stage of the 
model set-up as it must be done carefully in order to avoid bubbles, but thoroughly in 
order to ensure the osteocytes are evenly distributed within the solution. If this 
method is not performed accurately, some 3D cultures will have more or less 
osteocytes than others, therefore creating cell number variability between 
experimental replicates which could lead to, for example, differences in amounts of 
connections formed between embedded osteocytes and in turn lead to discrepancies 
in loading responses. Cell phenotype, behaviour and signalling could also be 
affected. The solution to this experimental variability is to increase the osteocyte cell 
number being embedded within the gels. This increase in cell number will decrease 
the chance of inaccurately mixing more cells in some gels than others, which in turn 
will reduce the chance of observing differences in phenotype, connectivity and 
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signalling between experimental replicates. However, an experiment should be 
conducted in order to assess the best osteocyte cell density for the 3D co-culture, as 
too many cells may lead to, for example, the contraction of the 3D gels. 
 
7.1.1.6 Loading device 
 
The loading plate also has some limitations. Although the device elicited the 
same trend in cell response to mechanical stimuli every time it was used, the extent 
of the response was different between independent experiments. This difference 
could be attributed to the variability between experiments due to cell number or also 
due to the fact that the strains across the wells of the silicone plate may not be equal 
during the same loading episode. An attempt was made to measure the strains in 3D 
cultures within the wells of the silicone plate by applying a speckle pattern on the 
surface of 3D collagen gels within the silicone plate. However, the speckles were too 
big for the surface area to be analysed by the DIC cameras and the 3D gels were also 
found to reflect the light of the cameras, interfering with the readings. Strain testing 
by applying the speckle pattern to the base of the silicone plate, but with 3D collagen 
gels within the plate, may be a better solution and would reveal the range of strains 
being applied and whether they are equal across all wells of the plate. The properties 
of the silicone used to make the loading plate should also be tested under the same 
mechanical loading conditions used. This testing would give information on whether 
the elasticity of the silicone is maintained throughout several uses of the same plate 
or not. Finally, the adaptor used to attach the silicone plate to the BOSE loading 
instrument was a prototype and therefore a finalised version must be manufactured. 
The use of a string to pull on the plate and mini-rollers which are not permanently 
attached to the adaptor could also cause variability in the applied strains and 
therefore the cell response produced. The string of the adaptor is the link between the 
silicone plate and the BOSE loading instrument but the properties of the string need 
to be measured in order to determine whether its elasticity deteriorates, and thus 
whether this affects the strains in the wells of the plate. The mini-rollers, which aid 
movement of the plate, must be a permanent part of the adaptor. At the moment, the 
rollers are carefully manually positioned avoiding the wells of the plate. However, 
manual positioning does not guarantee the rollers will be on the same place every 
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time or that the rollers will not move underneath a well, causing different strains 
across wells and thus causing variable results. 
 
7.1.1.7 Human 3D co-culture model 
 
Although a human 3D co-culture model would be more meaningful in the 
study of osteocyte-osteoblast interactions, particularly if screening for novel 
therapeutic targets, the development of such model poses many obstacles, such as the 
lack of a human osteocyte cell line and the difficulty in obtaining human primary 
osteocytes (section 1.4.2.3.2). However, having a 3D mouse co-culture model is an 
advantage as all findings obtained using the 3D mouse model can be related to in 
vivo mouse models, which in turn are generally used to model human disease.  
 
7.2 Application of the novel 3D co-culture model 
 
 This thesis used the 3D co-culture model to investigate the roles of 
AMPA/KA and A2A receptors on mechanically-induced bone formation by inhibiting 
these receptors with specific antagonists. Preliminary data showed that NBQX, an 
AMPA/KA antagonist, appeared to have an anabolic effect as it induced PINP 
synthesis in non-loaded 3D co-cultures (Figure 7.2A) to levels equal to those induced 
by loading, 5 days after treatment (Figure 7.1B). Whereas, the A2A antagonist SCH 
442416 had an additive effect on bone formation in loaded cultures (Figure 7.2B). In 
loaded cultures, at day 1, the A2A antagonist increased osteoblast ALP mRNA 
expression to levels which were double of those observed in untreated loaded 
cultures (Figure 7.1B). Moreover, at day 5, the antagonist further increased PINP 
release by 1.9-fold (Figure 7.2B), when compared to untreated control cultures.   
 
 Both NBQX and SCH 442416 seemed to evoke similar osteogenic responses 
on the 3D co-culture. Therefore, it could be hypothesised that both AMPA/KA and 
A2A receptors work in a similar manner in bone cells. As previously stated, A2A is a 
metabotropic receptor (Jacobson and Gao, 2006) whereas AMPA/KA receptors are 
ionotropic (Wisden and Seeburg, 1993, Hollmann and Heinemann, 1994) (pages 36 
and 40). However, AMPA/KA receptors have also been shown to act as 
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metabotropic receptors as they can instigate intracellular signalling cascades 
involving G-proteins (Rao and Finkbeiner, 2007, Rodriguez-Moreno and Sihra, 
2007, Sihra and Rodriguez-Moreno, 2011). The A2A receptor has been shown to 
work through the phosphoinositide-3-kinase–protein kinase B/Akt (PI3K-PKB/Akt) 
pathway; by activating MAPK; or the cAMP-protein kinase A-cAMP response 
element-binding protein (cAMP-PKA-CREB) pathway (Jacobson and Gao, 2006). 
Whereas, during their metabotropic function, KA receptors can work through the 
phospholipase C-protein kinase C (PLC-PKC) pathway as well as the adenylate 
cyclase-cAMP-protein kinase A (AC/cAMP/PKA) pathway and AMPA receptors 
can activate CREB and MAPK. Although NBQX blocks both AMPA and KA 
receptors, it has a higher affinity for AMPARs (Herrling, 1997). Therefore, it could 
be hypothesised that the similar osteogenic responses observed as a result of A2A and 
AMPAR inhibition could be due to both these receptors acting as metabotropic 
receptors through MAPK. Usually an ionotropic response deactivates within sub-
seconds, whereas metabotropic responses are long-lasting (Rodriguez-Moreno and 
Sihra, 2007). To confirm a metabotropic action of AMPAR on bone formation 
markers, the osteogenic response should be assessed whether it is sensitive to 
inhibitors of the putative metabotropic signalling pathways involved, in this case 
MAPK. 
 
Nevertheless, this experiment must be repeated in order to confirm the 
NBQX and SCH 442416 effects.  Unfortunately, it was not possible to assess the role 
of CaSR in mechanotransduction in this thesis, even though CaSR is expressed in the 
3D model. As adenosine, calcium-sensing and glutamate signalling pathways have 
been shown to be synergistic in the CNS (page 43) the effects on mechanically-
induced bone formation markers of these antagonists in combination should also be 
investigated. 
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RESTING 
 
LOADED 
 
(5 min, 10 Hz, 2.5 N) 
AMPAR/KA  inhibition 
 
(NBQX) 
↑ PINP (2-fold) 
A2A inhibition 
 
(SCH 442416) 
LOAD LOAD 
↑  PINP 
 (1.9-fold)  
↑ ↑ ALP mRNA 
(3.5-fold) 
A B 
Figure 7.2 A summary of the results using the 3D model to investigate the role of AMPA/KA and A2A receptors in mechanically-induced bone formation. A) 
In a resting state, at day 5 post-treatment, inhibition of AMPA/KA receptors induced a similar anabolic response to that obtained by mechanical loading 
(Figure 7.1B). B) Mechanical loading and A2A inhibition appeared to have additive effects on bone formation which led to a doubling of ALP mRNA 
expression at day 1 and a 1.9-fold increase in PINP release at day 5 when compared to untreated control cultures (Figure 7.1B). 
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7.2.1 Further applications of the 3D model 
 
7.2.1.1 Screening for novel therapeutic targets 
 
Currently there is a lack of effective therapies for common bone diseases and 
thus there is a great need to search for novel therapeutic targets (section 1.3.3). This 
thesis showed how the 3D co-culture can be effectively used to test compounds 
which could influence bone formation (Chapter 6). If the 3D model was to be scaled 
up it could be used for mass-scale pharmaceutical screening of new therapeutic 
targets for bone diseases. Anabolic therapies for diseases such as osteoporosis are 
particularly scarce. Thus the effect of adenosine and glutamate receptor antagonists 
on mechanically-induced bone formation markers within the 3D model has provided 
a stepping stone to not only for the delineation of the roles of these signalling 
pathways in mechanotransduction, but also as possible novel anabolic drug targets 
which could be used as therapies for not only bone diseases such as osteoporosis, but 
also for joint diseases such as OA and RA where osteoporosis treatments have 
already been proven to be useful treatments. 
 
7.2.1.2 Studying bone formation mechanisms  
 
The cell lines used in this 3D model could be replaced by primary cells from 
rodent genetically modified (GM) models which would, for example, be useful to 
model bone diseases in vitro or determine the effects of deletion of a signalling 
component of interest. Furthermore, the addition of other cell types to the 3D model 
could also be of great interest in revealing new mechanisms underlying bone 
remodelling. Osteocytes orchestrate bone remodelling by regulating the activity of 
both osteoblasts and osteoclasts (Klein-Nulend et al., 2013) (page 13 and 1.5), thus, 
if osteoclasts or BMSCs were to be added, making the 3D model a tri-culture, it 
could also be used for the investigation of bone remodelling, by essentially 
modelling the BMU (Frost, 1990b). Furthermore,  vascular endothelial cells and/or 
nerve cells could also be added to the 3D model as bone is a highly vascular and 
innervated tissue (section 1.1) and both cell types have been shown to produce 
factors that influence bone remodelling (Collin-Osdoby, 1994, Beckman, 2002, 
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Persson and Lerner, 2011, Clarkin and Gerstenfeld, 2013, Ma et al., 2013, Maes, 
2013). This would allow the in vitro 3D co-culture model to be adapted into a highly 
physiological representation of the in vivo bone environment enabling the accurate 
investigation of the role of each of the aforementioned cell types in the remodelling 
process. 
 
7.3 Concluding remarks 
 
This thesis has provided evidence to support the hypothesis that a 3D 
osteocyte-osteoblast co-culture model represents a useful in vitro model for the 
investigation of the osteocyte-osteoblast interactions that lead to mechanically-
induced bone formation. This thesis also provided evidence for the expression of 
adenosine, calcium-sensing and glutamate signalling components within the model, 
facilitating future investigations of their roles in mechanically-induced osteogenesis. 
Preliminary experiments indicated that adenosine and glutamate signalling may each 
contribute individually to the regulation of mechanically-induced bone formation 
markers. The model would be improved, in the first instance, by increasing the 
osteocyte cell density in order to reduce experiment variability and increase 
osteocyte connectivity, using osteocytes which express mature osteocyte markers, 
demonstrating the functionality of cell-cell connections, and optimising the ECM by, 
for example, mineralisation of the 3D collagen gel. 
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9. Appendix 
 
9.1 Serum batch test results (page 51) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.1 Effect of new batches of FCS and NCS on MC3T3-E1(14) and MLO-Y4 
cell number. A) MC3T3-E1(14) cell number significantly decreased 12.85 % on day 
3 when cultured with test FCS. B) MLO-Y4 cell number significantly increased 8.3 
% on day 3 when cultured with test FCS. C) MLO-Y4 cell number significantly 
increased 6 % on day 2 when cultured with test NCS. Significant differences were 
obtained by t-test and are denoted by *P<0.05, ***P<0.001. 
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9.2 Solutions 
 
1X TBE 
 10X TBE was obtained from Promega and diluted 1:10 in dH2O. 
 
LB agar 
LB agar tablets were dissolved in dH2O (50 ml/tablet) by autoclaving twice. 
The solution was cooled to rt before adding ampicillin (100 µg/ml), IPTG 
(0.5 mM) and X-gal (40 µg/ml). The agar was then poured into 10 cm agar 
petri dishes and allowed to solidify aseptically. Plates were stored at 4°C until 
needed. 
 
LB broth 
LB broth tablets were dissolved in dH2O (50 ml/tablet) by autoclaving once. 
The solution was cooled to rt before adding ampicillin (100 µg/ml) and stored 
at 4°C until needed. 
 
Phosphate Buffered Saline (PBS) 
1.42 g/L di-sodium orthophosphate anhydrous (Na2HPO4) 
0.32 g/L sodium phosphate monobasic anhydrous (NaH2PO4) 
8 g/L sodium chloride (NaCl)   
Dissolved in 1 L of distilled water (dH2O). Solution was sterilised by 
autoclaving for tissue culture use only. 
 
4 % PFA 
4 g of PFA powder was diluted in 100 ml of PBS with continuous stirring 
whilst heated up to 60°C forming a milky solution. At 60°C NaOH (1 M) was 
added until the milky solution became clear. The solution was then adjusted 
to pH 7.4, aliquoted and stored at -20°C until needed. For specimen fixation, 
PFA was diluted to 1 % using PBS. 
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9.3 Low molecular weight DNA ladder (page 55) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9.4 Example RT-qPCR cDNA standard curve (page 56) 
 
GAPDH (0.1 µM Primers, 3.5 mM MgCl2) 
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 9.5 pGEM®-T vector map and sequence reference points (page 61) 
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9.6 Examples of microplate assays standard curves 
 
Quant-iT™ dsDNA High-Sensitivity Assay Kit standard curve (page 54, 
fluorescence measured at 510/527 nm fluorescein wavelength) 
 
 
 
 
 
 
 
 
ELISAs 4 Parameter Logistic (4PL) standard curves (page 74) 
PGE2 (absorbance measured at 405 nm wavelength with correction between 570 and 
590 nm). 
 
 
 
 
 
 
 
IL-6 (absorbance measured at 450 nm wavelength with correction at 540 nm and 570 
nm). 
 
 
 
 
 
 
PINP (absorbance measured at 450 nm wavelength with correction at 650 nm). 
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9.7 Immunofluorescence controls for ColI staining (Figure 3.1) 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.2 Type I collagen immunofluorescence controls. IgG (A) and PBST (B) 
controls showed no labelling. Scale bars: 200 µm. 
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9.8 MC3T3-E1(14) cells cultured on an empty 3D collagen gel (page 113) 
 
Toluidine blue staining 
 
Rings were drawn around cryosections on poly-lysine coated slides using an 
ImmEdge pen. Sections were washed in tap water (5 min), stained in toluidine blue 
solution (5 min), washed in tap water (5 min) and dried before mounting with DPX 
mounting medium. Slides were left to dry o/n before imaging with a digital camera 
attached to a light microscope (page 48). 4-6 sections were observed for each 
replicate. 
 
 
 
 
 
 
 
 
 
 
Figure 9.3 Osteoblasts cultured on empty 3D type I collagen gels. A) Light 
microscope image of a day 7 transverse cryosection stained with toluidine blue to 
reveal MC3T3-E1(14) cell bodies and nuclei. Image shows no invasion of MC3T3-
E1(14) cells into the empty 3D collagen gel. B) Light microscope image of a day 7 
transverse cryosection stained with toluidine blue to reveal MG63 cell bodies and 
nuclei. Image shows extensive invasion of MG63 cells into the empty 3D collagen 
gel as previously shown by (Mason et al., 2009, Mason D., 2009). Images are 
representative of 2 independent experiments, n=3 per experiment. Scale bars: 100 
µm. 
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9.9 MLO-Y4 total cell number raw data (page 114) 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.4 Graph shows variation in total cell number counted for each replicate gel 
at day 1 and day 7 in all 3 independent experiments. 
 
 
 
9.10 mGluR5 (NM_001081414.2) RT-PCR (page 119)  
 
Primers (5'-3') 
Amplicon 
size (bp) 
PCR conditions qPCR conditions Source 
  [Primers] 
&  
[MgCl2] 
Cycle 
Nº 
Tm 
(ºC) 
[Primers] 
&  
[MgCl2] 
Tm 
(ºC) 
 
Fwd - CAATTGATGGACGGAAACT 
179 
0.2 µM 
Primers 
2.5 mM 
MgCl2 
40 60 NI NI 
Dr Cleo 
Bonnet 
Rev - CCATTGTCCCAACTTCCAAC 
 
Optimised conditions for brain cDNA (positive control) only; NI: not investigated. 
 
 
 
 
 
 
 
1 Day 
Replicate 
7 
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Figure 9.5 mGluR5 mRNA expression in 3D co-cultures after 7 days. Gel 
electrophoresis showing expression of mGluR5 (179 bp) by RT-PCR in mouse brain 
(positive control), but absence of expression in the surface and deep zones of the 
model. Negative control (blank) was clean. Gel is representative of 3 independent 
experiments, n=3 for both surface and deep zones. 
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9.11 PGE2 release raw data (Chapter 5) 
 
For all tables in this section: ABS- absorbance; W/O- without; NSB- non-
specific binding; STDEV- standard deviation; SEM- standard error or the mean. 
Outliers are highlighted in yellow. 
 
 
 
Pilot experiment (24 hr time pre-load time) 
 
 
 
 
 
TIME  
POST-LOAD 
(hr) 
ABS W/O BLANK pg/ml x64 AVERAGE STDEV SEM 
CONTROL 
0 
0.58 0.395 33.47 2142.13 
1862.02 396.14 280.11 
0.634 0.449 24.71 1581.90 
0.5 
0.688 0.503 18.26 1169.23 
1206.55 52.78 37.32 
0.677 0.492 19.43 1243.88 
1 
0.679 0.494 19.21 1229.98 
1258.22 39.93 28.23 
0.671 0.486 20.10 1286.46 
3 
0.572 0.387 35.02 2241.81 
2430.22 266.44 188.40 
0.545 0.36 40.91 2618.62 
6 
0.601 0.416 29.73 1902.72 
1691.07 299.31 211.64 
0.646 0.461 23.11 1479.43 
12 
0.438 0.253 79.75 5104.16 
3564.23 2177.78 1539.92 
0.59 0.405 31.62 2024.30 
24 
0.503 0.318 52.52 3361.34 
2788.88 809.57 572.45 
0.574 0.389 34.63 2216.42 
LOADED 
0 
0.657 0.472 21.73 1391.29 
2306.44 1294.21 915.14 
0.51 0.325 50.33 3221.58 
0.5 
0.406 0.221 100.10 6406.70 
4632.91 2508.51 1773.78 
0.53 0.345 44.67 2859.12 
1 
0.543 0.358 41.39 2649.29 
2458.41 269.94 190.88 
0.57 0.385 35.43 2267.53 
3 
0.726 0.541 14.71 941.57 
3558.54 3700.95 2616.96 
0.411 0.226 96.49 6175.51 
6 
0.461 0.276 68.40 4378.18 
3799.88 817.83 578.29 
0.51 0.325 50.33 3221.58 
12 
0.531 0.346 44.41 2842.31 
4696.73 2622.54 1854.42 
0.403 0.218 102.36 6551.15 
24 
0.406 0.221 100.10 6406.70 
4118.05 3236.62 2288.64 
0.608 0.423 28.58 1829.41 
BLANKS ABS NSB ABS W/O BLANK 
1 0.19 1 0.187 0.002 
2 0.18 2 0.181 -0.004 
AVERAGE 0.185 AVERAGE  -0.001 
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24 hr time pre-load time experiments 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
TIME 
POST-
LOAD 
(hr) 
ABS W/O BLANK 
W/O 
NSB pg/ml x64 
NORMALISED 
TO CELL 
NUMBER 
AVERAGE 
0.5 hr 
CONTROL 
W/O 
AVERAGE 
0.5 hr 
CONTROL 
AVERAGE STDEV SEM 
CONTROL 0.5 
0.581 0.353 0.34 10.35 662.51 1417.64 
1311.30 
106.34 
-7.572E-14 320.31 184.93 0.617 0.389 0.376 6.87 439.83 951.34 -359.95 
0.571 0.343 0.33 11.47 734.46 1564.91 253.61 
LOADED 0.5 
0.601 0.373 0.36 8.31 532.30 1103.59 -207.70 
-231.53 110.88 64.01 0.601 0.373 0.36 8.31 532.30 1176.79 -134.50 
0.619 0.391 0.378 6.70 428.94 958.89 -352.40 
 
TIME 
POST-
LOAD 
(hr) 
ABS W/O BLANK 
W/O 
NSB pg/ml x64 
NORMALISED 
TO CELL 
NUMBER 
AVERAGE 
0.5 hr 
CONTROL 
W/O 
AVERAGE 
0.5 hr 
CONTROL 
AVERAGE STDEV SEM 
CONTROL 0.5 
0.538 0.31 0.297 15.78 1010.51 2505.40 
3136.84 
-631.44 
0 1605.71 927.05 0.557 0.329 0.316 13.18 843.83 1942.83 -1194 
0.497 0.269 0.256 22.82 1460.56 4962.29 1825.44 
LOADED 0.5 
0.574 0.346 0.333 11.13 712.36 2016.13 -1120.71 
-261.41 832.67 480.74 0.532 0.304 0.291 16.68 1068.04 2931.50 -205.33 
0.501 0.273 0.26 22.03 1410.14 3678.64 541.80 
BLANKS ABS NSB ABS W/O BLANK 
1 0.224 1 0.234 0.006 
2 0.232 2 0.248 0.02 
AVERAGE 0.228 AVERAGE  0.013 
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48 hr time pre-load time experiment 
 
 
 
 
 
 
 
72 hr time pre-load time experiment 
 
 
 
 
 
 
 
 
 
 
 
TIME 
POST-
LOAD 
(hr) 
ABS W/O BLANK 
W/O 
NSB pg/ml x16 
NORMALISED 
TO CELL 
NUMBER 
AVERAGE 
0.5 hr 
CONTROL 
W/O 
AVERAGE 
0.5 hr 
CONTROL 
AVERAGE STDEV SEM 
CONTROL 0.5 
0.332 0.157 0.139 195.66 3130.65 38970.94 
36086.32 
2884.61 
-1.21E-12 5383.80 3108.34 0.352 0.177 0.159 157.46 2519.43 29874.88 -6211.44 
0.364 0.189 0.171 138.76 2220.26 39413.14 3326.82 
LOADED 0.5 
0.354 0.179 0.161 154.15 2466.43 49002.38 12916.05 
36120.75 23135.11 13357.06 0.295 0.12 0.102 299.93 4798.98 72346.90 36260.58 
0.279 0.104 0.086 365.20 5843.31 95271.96 59185.63 
 
TIME 
POST-
LOAD 
(hr) 
ABS W/O BLANK 
W/O 
NSB pg/ml x16 
NORMALISED 
TO CELL 
NUMBER 
AVERAGE 
0.5 hr 
CONTROL 
W/O 
AVERAGE 
0.5 hr 
CONTROL 
AVERAGE STDEV SEM 
CONTROL 0.5 
0.374 0.199 0.181 125.14 2002.34 16502.86 
20676.18 
-4173.31 
0 8073.61 4661.30 0.384 0.209 0.191 113.05 1808.92 29982.31 9306.13 
0.458 0.283 0.265 55.69 891.14 15543.36 -5132.82 
LOADED 0.5 
0.379 0.204 0.186 118.92 1902.78 37067.39 16391.21 
15896.88 4090.89 2361.87 0.389 0.214 0.196 107.52 1720.38 32257.46 11581.27 
0.385 0.21 0.192 111.92 1790.80 40394.32 19718.14 
BLANKS ABS NSB ABS W/O BLANK 
1 0.171 1 0.19 0.015 
2 0.179 2 0.196 0.021 
AVERAGE 0.175 AVERAGE  0.018 
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7 days time pre-load time experiment 
 
TIME 
POST-
LOAD 
(hr) 
ABS W/O BLANK 
W/O 
NSB pg/ml x40 
NORMALISED 
TO CELL 
NUMBER 
AVERAGE 
 STDEV SEM 
AVERAGE 
W/O 
OUTLIER 
STDEV SEM 
CONTROL 0.5 
0.303 0.119 0.107 22.38 895.32 1305.13 
3613.08 4188.97 2418.50 1195.40 155.18 109.72 0.317 0.133 0.121 17.12 685.06 1085.67 
0.236 0.052 0.040 139.39 5575.96 8448.43 
LOADED 0.5 
0.28 0.096 0.084 37.05 1482.04 2322.95 
3152.26 753.79 435.20 3152.26 753.79 435.20 0.26 0.076 0.064 62.72 2509.02 3795.79 
0.264 0.080 0.068 55.99 2239.82 3338.04 
 
BLANKS ABS NSB ABS W/O BLANK 
1 0.186 1 0.2 0.016 
2 0.181 2 0.191 0.007 
AVERAGE 0.183 AVERAGE  0.012 
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9.12 IL-6 release raw data (Chapter 5) 
 
For all tables in this section: ABS- absorbance; W/O- without; STDEV- 
standard deviation; SEM- standard error or the mean. 
 
Pilot experiment (24 hr time pre-load time) 
 
 
 
 
TIME 
POST-LOAD 
(hr) 
ABS W/O BLANK pg/ml AVERAGE STDEV SEM 
CONTROL 
0 
2.455 2.333 531.85 
522.33 13.46 9.52 
2.414 2.292 512.81 
0.5 
1.646 1.5245 259.80 
356.19 136.31 96.39 
2.272 2.1505 452.58 
1 
2.185 2.0635 419.48 
368.46 72.15 51.01 
1.867 1.7455 317.44 
3 
1.13 1.0085 152.92 
249.99 137.27 97.06 
1.968 1.8465 347.06 
6 
2.277 2.1555 454.56 
368 122.42 86.56 
1.733 1.6115 281.43 
12 
1.764 1.6425 289.45 
260.02 41.62 29.43 
1.52 1.3985 230.59 
24 
1.834 1.7125 308.25 
338.95 43.42 30.70 
2.04 1.9185 369.66 
LOADED 
0 
1.389 1.2675 202.57 
173.50 41.10 29.06 
1.082 0.9605 144.44 
0.5 
1.701 1.5795 273.32 
235.49 53.49 37.82 
1.365 1.2435 197.66 
1 
1.075 0.9535 143.21 
133.46 13.79 9.75 
0.96 0.8385 123.71 
3 
1.101 0.9795 147.77 
114.76 46.68 33.01 
0.692 0.5705 81.75 
6 
1.012 0.8905 132.40 
130.89 2.14 1.51 
0.994 0.8725 129.37 
12 
1.067 0.9455 141.82 
138.22 5.10 3.60 
1.025 0.9035 134.61 
24 
1.257 1.1355 176.40 
145.57 43.60 30.83 
0.905 0.7835 114.73 
BLANKS ABS 
1 0.116 
2 0.127 
AVERAGE 0.121 
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24 hr time pre-load time experiments 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TIME 
POST-
LOAD 
(hr) 
ABS W/O BLANK pg/ml 
NORMALISED 
TO CELL 
NUMBER 
AVERAGE 
0 hr 
CONTROL 
W/O AVERAGE 
0 hr  
CONTROL 
AVERAGE STDEV SEM 
 
0 
1.977 1.855 349.82 185.94 
188.05 
-2.11 
0 3.68 2.12 
CONTROL 
1.984 1.862 351.97 185.90 -2.14 
2.07 1.948 379.47 192.30 4.25 
0.5 
2.533 2.411 570.43 305.154 117.10 
107.32 
  
  
9.53 
  
  
5.50 
  
  
2.483 2.361 545.33 294.88 106.83 
2.466 2.344 537.10 286.10 98.05 
6 
2.571 2.449 590.45 287.55 99.50 
173.08 
  
  
80.31 
  
  
46.36 
  
  
2.695 2.573 662.21 349.02 160.97 
2.871 2.749 785.18 446.80 258.75 
24 
2.737 2.615 689.05 385.09 197.04 
279.45 
  
  
79.99 
  
  
46.18 
  
  
3.146 3.024 1053.37 544.85 356.80 
2.821 2.699 747.28 472.56 284.51 
LOADED 
 
 
0.5 
2.426 2.304 518.30 268.64 80.59 
101.12 
  
  
17.79 
  
  
10.27 
  
  
2.478 2.356 542.89 300.05 112.01 
2.461 2.339 534.71 298.83 110.78 
6 
2.668 2.546 645.67 349.13 161.08 
212.68 
  
  
53.68 
  
  
30.99 
  
  
2.838 2.716 759.88 456.29 268.24 
2.735 2.613 687.74 396.77 208.72 
24 
3.286 3.164 1248.10 740.56 552.51 
424.45 
  
  
181.87 
  
  
105.01 
  
  
3.268 3.146 1219.94 692.62 504.57 
2.965 2.843 864.19 404.33 216.28 
BLANKS ABS 
1 0.116 
2 0.127 
AVERAGE 0.121 
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TIME 
POST-
LOAD 
(hr) 
ABS W/O BLANK pg/ml 
NORMALISED 
TO CELL 
NUMBER 
AVERAGE 
0 hr 
CONTROL 
W/O AVERAGE 
0 hr  
CONTROL 
AVERAGE STDEV SEM 
 
0 
2.066 1.944 378.15 199.23 
218.38 
 
 
-19.14 1.89E-14 
 
 
22.37 
 
 
12.91 
 
 
CONTROL 
 
2.01 1.888 360.08 242.97 24.58 
1.982 1.860 351.35 212.94 -5.44 
0.5 
2.331 2.209 476.60 294.56 76.17 
161.01 
 
 
193.20 
 
 
111.54 
 
 
2.196 2.074 423.52 243.12 24.74 
2.768 2.646 709.80 600.51 382.12 
6 
2.707 2.585 669.73 404.92 186.53 
255.13 
 
 
95.74 
 
 
55.28 
 
 
2.821 2.699 747.28 582.90 364.52 
2.714 2.592 674.18 432.72 214.33 
24 
2.996 2.874 892.77 495.43 277.05 
247.56 
 
 
140.18 
 
 
80.93 
 
 
3.252 3.130 1195.77 589.04 370.66 
2.913 2.791 819.15 313.37 94.98 
LOADED 
 
 
0.5 
2.018 1.896 362.61 255.72 37.33 
113.80 
 
 
73.37 
 
 
42.36 
 
 
2.566 2.444 587.76 402.03 183.64 
2.432 2.310 521.07 338.80 120.41 
6 
2.839 2.717 760.63 474.80 256.41 
292.34 
 
 
58.04 
 
 
33.50 
 
 
2.984 2.862 881.54 577.68 359.30 
2.879 2.757 791.50 479.69 261.31 
24 
2.841 2.719 762.13 390.03 171.65 
174.68 
 
 
18.79 
 
 
10.85 
 
 
2.74 2.618 691.02 375.96 157.58 
2.741 2.619 691.68 413.19 194.80 
BLANKS ABS 
1 0.116 
2 0.127 
AVERAGE 0.121 
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48 hr time pre-load time experiment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BLANKS ABS 
1 0.117 
2 0.118 
AVERAGE 0.1175 
 
TIME 
POST-
LOAD 
(hr) 
ABS W/O BLANK pg/ml x10 
NORMALISED 
TO CELL 
NUMBER 
AVERAGE 
0 hr 
CONTROL 
W/O 
AVERAGE 
0 hr 
CONTROL 
AVERAGE STDEV SEM 
 
0 
0.44 0.322 60.42 604.22 10725.92 
7980.21 
 
 
2745.71 0 
 
 
3111.01 1796.14 
CONTROL 
 
 
0.4 0.282 53.69 536.90 8613.41 633.20 
0.27 0.152 30.52 305.21 4601.30 -3378.91 
0.5 
0.712 0.594 104.89 1048.91 13057.09 5076.88 
3989.93 
 
3732.66 
 2155.05 0.473 0.355 65.90 659.03 7814.65 -165.55 
0.588 0.470 84.71 847.17 15038.69 7058.47 
6 
0.651 0.533 94.95 949.56 21913.11 13932.89 
7935.85 5387.06  3110.22 0.67 0.552 98.04 980.46 14348.32 6368.11 
0.691 0.573 101.46 1014.66 11486.77 3506.55 
24 
0.747 0.629 110.61 1106.17 14304.08 6323.87 
12351.79 6916.40 3993.18 1.252 1.134 198.89 1988.97 27883.01 19902.79 
0.707 0.589 104.07 1040.75 18808.92 10828.70 
LOADED 
 
 
0.5 
0.58 0.462 83.41 834.16 16572.91 8592.69 
6524.94 2595.09 1498.27 0.54 0.422 76.90 769 11593.03 3612.81 
0.646 0.528 94.14 941.43 15349.53 7369.31 
6 
0.59 0.472 85.04 850.42 13219.13 5238.91 
7036.80 1557.03 898.952 0.648 0.530 94.46 944.68 15921.72 7941.51 
0.628 0.510 91.21 912.18 15910.21 7929.99 
24 
0.673 0.555 98.53 985.34 16607.06 8626.84 
6506.74 3229.09 1864.31 0.644 0.526 93.81 938.18 16083.20 8102.99 
0.566 0.448 81.13 811.38 10770.60 2790.38 
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72 hr time pre-load time experiment 
 
BLANKS ABS 
1 0.117 
2 0.118 
AVERAGE 0.1175 
 
TIME 
POST-
LOAD 
(hr) 
ABS W/O BLANK pg/ml x10 
NORMALISED 
TO CELL 
NUMBER 
AVERAGE 
0 hr 
CONTROL 
W/O 
AVERAGE 
0 hr 
CONTROL 
AVERAGE STDEV SEM 
 
0 
0.358 0.240 46.47 464.73 7223.96 
7902.09 
 
-678.13 
-6.06E-13 889.58 513.60 
CONTROL 
 
 
0.364 0.246 47.51 475.16 8909.34 1007.25 
0.332 0.214 41.90 419.03 7572.97 -329.12 
0.5 
0.604 0.486 87.31 873.18 7196.57 -705.52 
2080.43 2429.49 1402.66 0.5 0.382 70.35 703.51 11660.58 3758.48 
0.459 0.341 63.58 635.84 11090.43 3188.33 
6 
0.583 0.465 83.90 839.04 13906.87 6004.78 
8898.65 6668.14 3849.85 0.938 0.820 142.48 1424.89 24426.94 16524.84 
0.515 0.397 72.81 728.12 12068.41 4166.32 
24 
0.47 0.352 65.40 654.07 8799.22 897.12 
7192.60 5867.99 3387.88 0.693 0.575 101.79 1017.92 16072.52 8170.42 
0.786 0.668 117.03 1170.30 20412.36 12510.26 
LOADED 
 
 
0.5 
0.43 0.312 58.74 587.49 11444.79 3542.70 
5532.48 1932.90 1115.96 0.569 0.451 81.62 816.26 15305.08 7402.98 
0.438 0.320 60.08 600.88 13553.85 5651.75 
6 
0.498 0.380 70.02 700.23 9173.38 1271.28 
1425.86 452.01 260.97 0.674 0.556 98.69 986.97 9836.98 1934.88 
0.549 0.431 78.36 783.68 8973.50 1071.41 
24 
1.095 0.977 169.90 1699.07 15261.16 7359.06 
3672.36 4470.89 2581.27 0.866 0.748 130.32 1303.22 12860.82 4958.72 
0.483 0.365 67.55 675.54 6601.40 -1300.68 
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9.13 Cell death raw data (Chapter 5) 
 
For all tables in this section: ABS- absorbance; W/O- without. 
 
Pilot experiment (24 hr time pre-load time) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 TIME POST-LOAD (hr) ABS W/O BLANK 
CONTROL 
0 
0.19 -0.020 
0.184 -0.026 
0.5 
0.203 -0.007 
0.196 -0.014 
1 
0.182 -0.028 
0.186 -0.024 
3 
0.201 -0.009 
0.194 -0.016 
6 
0.187 -0.023 
0.181 -0.029 
12 
0.203 -0.007 
0.198 -0.012 
24 
0.19 -0.020 
0.193 -0.017 
LOADED 
0 
0.193 -0.017 
0.196 -0.014 
0.5 
0.192 -0.018 
0.197 -0.013 
1 
0.193 -0.017 
0.2 -0.010 
3 
0.194 -0.016 
0.202 -0.008 
6 
0.196 -0.014 
0.195 -0.015 
12 
0.199 -0.011 
0.199 -0.011 
24 
0.193 -0.017 
0.199 -0.011 
BLANKS ABS 
1 0.207 
2 0.209 
3 0.216 
AVERAGE 0.210 
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24 hr time pre-load time experiments 
 TIME POST-LOAD (hr) ABS W/O BLANK 
CONTROL 
0 
0.201 -0.009 
0.215 0.004 
0.213 0.002 
0.5 
0.222 0.011 
0.21 -0.001 
0.205 -0.005 
6 
0.198 -0.012 
0.206 -0.004 
0.208 -0.002 
24 
0.222 0.011 
0.192 -0.018 
0.194 -0.016 
LOADED 
 
0.5 
0.209 -0.001 
0.214 0.003 
0.198 -0.012 
6 
0.21 -0.001 
0.213 0.002 
0.211 0.001 
24 
0.208 -0.002 
0.208 -0.002 
0.206 -0.004 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BLANKS ABS 
1 0.207 
2 0.209 
3 0.216 
AVERAGE 0.210 
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 TIME POST-LOAD (hr) ABS W/O BLANK 
CONTROL 
0 
0.2 -0.010 
0.202 -0.008 
0.202 -0.008 
0.5 
0.205 -0.005 
0.211 0.001 
0.209 -0.001 
6 
0.191 -0.019 
0.196 -0.014 
0.205 -0.005 
24 
0.212 0.001 
0.201 -0.009 
0.204 -0.006 
LOADED 
 
0.5 
0.208 -0.002 
0.214 0.003 
0.192 -0.018 
6 
0.202 -0.008 
0.201 -0.009 
0.204 -0.006 
24 
0.212 0.001 
0.215 0.004 
0.224 0.013 
BLANKS ABS 
1 0.207 
2 0.209 
3 0.216 
AVERAGE 0.210 
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48 hr time pre-load time experiment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 TIME POST-LOAD (hr) ABS W/O BLANK 
CONTROL 
0 
0.196 -0.036 
0.194 -0.038 
0.197 -0.035 
0.5 
0.198 -0.034 
0.200 -0.032 
0.194 -0.038 
6 
0.187 -0.045 
0.192 -0.04 
0.198 -0.034 
24 
0.199 -0.033 
0.193 -0.039 
0.192 -0.04 
LOADED 
 
0.5 
0.201 -0.031 
0.205 -0.027 
0.191 -0.041 
6 
0.200 -0.032 
0.198 -0.034 
0.192 -0.04 
24 
0.198 -0.034 
0.195 -0.037 
0.210 -0.022 
BLANKS ABS 
1 0.230 
2 0.232 
3 0.234 
AVERAGE 0.232 
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72 hr time pre-load time experiment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 TIME POST-LOAD (hr) ABS W/O BLANK 
CONTROL 
0 
0.195 -0.037 
0.192 -0.04 
0.204 -0.028 
0.5 
0.199 -0.033 
0.194 -0.038 
0.195 -0.037 
6 
0.189 -0.043 
0.190 -0.042 
0.200 -0.032 
24 
0.198 -0.034 
0.186 -0.046 
0.192 -0.04 
LOADED 
 
0.5 
0.206 -0.026 
0.197 -0.035 
0.192 -0.04 
6 
0.199 -0.033 
0.197 -0.035 
0.201 -0.031 
24 
0.192 -0.04 
0.199 -0.033 
0.203 -0.029 
BLANKS ABS 
1 0.230 
2 0.232 
3 0.234 
AVERAGE 0.232 
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7 days time pre-load time experiment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 TIME POST-LOAD (hr) ABS W/O BLANK 
CONTROL 
0 
0.237 -0.001 
0.227 -0.010 
0.251 0.013 
0.5 
0.21 -0.027 
0.214 -0.023 
0.203 -0.034 
LOADED  0.5 
0.226 -0.011 
0.223 -0.014 
0.209 -0.028 
BLANKS ABS 
1 0.231 
2 0.229 
3 0.253 
AVERAGE 0.237 
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9.14 Cell death and PGE2 raw data (Chapter 6) 
 
For all tables in this section: ABS- absorbance; W/O- without. 
 
Cell death 
 
TIME 
POST-
LOAD  
TREATMENT ABS W/O BLANK 
DAY 1 
CONTROL 
NBQX 
0.217 -0.019333 
0.24 0.003667 
0.232 -0.004333 
LOADED 
0.334 0.097667 
0.269 0.032667 
0.25 0.013667 
CONTROL 
SCH 442416 
0.241 0.004667 
0.254 0.017667 
0.227 -0.009333 
LOADED 
0.27 0.033667 
0.33 0.093667 
0.298 0.061667 
CONTROL 
UNTREATED 
0.233 -0.003333 
0.23 -0.006333 
LOADED 
0.225 -0.011333 
0.332 0.095667 
DAY 5 
CONTROL 
NBQX 
0.246 0.009667 
0.222 -0.014333 
LOADED 
0.223 -0.013333 
0.235 -0.001333 
CONTROL 
SCH 442416 
 
0.241 0.004667 
0.232 -0.004333 
0.229 -0.007333 
LOADED 
0.276 0.039667 
0.229 -0.007333 
0.222 -0.014333 
CONTROL 
UNTREATED 
0.244 0.007667 
0.242 0.005667 
LOADED 
0.231 -0.005333 
0.259 0.022667 
 
 
 
 
BLANKS ABS 
1 0.231 
2 0.237 
3 0.241 
AVERAGE 0.236333 
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PGE2 (0.5 hr post-load) 
 
 ABS 
W/O 
BLANK pg/ml 
NORMALISED 
TO ng DNA AVERAGE STDEV SEM 
CONTROL 
0.3 0.107 38.60 0.040 0.030 0.008 0.004 
0.331 0.138 17.12 0.025    
0.331 0.138 17.12 0.027    
LOADED 
0.325 0.132 20.14 0.033 0.023 0.011 0.006 
0.334 0.141 15.75 0.023    
0.318 0.125 24.25 0.011    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BLANKS ABS NSB ABS W/O BLANK 
1 0.194 1 0.195 0.002 
2 0.192 2 0.188 -0.005 
AVERAGE 0.193 AVERAGE  -0.0015 
lo
g 1
0 
O
D
 (4
05
 n
m
) 
log10 PGE2 (pg/ml) 
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